id	sid	tid	token	lemma	pos
ajlm-283	1	1	abstract	abstract	ADJ
ajlm-283	1	2	introduction	introduction	NOUN
ajlm-283	1	3	research	research	NOUN
ajlm-283	1	4	method	method	NOUN
ajlm-283	1	5	and	and	CCONJ
ajlm-283	1	6	design	design	NOUN
ajlm-283	1	7	results	result	NOUN
ajlm-283	1	8	discussion	discussion	NOUN
ajlm-283	1	9	acknowledgements	acknowledgement	NOUN
ajlm-283	1	10	references	reference	NOUN
ajlm-283	1	11	about	about	ADP
ajlm-283	1	12	the	the	DET
ajlm-283	1	13	author(s	author(s	NOUN
ajlm-283	1	14	)	)	PUNCT
ajlm-283	1	15	nokukhanya	nokukhanya	PROPN
ajlm-283	1	16	mdlalose	mdlalose	X
ajlm-283	1	17	department	department	PROPN
ajlm-283	1	18	of	of	ADP
ajlm-283	1	19	virology	virology	NOUN
ajlm-283	1	20	,	,	PUNCT
ajlm-283	1	21	national	national	PROPN
ajlm-283	1	22	health	health	PROPN
ajlm-283	1	23	laboratory	laboratory	PROPN
ajlm-283	1	24	service	service	PROPN
ajlm-283	1	25	,	,	PUNCT
ajlm-283	1	26	university	university	NOUN
ajlm-283	1	27	of	of	ADP
ajlm-283	1	28	kwazulu	kwazulu	PROPN
ajlm-283	1	29	-	-	PUNCT
ajlm-283	1	30	natal	natal	ADJ
ajlm-283	1	31	,	,	PUNCT
ajlm-283	1	32	south	south	PROPN
ajlm-283	1	33	africa	africa	PROPN
ajlm-283	1	34	raveen	raveen	ADJ
ajlm-283	1	35	parboosing	parboose	VERB
ajlm-283	1	36	department	department	NOUN
ajlm-283	1	37	of	of	ADP
ajlm-283	1	38	virology	virology	NOUN
ajlm-283	1	39	,	,	PUNCT
ajlm-283	1	40	national	national	PROPN
ajlm-283	1	41	health	health	PROPN
ajlm-283	1	42	laboratory	laboratory	PROPN
ajlm-283	1	43	service	service	PROPN
ajlm-283	1	44	,	,	PUNCT
ajlm-283	1	45	university	university	NOUN
ajlm-283	1	46	of	of	ADP
ajlm-283	1	47	kwazulu	kwazulu	PROPN
ajlm-283	1	48	-	-	PUNCT
ajlm-283	1	49	natal	natal	ADJ
ajlm-283	1	50	,	,	PUNCT
ajlm-283	1	51	south	south	PROPN
ajlm-283	1	52	africa	africa	PROPN
ajlm-283	1	53	pravi	pravi	PROPN
ajlm-283	1	54	moodley	moodley	PROPN
ajlm-283	1	55	department	department	PROPN
ajlm-283	1	56	of	of	ADP
ajlm-283	1	57	virology	virology	NOUN
ajlm-283	1	58	,	,	PUNCT
ajlm-283	1	59	national	national	PROPN
ajlm-283	1	60	health	health	PROPN
ajlm-283	1	61	laboratory	laboratory	PROPN
ajlm-283	1	62	service	service	PROPN
ajlm-283	1	63	,	,	PUNCT
ajlm-283	1	64	university	university	NOUN
ajlm-283	1	65	of	of	ADP
ajlm-283	1	66	kwazulu	kwazulu	PROPN
ajlm-283	1	67	-	-	PUNCT
ajlm-283	1	68	natal	natal	ADJ
ajlm-283	1	69	,	,	PUNCT
ajlm-283	1	70	south	south	PROPN
ajlm-283	1	71	africa	africa	PROPN
ajlm-283	1	72	citation	citation	PROPN
ajlm-283	1	73	mdlalose	mdlalose	VERB
ajlm-283	1	74	n	n	CCONJ
ajlm-283	1	75	,	,	PUNCT
ajlm-283	1	76	parboosing	parboose	VERB
ajlm-283	1	77	r	r	NOUN
ajlm-283	1	78	,	,	PUNCT
ajlm-283	1	79	moodley	moodley	NOUN
ajlm-283	1	80	p.	p.	NOUN
ajlm-283	1	81	the	the	DET
ajlm-283	1	82	prevalence	prevalence	NOUN
ajlm-283	1	83	of	of	ADP
ajlm-283	1	84	hepatitis	hepatitis	PROPN
ajlm-283	1	85	b	b	PROPN
ajlm-283	1	86	virus	virus	NOUN
ajlm-283	1	87	infection	infection	NOUN
ajlm-283	1	88	in	in	ADP
ajlm-283	1	89	hiv	hiv	PROPN
ajlm-283	1	90	-	-	PUNCT
ajlm-283	1	91	positive	positive	ADJ
ajlm-283	1	92	and	and	CCONJ
ajlm-283	1	93	hiv	hiv	NOUN
ajlm-283	1	94	-	-	PUNCT
ajlm-283	1	95	negative	negative	ADJ
ajlm-283	1	96	infants	infant	NOUN
ajlm-283	1	97	:	:	PUNCT
ajlm-283	1	98	kwazulu	kwazulu	VERB
ajlm-283	1	99	-	-	PUNCT
ajlm-283	1	100	natal	natal	ADJ
ajlm-283	1	101	,	,	PUNCT
ajlm-283	1	102	south	south	PROPN
ajlm-283	1	103	africa	africa	PROPN
ajlm-283	1	104	.	.	PUNCT
ajlm-283	2	1	afr	afr	PROPN
ajlm-283	2	2	j	j	PROPN
ajlm-283	2	3	lab	lab	PROPN
ajlm-283	2	4	med	med	PROPN
ajlm-283	2	5	.	.	PROPN
ajlm-283	2	6	2016;5(1	2016;5(1	NUM
ajlm-283	2	7	)	)	PUNCT
ajlm-283	2	8	,	,	PUNCT
ajlm-283	2	9	a283	a283	PROPN
ajlm-283	2	10	.	.	PUNCT
ajlm-283	3	1	http://dx.doi.org/10.4102/ajlm.v5i1.283	http://dx.doi.org/10.4102/ajlm.v5i1.283	PROPN
ajlm-283	3	2	original	original	ADJ
ajlm-283	3	3	research	research	NOUN
ajlm-283	3	4	the	the	DET
ajlm-283	3	5	prevalence	prevalence	NOUN
ajlm-283	3	6	of	of	ADP
ajlm-283	3	7	hepatitis	hepatitis	PROPN
ajlm-283	3	8	b	b	PROPN
ajlm-283	3	9	virus	virus	NOUN
ajlm-283	3	10	infection	infection	NOUN
ajlm-283	3	11	in	in	ADP
ajlm-283	3	12	hiv	hiv	PROPN
ajlm-283	3	13	-	-	PUNCT
ajlm-283	3	14	positive	positive	ADJ
ajlm-283	3	15	and	and	CCONJ
ajlm-283	3	16	hiv	hiv	NOUN
ajlm-283	3	17	-	-	PUNCT
ajlm-283	3	18	negative	negative	ADJ
ajlm-283	3	19	infants	infant	NOUN
ajlm-283	3	20	:	:	PUNCT
ajlm-283	3	21	kwazulu	kwazulu	VERB
ajlm-283	3	22	-	-	PUNCT
ajlm-283	3	23	natal	natal	ADJ
ajlm-283	3	24	,	,	PUNCT
ajlm-283	3	25	south	south	PROPN
ajlm-283	3	26	africa	africa	PROPN
ajlm-283	3	27	nokukhanya	nokukhanya	PROPN
ajlm-283	3	28	mdlalose	mdlalose	PROPN
ajlm-283	3	29	,	,	PUNCT
ajlm-283	3	30	raveen	raveen	ADJ
ajlm-283	3	31	parboosing	parboose	VERB
ajlm-283	3	32	,	,	PUNCT
ajlm-283	3	33	pravi	pravi	PROPN
ajlm-283	3	34	moodley	moodley	PROPN
ajlm-283	3	35	received	receive	VERB
ajlm-283	3	36	:	:	PUNCT
ajlm-283	3	37	18	18	NUM
ajlm-283	3	38	nov	nov	PROPN
ajlm-283	3	39	.	.	PROPN
ajlm-283	3	40	2014	2014	NUM
ajlm-283	3	41	;	;	PUNCT
ajlm-283	3	42	accepted	accept	VERB
ajlm-283	3	43	:	:	PUNCT
ajlm-283	3	44	24	24	NUM
ajlm-283	3	45	nov	nov	PROPN
ajlm-283	3	46	.	.	PROPN
ajlm-283	3	47	2015	2015	NUM
ajlm-283	3	48	;	;	PUNCT
ajlm-283	3	49	published	publish	VERB
ajlm-283	3	50	:	:	PUNCT
ajlm-283	3	51	31	31	NUM
ajlm-283	3	52	mar	mar	PROPN
ajlm-283	3	53	.	.	PROPN
ajlm-283	4	1	2016	2016	NUM
ajlm-283	4	2	copyright	copyright	NOUN
ajlm-283	4	3	:	:	PUNCT
ajlm-283	4	4	©	©	PROPN
ajlm-283	4	5	2016	2016	NUM
ajlm-283	4	6	.	.	PUNCT
ajlm-283	5	1	the	the	DET
ajlm-283	5	2	author(s	author(s	PROPN
ajlm-283	5	3	)	)	PUNCT
ajlm-283	5	4	.	.	PUNCT
ajlm-283	6	1	licensee	licensee	NOUN
ajlm-283	6	2	:	:	PUNCT
ajlm-283	6	3	aosis	aosis	NOUN
ajlm-283	6	4	.	.	PUNCT
ajlm-283	7	1	this	this	PRON
ajlm-283	7	2	is	be	AUX
ajlm-283	7	3	an	an	DET
ajlm-283	7	4	open	open	ADJ
ajlm-283	7	5	access	access	NOUN
ajlm-283	7	6	article	article	NOUN
ajlm-283	7	7	distributed	distribute	VERB
ajlm-283	7	8	under	under	ADP
ajlm-283	7	9	the	the	DET
ajlm-283	7	10	terms	term	NOUN
ajlm-283	7	11	of	of	ADP
ajlm-283	7	12	the	the	DET
ajlm-283	7	13	creative	creative	ADJ
ajlm-283	7	14	commons	common	NOUN
ajlm-283	7	15	attribution	attribution	NOUN
ajlm-283	7	16	license	license	NOUN
ajlm-283	7	17	,	,	PUNCT
ajlm-283	7	18	which	which	PRON
ajlm-283	7	19	permits	permit	VERB
ajlm-283	7	20	unrestricted	unrestricted	ADJ
ajlm-283	7	21	use	use	NOUN
ajlm-283	7	22	,	,	PUNCT
ajlm-283	7	23	distribution	distribution	NOUN
ajlm-283	7	24	,	,	PUNCT
ajlm-283	7	25	and	and	CCONJ
ajlm-283	7	26	reproduction	reproduction	NOUN
ajlm-283	7	27	in	in	ADP
ajlm-283	7	28	any	any	DET
ajlm-283	7	29	medium	medium	NOUN
ajlm-283	7	30	,	,	PUNCT
ajlm-283	7	31	provided	provide	VERB
ajlm-283	7	32	the	the	DET
ajlm-283	7	33	original	original	ADJ
ajlm-283	7	34	work	work	NOUN
ajlm-283	7	35	is	be	AUX
ajlm-283	7	36	properly	properly	ADV
ajlm-283	7	37	cited	cite	VERB
ajlm-283	7	38	.	.	PUNCT
ajlm-283	8	1	abstract	abstract	ADJ
ajlm-283	8	2	background	background	NOUN
ajlm-283	8	3	:	:	PUNCT
ajlm-283	8	4	the	the	DET
ajlm-283	8	5	prevalence	prevalence	NOUN
ajlm-283	8	6	of	of	ADP
ajlm-283	8	7	hepatitis	hepatitis	PROPN
ajlm-283	8	8	b	b	PROPN
ajlm-283	8	9	virus	virus	NOUN
ajlm-283	8	10	(	(	PUNCT
ajlm-283	8	11	hbv	hbv	NOUN
ajlm-283	8	12	)	)	PUNCT
ajlm-283	8	13	amongst	amongst	ADP
ajlm-283	8	14	south	south	ADJ
ajlm-283	8	15	african	african	ADJ
ajlm-283	8	16	infants	infant	NOUN
ajlm-283	8	17	and	and	CCONJ
ajlm-283	8	18	children	child	NOUN
ajlm-283	8	19	has	have	AUX
ajlm-283	8	20	been	be	AUX
ajlm-283	8	21	reported	report	VERB
ajlm-283	8	22	in	in	ADP
ajlm-283	8	23	the	the	DET
ajlm-283	8	24	pre	pre	PROPN
ajlm-283	8	25	-	-	PROPN
ajlm-283	8	26	hiv	hiv	ADJ
ajlm-283	8	27	era	era	NOUN
ajlm-283	8	28	.	.	PUNCT
ajlm-283	9	1	despite	despite	SCONJ
ajlm-283	9	2	the	the	DET
ajlm-283	9	3	reported	report	VERB
ajlm-283	9	4	high	high	ADJ
ajlm-283	9	5	prevalence	prevalence	NOUN
ajlm-283	9	6	of	of	ADP
ajlm-283	9	7	hiv	hiv	PROPN
ajlm-283	9	8	in	in	ADP
ajlm-283	9	9	the	the	DET
ajlm-283	9	10	general	general	ADJ
ajlm-283	9	11	population	population	NOUN
ajlm-283	9	12	of	of	ADP
ajlm-283	9	13	south	south	PROPN
ajlm-283	9	14	africa	africa	PROPN
ajlm-283	9	15	,	,	PUNCT
ajlm-283	9	16	the	the	DET
ajlm-283	9	17	rate	rate	NOUN
ajlm-283	9	18	of	of	ADP
ajlm-283	9	19	hiv	hiv	PROPN
ajlm-283	9	20	/	/	SYM
ajlm-283	9	21	hbv	hbv	PROPN
ajlm-283	9	22	co	co	NOUN
ajlm-283	9	23	-	-	NOUN
ajlm-283	9	24	infection	infection	NOUN
ajlm-283	9	25	amongst	amongst	ADP
ajlm-283	9	26	infants	infant	NOUN
ajlm-283	9	27	and	and	CCONJ
ajlm-283	9	28	children	child	NOUN
ajlm-283	9	29	remains	remain	VERB
ajlm-283	9	30	poorly	poorly	ADV
ajlm-283	9	31	reported	report	VERB
ajlm-283	9	32	.	.	PUNCT
ajlm-283	10	1	objectives	objective	NOUN
ajlm-283	10	2	:	:	PUNCT
ajlm-283	10	3	we	we	PRON
ajlm-283	10	4	describe	describe	VERB
ajlm-283	10	5	the	the	DET
ajlm-283	10	6	prevalence	prevalence	NOUN
ajlm-283	10	7	of	of	ADP
ajlm-283	10	8	hbv	hbv	NOUN
ajlm-283	10	9	infection	infection	NOUN
ajlm-283	10	10	amongst	amongst	ADP
ajlm-283	10	11	hiv	hiv	PROPN
ajlm-283	10	12	-	-	PUNCT
ajlm-283	10	13	positive	positive	ADJ
ajlm-283	10	14	and	and	CCONJ
ajlm-283	10	15	hiv	hiv	NOUN
ajlm-283	10	16	-	-	PUNCT
ajlm-283	10	17	negative	negative	ADJ
ajlm-283	10	18	infants	infant	NOUN
ajlm-283	10	19	by	by	ADP
ajlm-283	10	20	molecular	molecular	ADJ
ajlm-283	10	21	methods	method	NOUN
ajlm-283	10	22	of	of	ADP
ajlm-283	10	23	diagnosis	diagnosis	NOUN
ajlm-283	10	24	using	use	VERB
ajlm-283	10	25	dried	dry	VERB
ajlm-283	10	26	blood	blood	NOUN
ajlm-283	10	27	spot	spot	NOUN
ajlm-283	10	28	samples	sample	NOUN
ajlm-283	10	29	.	.	PUNCT
ajlm-283	11	1	methods	method	NOUN
ajlm-283	11	2	:	:	PUNCT
ajlm-283	11	3	this	this	DET
ajlm-283	11	4	retrospective	retrospective	ADJ
ajlm-283	11	5	cross	cross	ADJ
ajlm-283	11	6	-	-	ADJ
ajlm-283	11	7	sectional	sectional	ADJ
ajlm-283	11	8	study	study	NOUN
ajlm-283	11	9	was	be	AUX
ajlm-283	11	10	conducted	conduct	VERB
ajlm-283	11	11	between	between	ADP
ajlm-283	11	12	july	july	PROPN
ajlm-283	11	13	2011	2011	NUM
ajlm-283	11	14	and	and	CCONJ
ajlm-283	11	15	december	december	PROPN
ajlm-283	11	16	2011	2011	NUM
ajlm-283	11	17	in	in	ADP
ajlm-283	11	18	an	an	DET
ajlm-283	11	19	academic	academic	ADJ
ajlm-283	11	20	referral	referral	NOUN
ajlm-283	11	21	laboratory	laboratory	NOUN
ajlm-283	11	22	offering	offer	VERB
ajlm-283	11	23	viral	viral	ADJ
ajlm-283	11	24	diagnostic	diagnostic	ADJ
ajlm-283	11	25	services	service	NOUN
ajlm-283	11	26	to	to	ADP
ajlm-283	11	27	the	the	DET
ajlm-283	11	28	entire	entire	ADJ
ajlm-283	11	29	kwazulu	kwazulu	VERB
ajlm-283	11	30	-	-	PUNCT
ajlm-283	11	31	natal	natal	ADJ
ajlm-283	11	32	province	province	NOUN
ajlm-283	11	33	of	of	ADP
ajlm-283	11	34	south	south	PROPN
ajlm-283	11	35	africa	africa	PROPN
ajlm-283	11	36	.	.	PUNCT
ajlm-283	12	1	a	a	DET
ajlm-283	12	2	total	total	NOUN
ajlm-283	12	3	of	of	ADP
ajlm-283	12	4	322	322	NUM
ajlm-283	12	5	study	study	NOUN
ajlm-283	12	6	samples	sample	NOUN
ajlm-283	12	7	were	be	AUX
ajlm-283	12	8	collected	collect	VERB
ajlm-283	12	9	from	from	ADP
ajlm-283	12	10	discarded	discard	VERB
ajlm-283	12	11	residual	residual	ADJ
ajlm-283	12	12	dried	dry	VERB
ajlm-283	12	13	blood	blood	NOUN
ajlm-283	12	14	spot	spot	NOUN
ajlm-283	12	15	samples	sample	NOUN
ajlm-283	12	16	following	follow	VERB
ajlm-283	12	17	routine	routine	ADJ
ajlm-283	12	18	infant	infant	NOUN
ajlm-283	12	19	diagnosis	diagnosis	NOUN
ajlm-283	12	20	of	of	ADP
ajlm-283	12	21	hiv	hiv	PROPN
ajlm-283	12	22	.	.	PUNCT
ajlm-283	13	1	equal	equal	ADJ
ajlm-283	13	2	proportions	proportion	NOUN
ajlm-283	13	3	of	of	ADP
ajlm-283	13	4	hiv	hiv	PROPN
ajlm-283	13	5	-	-	PUNCT
ajlm-283	13	6	positive	positive	ADJ
ajlm-283	13	7	and	and	CCONJ
ajlm-283	13	8	hiv	hiv	NOUN
ajlm-283	13	9	-	-	PUNCT
ajlm-283	13	10	negative	negative	ADJ
ajlm-283	13	11	infant	infant	NOUN
ajlm-283	13	12	specimens	specimen	NOUN
ajlm-283	13	13	were	be	AUX
ajlm-283	13	14	studied	study	VERB
ajlm-283	13	15	.	.	PUNCT
ajlm-283	14	1	statistical	statistical	ADJ
ajlm-283	14	2	differences	difference	NOUN
ajlm-283	14	3	in	in	ADP
ajlm-283	14	4	the	the	DET
ajlm-283	14	5	prevalence	prevalence	NOUN
ajlm-283	14	6	of	of	ADP
ajlm-283	14	7	hbv	hbv	NOUN
ajlm-283	14	8	between	between	ADP
ajlm-283	14	9	the	the	DET
ajlm-283	14	10	hiv	hiv	PROPN
ajlm-283	14	11	-	-	PUNCT
ajlm-283	14	12	positive	positive	ADJ
ajlm-283	14	13	and	and	CCONJ
ajlm-283	14	14	hiv	hiv	NOUN
ajlm-283	14	15	-	-	PUNCT
ajlm-283	14	16	negative	negative	ADJ
ajlm-283	14	17	samples	sample	NOUN
ajlm-283	14	18	were	be	AUX
ajlm-283	14	19	calculated	calculate	VERB
ajlm-283	14	20	using	use	VERB
ajlm-283	14	21	the	the	DET
ajlm-283	14	22	pearson	pearson	PROPN
ajlm-283	14	23	chi	chi	PROPN
ajlm-283	14	24	-	-	PUNCT
ajlm-283	14	25	square	square	PROPN
ajlm-283	14	26	test	test	NOUN
ajlm-283	14	27	,	,	PUNCT
ajlm-283	14	28	and	and	CCONJ
ajlm-283	14	29	a	a	DET
ajlm-283	14	30	p	p	NOUN
ajlm-283	14	31	-	-	PUNCT
ajlm-283	14	32	value	value	NOUN
ajlm-283	14	33	<	<	X
ajlm-283	14	34	0.05	0.05	NUM
ajlm-283	14	35	was	be	AUX
ajlm-283	14	36	considered	consider	VERB
ajlm-283	14	37	statistically	statistically	ADV
ajlm-283	14	38	significant	significant	ADJ
ajlm-283	14	39	.	.	PUNCT
ajlm-283	15	1	further	further	ADJ
ajlm-283	15	2	testing	testing	NOUN
ajlm-283	15	3	for	for	ADP
ajlm-283	15	4	hbv	hbv	NOUN
ajlm-283	15	5	dna	dna	PROPN
ajlm-283	15	6	using	use	VERB
ajlm-283	15	7	a	a	DET
ajlm-283	15	8	nested	nested	ADJ
ajlm-283	15	9	polymerase	polymerase	NOUN
ajlm-283	15	10	chain	chain	NOUN
ajlm-283	15	11	reaction	reaction	NOUN
ajlm-283	15	12	method	method	NOUN
ajlm-283	15	13	was	be	AUX
ajlm-283	15	14	performed	perform	VERB
ajlm-283	15	15	.	.	PUNCT
ajlm-283	16	1	results	result	NOUN
ajlm-283	16	2	:	:	PUNCT
ajlm-283	16	3	the	the	DET
ajlm-283	16	4	overall	overall	ADJ
ajlm-283	16	5	prevalence	prevalence	NOUN
ajlm-283	16	6	of	of	ADP
ajlm-283	16	7	hbv	hbv	NOUN
ajlm-283	16	8	was	be	AUX
ajlm-283	16	9	10	10	NUM
ajlm-283	16	10	%	%	NOUN
ajlm-283	16	11	.	.	PUNCT
ajlm-283	17	1	in	in	ADP
ajlm-283	17	2	the	the	DET
ajlm-283	17	3	hiv	hiv	PROPN
ajlm-283	17	4	-	-	PUNCT
ajlm-283	17	5	positive	positive	ADJ
ajlm-283	17	6	group	group	NOUN
ajlm-283	17	7	,	,	PUNCT
ajlm-283	17	8	21	21	NUM
ajlm-283	17	9	of	of	ADP
ajlm-283	17	10	161	161	NUM
ajlm-283	17	11	infants	infant	NOUN
ajlm-283	17	12	tested	test	VERB
ajlm-283	17	13	positive	positive	ADJ
ajlm-283	17	14	for	for	ADP
ajlm-283	17	15	hbv	hbv	NOUN
ajlm-283	17	16	compared	compare	VERB
ajlm-283	17	17	with	with	ADP
ajlm-283	17	18	12	12	NUM
ajlm-283	17	19	of	of	ADP
ajlm-283	17	20	161	161	NUM
ajlm-283	17	21	hiv	hiv	NOUN
ajlm-283	17	22	-	-	PUNCT
ajlm-283	17	23	negative	negative	ADJ
ajlm-283	17	24	infants	infant	NOUN
ajlm-283	17	25	who	who	PRON
ajlm-283	17	26	tested	test	VERB
ajlm-283	17	27	positive	positive	ADJ
ajlm-283	17	28	for	for	ADP
ajlm-283	17	29	hbv	hbv	NOUN
ajlm-283	17	30	.	.	PUNCT
ajlm-283	18	1	the	the	DET
ajlm-283	18	2	proportion	proportion	NOUN
ajlm-283	18	3	of	of	ADP
ajlm-283	18	4	infants	infant	NOUN
ajlm-283	18	5	infected	infect	VERB
ajlm-283	18	6	with	with	ADP
ajlm-283	18	7	hbv	hbv	NOUN
ajlm-283	18	8	was	be	AUX
ajlm-283	18	9	marginally	marginally	ADV
ajlm-283	18	10	higher	high	ADJ
ajlm-283	18	11	amongst	amongst	ADP
ajlm-283	18	12	hiv	hiv	PROPN
ajlm-283	18	13	-	-	PUNCT
ajlm-283	18	14	positive	positive	ADJ
ajlm-283	18	15	infants	infant	NOUN
ajlm-283	18	16	(	(	PUNCT
ajlm-283	18	17	13.0	13.0	NUM
ajlm-283	18	18	%	%	NOUN
ajlm-283	18	19	;	;	PUNCT
ajlm-283	18	20	95	95	NUM
ajlm-283	18	21	%	%	NOUN
ajlm-283	18	22	ci	ci	NOUN
ajlm-283	18	23	6.8–19.9	6.8–19.9	PROPN
ajlm-283	18	24	)	)	PUNCT
ajlm-283	18	25	compared	compare	VERB
ajlm-283	18	26	with	with	ADP
ajlm-283	18	27	hiv	hiv	PROPN
ajlm-283	18	28	-	-	PUNCT
ajlm-283	18	29	negative	negative	ADJ
ajlm-283	18	30	infants	infant	NOUN
ajlm-283	18	31	(	(	PUNCT
ajlm-283	18	32	7.5	7.5	NUM
ajlm-283	18	33	%	%	NOUN
ajlm-283	18	34	;	;	PUNCT
ajlm-283	18	35	95	95	NUM
ajlm-283	18	36	%	%	NOUN
ajlm-283	18	37	ci	ci	NOUN
ajlm-283	18	38	2.5–13.7	2.5–13.7	NOUN
ajlm-283	18	39	;	;	PUNCT
ajlm-283	18	40	p	p	X
ajlm-283	18	41	=	=	NOUN
ajlm-283	18	42	0.098	0.098	NUM
ajlm-283	18	43	)	)	PUNCT
ajlm-283	18	44	,	,	PUNCT
ajlm-283	18	45	though	though	SCONJ
ajlm-283	18	46	not	not	PART
ajlm-283	18	47	statistically	statistically	ADV
ajlm-283	18	48	significant	significant	ADJ
ajlm-283	18	49	.	.	PUNCT
ajlm-283	19	1	conclusion	conclusion	NOUN
ajlm-283	19	2	:	:	PUNCT
ajlm-283	19	3	the	the	DET
ajlm-283	19	4	finding	finding	NOUN
ajlm-283	19	5	of	of	ADP
ajlm-283	19	6	a	a	DET
ajlm-283	19	7	10	10	NUM
ajlm-283	19	8	%	%	NOUN
ajlm-283	19	9	hbv	hbv	NOUN
ajlm-283	19	10	prevalence	prevalence	NOUN
ajlm-283	19	11	in	in	ADP
ajlm-283	19	12	this	this	DET
ajlm-283	19	13	infant	infant	NOUN
ajlm-283	19	14	cohort	cohort	NOUN
ajlm-283	19	15	is	be	AUX
ajlm-283	19	16	clinically	clinically	ADV
ajlm-283	19	17	significant	significant	ADJ
ajlm-283	19	18	.	.	PUNCT
ajlm-283	20	1	the	the	DET
ajlm-283	20	2	non	non	ADJ
ajlm-283	20	3	-	-	ADJ
ajlm-283	20	4	statistically	statistically	ADV
ajlm-283	20	5	significant	significant	ADJ
ajlm-283	20	6	difference	difference	NOUN
ajlm-283	20	7	in	in	ADP
ajlm-283	20	8	hbv	hbv	NOUN
ajlm-283	20	9	prevalence	prevalence	NOUN
ajlm-283	20	10	between	between	ADP
ajlm-283	20	11	the	the	DET
ajlm-283	20	12	hiv	hiv	PROPN
ajlm-283	20	13	-	-	PUNCT
ajlm-283	20	14	positive	positive	ADJ
ajlm-283	20	15	and	and	CCONJ
ajlm-283	20	16	hiv	hiv	NOUN
ajlm-283	20	17	-	-	PUNCT
ajlm-283	20	18	negative	negative	ADJ
ajlm-283	20	19	infants	infant	NOUN
ajlm-283	20	20	suggests	suggest	VERB
ajlm-283	20	21	that	that	SCONJ
ajlm-283	20	22	high	high	ADJ
ajlm-283	20	23	prevalence	prevalence	NOUN
ajlm-283	20	24	of	of	ADP
ajlm-283	20	25	hbv	hbv	NOUN
ajlm-283	20	26	infection	infection	NOUN
ajlm-283	20	27	in	in	ADP
ajlm-283	20	28	children	child	NOUN
ajlm-283	20	29	may	may	AUX
ajlm-283	20	30	be	be	AUX
ajlm-283	20	31	a	a	DET
ajlm-283	20	32	problem	problem	NOUN
ajlm-283	20	33	independent	independent	ADJ
ajlm-283	20	34	of	of	ADP
ajlm-283	20	35	hiv	hiv	PROPN
ajlm-283	20	36	.	.	PUNCT
ajlm-283	21	1	introduction	introduction	NOUN
ajlm-283	21	2	hepatitis	hepatitis	PROPN
ajlm-283	21	3	b	b	PROPN
ajlm-283	21	4	virus	virus	NOUN
ajlm-283	21	5	(	(	PUNCT
ajlm-283	21	6	hbv	hbv	NOUN
ajlm-283	21	7	)	)	PUNCT
ajlm-283	21	8	infection	infection	NOUN
ajlm-283	21	9	remains	remain	VERB
ajlm-283	21	10	a	a	DET
ajlm-283	21	11	major	major	ADJ
ajlm-283	21	12	health	health	NOUN
ajlm-283	21	13	care	care	NOUN
ajlm-283	21	14	problem	problem	NOUN
ajlm-283	21	15	throughout	throughout	ADP
ajlm-283	21	16	the	the	DET
ajlm-283	21	17	world	world	NOUN
ajlm-283	21	18	.	.	PUNCT
ajlm-283	22	1	of	of	ADP
ajlm-283	22	2	the	the	DET
ajlm-283	22	3	two	two	NUM
ajlm-283	22	4	billion	billion	NUM
ajlm-283	22	5	people	people	NOUN
ajlm-283	22	6	infected	infect	VERB
ajlm-283	22	7	with	with	ADP
ajlm-283	22	8	the	the	DET
ajlm-283	22	9	virus	virus	NOUN
ajlm-283	22	10	,	,	PUNCT
ajlm-283	22	11	more	more	ADJ
ajlm-283	22	12	than	than	ADP
ajlm-283	22	13	350	350	NUM
ajlm-283	22	14	million	million	NUM
ajlm-283	22	15	are	be	AUX
ajlm-283	22	16	chronic	chronic	ADJ
ajlm-283	22	17	carriers	carrier	NOUN
ajlm-283	22	18	of	of	ADP
ajlm-283	22	19	hbv	hbv	NOUN
ajlm-283	22	20	,	,	PUNCT
ajlm-283	22	21	and	and	CCONJ
ajlm-283	22	22	approximately	approximately	ADV
ajlm-283	22	23	600	600	NUM
ajlm-283	22	24	000	000	NUM
ajlm-283	22	25	die	die	VERB
ajlm-283	22	26	annually	annually	ADV
ajlm-283	22	27	from	from	ADP
ajlm-283	22	28	hbv	hbv	NOUN
ajlm-283	22	29	-	-	PUNCT
ajlm-283	22	30	related	relate	VERB
ajlm-283	22	31	complications	complication	NOUN
ajlm-283	22	32	,	,	PUNCT
ajlm-283	22	33	including	include	VERB
ajlm-283	22	34	hepatocellular	hepatocellular	ADJ
ajlm-283	22	35	carcinoma.1	carcinoma.1	NOUN
ajlm-283	22	36	expanded	expand	VERB
ajlm-283	22	37	vaccination	vaccination	NOUN
ajlm-283	22	38	initiatives	initiative	NOUN
ajlm-283	22	39	have	have	AUX
ajlm-283	22	40	been	be	AUX
ajlm-283	22	41	associated	associate	VERB
ajlm-283	22	42	with	with	ADP
ajlm-283	22	43	a	a	DET
ajlm-283	22	44	decline	decline	NOUN
ajlm-283	22	45	in	in	ADP
ajlm-283	22	46	global	global	ADJ
ajlm-283	22	47	hbv	hbv	NOUN
ajlm-283	22	48	prevalence	prevalence	NOUN
ajlm-283	22	49	,	,	PUNCT
ajlm-283	22	50	but	but	CCONJ
ajlm-283	22	51	national	national	ADJ
ajlm-283	22	52	and	and	CCONJ
ajlm-283	22	53	sub	sub	ADJ
ajlm-283	22	54	-	-	ADJ
ajlm-283	22	55	national	national	ADJ
ajlm-283	22	56	prevalence	prevalence	NOUN
ajlm-283	22	57	data	datum	NOUN
ajlm-283	22	58	are	be	AUX
ajlm-283	22	59	still	still	ADV
ajlm-283	22	60	required	require	VERB
ajlm-283	22	61	to	to	PART
ajlm-283	22	62	monitor	monitor	VERB
ajlm-283	22	63	disease	disease	NOUN
ajlm-283	22	64	burden	burden	NOUN
ajlm-283	22	65	continuously	continuously	ADV
ajlm-283	22	66	and	and	CCONJ
ajlm-283	22	67	guide	guide	VERB
ajlm-283	22	68	vaccine	vaccine	NOUN
ajlm-283	22	69	policies.2	policies.2	PROPN
ajlm-283	22	70	south	south	PROPN
ajlm-283	22	71	africa	africa	PROPN
ajlm-283	22	72	introduced	introduce	VERB
ajlm-283	22	73	compulsory	compulsory	ADJ
ajlm-283	22	74	infant	infant	NOUN
ajlm-283	22	75	vaccination	vaccination	NOUN
ajlm-283	22	76	against	against	ADP
ajlm-283	22	77	hbv	hbv	NOUN
ajlm-283	22	78	as	as	ADP
ajlm-283	22	79	part	part	NOUN
ajlm-283	22	80	of	of	ADP
ajlm-283	22	81	an	an	DET
ajlm-283	22	82	expanded	expand	VERB
ajlm-283	22	83	programme	programme	NOUN
ajlm-283	22	84	on	on	ADP
ajlm-283	22	85	immunisation	immunisation	NOUN
ajlm-283	22	86	in	in	ADP
ajlm-283	22	87	1995.3	1995.3	NUM
ajlm-283	22	88	pre	pre	ADJ
ajlm-283	22	89	-	-	ADJ
ajlm-283	22	90	immunisation	immunisation	ADJ
ajlm-283	22	91	seroprevalence	seroprevalence	NOUN
ajlm-283	22	92	of	of	ADP
ajlm-283	22	93	hbv	hbv	NOUN
ajlm-283	22	94	infection	infection	NOUN
ajlm-283	22	95	amongst	amongst	ADP
ajlm-283	22	96	children	child	NOUN
ajlm-283	22	97	from	from	ADP
ajlm-283	22	98	the	the	DET
ajlm-283	22	99	eastern	eastern	ADJ
ajlm-283	22	100	cape	cape	NOUN
ajlm-283	22	101	province	province	NOUN
ajlm-283	22	102	of	of	ADP
ajlm-283	22	103	south	south	PROPN
ajlm-283	22	104	africa	africa	PROPN
ajlm-283	22	105	was	be	AUX
ajlm-283	22	106	reported	report	VERB
ajlm-283	22	107	to	to	PART
ajlm-283	22	108	be	be	AUX
ajlm-283	22	109	10.4	10.4	NUM
ajlm-283	22	110	%	%	NOUN
ajlm-283	22	111	in	in	ADP
ajlm-283	22	112	a	a	DET
ajlm-283	22	113	study	study	NOUN
ajlm-283	22	114	conducted	conduct	VERB
ajlm-283	22	115	between	between	ADP
ajlm-283	22	116	1995	1995	NUM
ajlm-283	22	117	and	and	CCONJ
ajlm-283	22	118	1996.4	1996.4	NUM
ajlm-283	22	119	a	a	DET
ajlm-283	22	120	study	study	NOUN
ajlm-283	22	121	conducted	conduct	VERB
ajlm-283	22	122	in	in	ADP
ajlm-283	22	123	the	the	DET
ajlm-283	22	124	limpopo	limpopo	PROPN
ajlm-283	22	125	province	province	NOUN
ajlm-283	22	126	showed	show	VERB
ajlm-283	22	127	that	that	SCONJ
ajlm-283	22	128	the	the	DET
ajlm-283	22	129	vaccination	vaccination	NOUN
ajlm-283	22	130	programme	programme	NOUN
ajlm-283	22	131	had	have	VERB
ajlm-283	22	132	a	a	DET
ajlm-283	22	133	positive	positive	ADJ
ajlm-283	22	134	impact	impact	NOUN
ajlm-283	22	135	,	,	PUNCT
ajlm-283	22	136	and	and	CCONJ
ajlm-283	22	137	there	there	PRON
ajlm-283	22	138	was	be	VERB
ajlm-283	22	139	evidence	evidence	NOUN
ajlm-283	22	140	of	of	ADP
ajlm-283	22	141	elimination	elimination	NOUN
ajlm-283	22	142	of	of	ADP
ajlm-283	22	143	hbv	hbv	NOUN
ajlm-283	22	144	surface	surface	NOUN
ajlm-283	23	1	antigen	antigen	ADJ
ajlm-283	23	2	carriage	carriage	NOUN
ajlm-283	23	3	amongst	amongst	ADP
ajlm-283	23	4	children	child	NOUN
ajlm-283	23	5	aged	age	VERB
ajlm-283	23	6	5	5	NUM
ajlm-283	23	7	years	year	NOUN
ajlm-283	23	8	or	or	CCONJ
ajlm-283	23	9	younger.5	younger.5	NOUN
ajlm-283	23	10	however	however	ADV
ajlm-283	24	1	,	,	PUNCT
ajlm-283	24	2	another	another	DET
ajlm-283	24	3	south	south	ADJ
ajlm-283	24	4	african	african	ADJ
ajlm-283	24	5	study	study	NOUN
ajlm-283	24	6	suggested	suggest	VERB
ajlm-283	24	7	that	that	SCONJ
ajlm-283	24	8	the	the	DET
ajlm-283	24	9	response	response	NOUN
ajlm-283	24	10	to	to	ADP
ajlm-283	24	11	hbv	hbv	NOUN
ajlm-283	24	12	vaccination	vaccination	NOUN
ajlm-283	24	13	amongst	amongst	ADP
ajlm-283	24	14	hiv	hiv	PROPN
ajlm-283	24	15	-	-	PUNCT
ajlm-283	24	16	positive	positive	ADJ
ajlm-283	24	17	infants	infant	NOUN
ajlm-283	24	18	may	may	AUX
ajlm-283	24	19	be	be	AUX
ajlm-283	24	20	sub	sub	ADJ
ajlm-283	24	21	-	-	ADJ
ajlm-283	24	22	optimal.6	optimal.6	ADJ
ajlm-283	24	23	there	there	PRON
ajlm-283	24	24	is	be	VERB
ajlm-283	24	25	a	a	DET
ajlm-283	24	26	growing	grow	VERB
ajlm-283	24	27	body	body	NOUN
ajlm-283	24	28	of	of	ADP
ajlm-283	24	29	evidence	evidence	NOUN
ajlm-283	24	30	showing	show	VERB
ajlm-283	24	31	that	that	SCONJ
ajlm-283	24	32	the	the	DET
ajlm-283	24	33	prevalence	prevalence	NOUN
ajlm-283	24	34	of	of	ADP
ajlm-283	24	35	hbv	hbv	NOUN
ajlm-283	24	36	is	be	AUX
ajlm-283	24	37	significantly	significantly	ADV
ajlm-283	24	38	higher	high	ADJ
ajlm-283	24	39	amongst	amongst	ADP
ajlm-283	24	40	hiv	hiv	PROPN
ajlm-283	24	41	-	-	PUNCT
ajlm-283	24	42	positive	positive	ADJ
ajlm-283	24	43	individuals	individual	NOUN
ajlm-283	24	44	,	,	PUNCT
ajlm-283	24	45	mainly	mainly	ADV
ajlm-283	24	46	because	because	SCONJ
ajlm-283	24	47	of	of	ADP
ajlm-283	24	48	shared	share	VERB
ajlm-283	24	49	risk	risk	NOUN
ajlm-283	24	50	factors.7,8,9,10	factors.7,8,9,10	NOUN
ajlm-283	24	51	despite	despite	SCONJ
ajlm-283	24	52	the	the	DET
ajlm-283	24	53	generally	generally	ADV
ajlm-283	24	54	reported	report	VERB
ajlm-283	24	55	high	high	ADJ
ajlm-283	24	56	prevalence	prevalence	NOUN
ajlm-283	24	57	of	of	ADP
ajlm-283	24	58	hiv	hiv	PROPN
ajlm-283	24	59	and	and	CCONJ
ajlm-283	24	60	hbv	hbv	PROPN
ajlm-283	24	61	,	,	PUNCT
ajlm-283	24	62	there	there	PRON
ajlm-283	24	63	is	be	VERB
ajlm-283	24	64	still	still	ADV
ajlm-283	24	65	no	no	DET
ajlm-283	24	66	clear	clear	ADJ
ajlm-283	24	67	government	government	NOUN
ajlm-283	24	68	policy	policy	NOUN
ajlm-283	24	69	in	in	ADP
ajlm-283	24	70	south	south	PROPN
ajlm-283	24	71	africa	africa	PROPN
ajlm-283	24	72	for	for	ADP
ajlm-283	24	73	screening	screen	VERB
ajlm-283	24	74	or	or	CCONJ
ajlm-283	24	75	active	active	ADJ
ajlm-283	24	76	case	case	NOUN
ajlm-283	24	77	finding	find	VERB
ajlm-283	24	78	for	for	ADP
ajlm-283	24	79	hbv	hbv	NOUN
ajlm-283	24	80	amongst	amongst	ADP
ajlm-283	24	81	high	high	ADJ
ajlm-283	24	82	-	-	PUNCT
ajlm-283	24	83	risk	risk	NOUN
ajlm-283	24	84	individuals	individual	NOUN
ajlm-283	24	85	or	or	CCONJ
ajlm-283	24	86	pregnant	pregnant	ADJ
ajlm-283	24	87	women.9	women.9	NOUN
ajlm-283	24	88	the	the	DET
ajlm-283	24	89	general	general	ADJ
ajlm-283	24	90	prevalence	prevalence	NOUN
ajlm-283	24	91	of	of	ADP
ajlm-283	24	92	hbv	hbv	NOUN
ajlm-283	24	93	amongst	amongst	ADP
ajlm-283	24	94	pregnant	pregnant	ADJ
ajlm-283	24	95	women	woman	NOUN
ajlm-283	24	96	is	be	AUX
ajlm-283	24	97	under	under	ADV
ajlm-283	24	98	-	-	PUNCT
ajlm-283	24	99	reported	report	VERB
ajlm-283	24	100	,	,	PUNCT
ajlm-283	24	101	with	with	ADP
ajlm-283	24	102	a	a	DET
ajlm-283	24	103	retrospective	retrospective	ADJ
ajlm-283	24	104	cross	cross	ADJ
ajlm-283	24	105	-	-	ADJ
ajlm-283	24	106	sectional	sectional	ADJ
ajlm-283	24	107	study	study	NOUN
ajlm-283	24	108	in	in	ADP
ajlm-283	24	109	the	the	DET
ajlm-283	24	110	western	western	ADJ
ajlm-283	24	111	cape	cape	NOUN
ajlm-283	24	112	province	province	NOUN
ajlm-283	24	113	of	of	ADP
ajlm-283	24	114	south	south	PROPN
ajlm-283	24	115	africa	africa	PROPN
ajlm-283	24	116	reporting	report	VERB
ajlm-283	24	117	a	a	DET
ajlm-283	24	118	regional	regional	ADJ
ajlm-283	24	119	seroprevalence	seroprevalence	NOUN
ajlm-283	24	120	of	of	ADP
ajlm-283	24	121	3.4	3.4	NUM
ajlm-283	24	122	%	%	NOUN
ajlm-283	24	123	amongst	amongst	ADP
ajlm-283	24	124	hiv	hiv	PROPN
ajlm-283	24	125	-	-	PUNCT
ajlm-283	24	126	positive	positive	ADJ
ajlm-283	24	127	women	woman	NOUN
ajlm-283	24	128	and	and	CCONJ
ajlm-283	24	129	2.9	2.9	NUM
ajlm-283	24	130	%	%	NOUN
ajlm-283	24	131	amongst	amongst	ADP
ajlm-283	24	132	hiv	hiv	PROPN
ajlm-283	24	133	-	-	PUNCT
ajlm-283	24	134	negative	negative	ADJ
ajlm-283	24	135	women.11	women.11	NOUN
ajlm-283	24	136	a	a	DET
ajlm-283	24	137	study	study	NOUN
ajlm-283	24	138	in	in	ADP
ajlm-283	24	139	the	the	DET
ajlm-283	24	140	kwazulu	kwazulu	VERB
ajlm-283	24	141	-	-	PUNCT
ajlm-283	24	142	natal	natal	ADJ
ajlm-283	24	143	province	province	NOUN
ajlm-283	24	144	of	of	ADP
ajlm-283	24	145	south	south	PROPN
ajlm-283	24	146	africa	africa	PROPN
ajlm-283	24	147	reported	report	VERB
ajlm-283	24	148	a	a	DET
ajlm-283	24	149	5.3	5.3	NUM
ajlm-283	24	150	%	%	NOUN
ajlm-283	24	151	hbv	hbv	NOUN
ajlm-283	24	152	prevalence	prevalence	NOUN
ajlm-283	24	153	and	and	CCONJ
ajlm-283	24	154	a	a	DET
ajlm-283	24	155	3.1	3.1	NUM
ajlm-283	24	156	%	%	NOUN
ajlm-283	24	157	hiv	hiv	PROPN
ajlm-283	24	158	/	/	SYM
ajlm-283	24	159	hbv	hbv	PROPN
ajlm-283	24	160	co	co	NOUN
ajlm-283	24	161	-	-	NOUN
ajlm-283	24	162	infection	infection	ADJ
ajlm-283	24	163	prevalence	prevalence	NOUN
ajlm-283	24	164	amongst	amongst	ADP
ajlm-283	24	165	pregnant	pregnant	ADJ
ajlm-283	24	166	women	woman	NOUN
ajlm-283	24	167	in	in	ADP
ajlm-283	24	168	a	a	DET
ajlm-283	24	169	province	province	NOUN
ajlm-283	24	170	where	where	SCONJ
ajlm-283	24	171	antenatal	antenatal	NOUN
ajlm-283	24	172	hiv	hiv	PROPN
ajlm-283	24	173	prevalence	prevalence	NOUN
ajlm-283	24	174	was	be	AUX
ajlm-283	24	175	reported	report	VERB
ajlm-283	24	176	to	to	PART
ajlm-283	24	177	be	be	AUX
ajlm-283	24	178	37.4	37.4	NUM
ajlm-283	24	179	%	%	NOUN
ajlm-283	24	180	in	in	ADP
ajlm-283	24	181	2012.12	2012.12	NUM
ajlm-283	24	182	the	the	DET
ajlm-283	24	183	prevalence	prevalence	NOUN
ajlm-283	24	184	of	of	ADP
ajlm-283	24	185	hbv	hbv	NOUN
ajlm-283	24	186	amongst	amongst	ADP
ajlm-283	24	187	south	south	ADJ
ajlm-283	24	188	african	african	ADJ
ajlm-283	24	189	infants	infant	NOUN
ajlm-283	24	190	and	and	CCONJ
ajlm-283	24	191	children	child	NOUN
ajlm-283	24	192	was	be	AUX
ajlm-283	24	193	widely	widely	ADV
ajlm-283	24	194	reported	report	VERB
ajlm-283	24	195	in	in	ADP
ajlm-283	24	196	the	the	DET
ajlm-283	24	197	pre	pre	PROPN
ajlm-283	24	198	-	-	PROPN
ajlm-283	24	199	hiv	hiv	ADJ
ajlm-283	24	200	era	era	NOUN
ajlm-283	24	201	.	.	PUNCT
ajlm-283	25	1	vardas	vardas	PROPN
ajlm-283	25	2	et	et	PROPN
ajlm-283	25	3	al	al	PROPN
ajlm-283	25	4	.	.	PROPN
ajlm-283	25	5	reported	report	VERB
ajlm-283	25	6	the	the	DET
ajlm-283	25	7	overall	overall	ADJ
ajlm-283	25	8	prevalence	prevalence	NOUN
ajlm-283	25	9	of	of	ADP
ajlm-283	25	10	hbv	hbv	NOUN
ajlm-283	25	11	in	in	ADP
ajlm-283	25	12	the	the	DET
ajlm-283	25	13	eastern	eastern	ADJ
ajlm-283	25	14	cape	cape	NOUN
ajlm-283	25	15	to	to	PART
ajlm-283	25	16	be	be	AUX
ajlm-283	25	17	10.4	10.4	NUM
ajlm-283	25	18	%	%	NOUN
ajlm-283	25	19	,	,	PUNCT
ajlm-283	25	20	ranging	range	VERB
ajlm-283	25	21	from	from	ADP
ajlm-283	25	22	8.9	8.9	NUM
ajlm-283	25	23	%	%	NOUN
ajlm-283	25	24	in	in	ADP
ajlm-283	25	25	the	the	DET
ajlm-283	25	26	0–6	0–6	NOUN
ajlm-283	25	27	-	-	PUNCT
ajlm-283	25	28	months	month	NOUN
ajlm-283	25	29	age	age	NOUN
ajlm-283	25	30	group	group	NOUN
ajlm-283	25	31	to	to	ADP
ajlm-283	25	32	15.7	15.7	NUM
ajlm-283	25	33	%	%	NOUN
ajlm-283	25	34	in	in	ADP
ajlm-283	25	35	the	the	DET
ajlm-283	25	36	61–72	61–72	NUM
ajlm-283	25	37	-	-	PUNCT
ajlm-283	25	38	months	month	NOUN
ajlm-283	25	39	age	age	NOUN
ajlm-283	25	40	group	group	NOUN
ajlm-283	25	41	between	between	ADP
ajlm-283	25	42	1995	1995	NUM
ajlm-283	25	43	and	and	CCONJ
ajlm-283	25	44	1996.4	1996.4	NUM
ajlm-283	25	45	another	another	DET
ajlm-283	25	46	,	,	PUNCT
ajlm-283	25	47	earlier	early	ADJ
ajlm-283	25	48	study	study	NOUN
ajlm-283	25	49	in	in	ADP
ajlm-283	25	50	kwazulu	kwazulu	PROPN
ajlm-283	25	51	-	-	PUNCT
ajlm-283	25	52	natal	natal	ADJ
ajlm-283	25	53	province	province	NOUN
ajlm-283	25	54	reported	report	VERB
ajlm-283	25	55	the	the	DET
ajlm-283	25	56	prevalence	prevalence	NOUN
ajlm-283	25	57	of	of	ADP
ajlm-283	25	58	hbv	hbv	NOUN
ajlm-283	25	59	in	in	ADP
ajlm-283	25	60	urban	urban	ADJ
ajlm-283	25	61	,	,	PUNCT
ajlm-283	25	62	rural	rural	ADJ
ajlm-283	25	63	and	and	CCONJ
ajlm-283	25	64	institutionalised	institutionalised	ADJ
ajlm-283	25	65	children	child	NOUN
ajlm-283	25	66	to	to	PART
ajlm-283	25	67	be	be	AUX
ajlm-283	25	68	10	10	NUM
ajlm-283	25	69	%	%	NOUN
ajlm-283	25	70	,	,	PUNCT
ajlm-283	25	71	18.5	18.5	NUM
ajlm-283	25	72	%	%	NOUN
ajlm-283	25	73	and	and	CCONJ
ajlm-283	25	74	25.1	25.1	NUM
ajlm-283	25	75	%	%	NOUN
ajlm-283	25	76	,	,	PUNCT
ajlm-283	25	77	respectively.13	respectively.13	VERB
ajlm-283	25	78	in	in	ADP
ajlm-283	25	79	the	the	DET
ajlm-283	25	80	era	era	NOUN
ajlm-283	25	81	of	of	ADP
ajlm-283	25	82	the	the	DET
ajlm-283	25	83	south	south	ADJ
ajlm-283	25	84	african	african	PROPN
ajlm-283	25	85	hiv	hiv	PROPN
ajlm-283	25	86	epidemic	epidemic	NOUN
ajlm-283	25	87	,	,	PUNCT
ajlm-283	25	88	a	a	DET
ajlm-283	25	89	study	study	NOUN
ajlm-283	25	90	conducted	conduct	VERB
ajlm-283	25	91	in	in	ADP
ajlm-283	25	92	the	the	DET
ajlm-283	25	93	western	western	ADJ
ajlm-283	25	94	cape	cape	NOUN
ajlm-283	25	95	in	in	ADP
ajlm-283	25	96	2011	2011	NUM
ajlm-283	25	97	found	find	VERB
ajlm-283	25	98	the	the	DET
ajlm-283	25	99	prevalence	prevalence	NOUN
ajlm-283	25	100	of	of	ADP
ajlm-283	25	101	hbv	hbv	NOUN
ajlm-283	25	102	amongst	amongst	ADP
ajlm-283	25	103	hiv	hiv	PROPN
ajlm-283	25	104	-	-	PUNCT
ajlm-283	25	105	exposed	expose	VERB
ajlm-283	25	106	infants	infant	NOUN
ajlm-283	25	107	to	to	PART
ajlm-283	25	108	be	be	AUX
ajlm-283	25	109	0.4%.14	0.4%.14	PRON
ajlm-283	25	110	the	the	DET
ajlm-283	25	111	rate	rate	NOUN
ajlm-283	25	112	of	of	ADP
ajlm-283	25	113	hiv	hiv	PROPN
ajlm-283	25	114	/	/	SYM
ajlm-283	25	115	hbv	hbv	PROPN
ajlm-283	25	116	co	co	NOUN
ajlm-283	25	117	-	-	NOUN
ajlm-283	25	118	infection	infection	NOUN
ajlm-283	25	119	amongst	amongst	ADP
ajlm-283	25	120	infants	infant	NOUN
ajlm-283	25	121	and	and	CCONJ
ajlm-283	25	122	children	child	NOUN
ajlm-283	25	123	remains	remains	AUX
ajlm-283	25	124	poorly	poorly	ADV
ajlm-283	25	125	reported	report	VERB
ajlm-283	25	126	compared	compare	VERB
ajlm-283	25	127	with	with	ADP
ajlm-283	25	128	reports	report	NOUN
ajlm-283	25	129	of	of	ADP
ajlm-283	25	130	high	high	ADJ
ajlm-283	25	131	exposure	exposure	NOUN
ajlm-283	25	132	to	to	ADP
ajlm-283	25	133	hbv	hbv	NOUN
ajlm-283	25	134	in	in	ADP
ajlm-283	25	135	hiv	hiv	PROPN
ajlm-283	25	136	-	-	PUNCT
ajlm-283	25	137	infected	infect	VERB
ajlm-283	25	138	pregnant	pregnant	ADJ
ajlm-283	25	139	women.9	women.9	NOUN
ajlm-283	25	140	the	the	DET
ajlm-283	25	141	concept	concept	NOUN
ajlm-283	25	142	of	of	ADP
ajlm-283	25	143	using	use	VERB
ajlm-283	25	144	whole	whole	ADJ
ajlm-283	25	145	blood	blood	NOUN
ajlm-283	25	146	or	or	CCONJ
ajlm-283	25	147	plasma	plasma	NOUN
ajlm-283	25	148	blotted	blot	VERB
ajlm-283	25	149	onto	onto	ADP
ajlm-283	25	150	a	a	DET
ajlm-283	25	151	filter	filter	NOUN
ajlm-283	25	152	paper	paper	NOUN
ajlm-283	25	153	to	to	PART
ajlm-283	25	154	screen	screen	VERB
ajlm-283	25	155	for	for	ADP
ajlm-283	25	156	neonatal	neonatal	ADJ
ajlm-283	25	157	metabolic	metabolic	NOUN
ajlm-283	25	158	disorders	disorder	NOUN
ajlm-283	25	159	was	be	AUX
ajlm-283	25	160	introduced	introduce	VERB
ajlm-283	25	161	in	in	ADP
ajlm-283	25	162	scotland	scotland	PROPN
ajlm-283	25	163	by	by	ADP
ajlm-283	25	164	guthrie	guthrie	PROPN
ajlm-283	25	165	et	et	PROPN
ajlm-283	25	166	al	al	PROPN
ajlm-283	25	167	.	.	PROPN
ajlm-283	26	1	in	in	ADP
ajlm-283	26	2	1963.15	1963.15	NUM
ajlm-283	26	3	the	the	DET
ajlm-283	26	4	use	use	NOUN
ajlm-283	26	5	of	of	ADP
ajlm-283	26	6	dried	dry	VERB
ajlm-283	26	7	blood	blood	NOUN
ajlm-283	26	8	spot	spot	NOUN
ajlm-283	26	9	(	(	PUNCT
ajlm-283	26	10	dbs	dbs	NOUN
ajlm-283	26	11	)	)	PUNCT
ajlm-283	26	12	samples	sample	NOUN
ajlm-283	26	13	for	for	ADP
ajlm-283	26	14	the	the	DET
ajlm-283	26	15	detection	detection	NOUN
ajlm-283	26	16	of	of	ADP
ajlm-283	26	17	hiv	hiv	PROPN
ajlm-283	26	18	,	,	PUNCT
ajlm-283	26	19	as	as	ADV
ajlm-283	26	20	well	well	ADV
ajlm-283	26	21	as	as	ADP
ajlm-283	26	22	the	the	DET
ajlm-283	26	23	stability	stability	NOUN
ajlm-283	26	24	of	of	ADP
ajlm-283	26	25	nucleic	nucleic	ADJ
ajlm-283	26	26	acids	acid	NOUN
ajlm-283	26	27	in	in	ADP
ajlm-283	26	28	this	this	DET
ajlm-283	26	29	sample	sample	NOUN
ajlm-283	26	30	collection	collection	NOUN
ajlm-283	26	31	method	method	NOUN
ajlm-283	26	32	,	,	PUNCT
ajlm-283	26	33	is	be	AUX
ajlm-283	26	34	well	well	ADV
ajlm-283	26	35	described.16,17	described.16,17	NOUN
ajlm-283	26	36	dbs	dbs	NOUN
ajlm-283	26	37	samples	sample	NOUN
ajlm-283	26	38	have	have	AUX
ajlm-283	26	39	been	be	AUX
ajlm-283	26	40	shown	show	VERB
ajlm-283	26	41	not	not	PART
ajlm-283	26	42	only	only	ADV
ajlm-283	26	43	to	to	PART
ajlm-283	26	44	be	be	AUX
ajlm-283	26	45	reliable	reliable	ADJ
ajlm-283	26	46	and	and	CCONJ
ajlm-283	26	47	convenient	convenient	ADJ
ajlm-283	26	48	,	,	PUNCT
ajlm-283	26	49	but	but	CCONJ
ajlm-283	26	50	also	also	ADV
ajlm-283	26	51	to	to	PART
ajlm-283	26	52	have	have	AUX
ajlm-283	26	53	improved	improve	VERB
ajlm-283	26	54	access	access	NOUN
ajlm-283	26	55	to	to	ADP
ajlm-283	26	56	laboratory	laboratory	NOUN
ajlm-283	26	57	testing	testing	NOUN
ajlm-283	26	58	in	in	ADP
ajlm-283	26	59	developing	develop	VERB
ajlm-283	26	60	countries.18	countries.18	NOUN
ajlm-283	26	61	the	the	DET
ajlm-283	26	62	stability	stability	NOUN
ajlm-283	26	63	of	of	ADP
ajlm-283	26	64	markers	marker	NOUN
ajlm-283	26	65	for	for	ADP
ajlm-283	26	66	the	the	DET
ajlm-283	26	67	testing	testing	NOUN
ajlm-283	26	68	of	of	ADP
ajlm-283	26	69	other	other	ADJ
ajlm-283	26	70	infectious	infectious	ADJ
ajlm-283	26	71	diseases	disease	NOUN
ajlm-283	26	72	,	,	PUNCT
ajlm-283	26	73	including	include	VERB
ajlm-283	26	74	hbv	hbv	NOUN
ajlm-283	26	75	,	,	PUNCT
ajlm-283	26	76	on	on	ADP
ajlm-283	26	77	dbs	dbs	NOUN
ajlm-283	26	78	samples	sample	NOUN
ajlm-283	26	79	is	be	AUX
ajlm-283	26	80	well	well	ADV
ajlm-283	26	81	documented.19,20	documented.19,20	VERB
ajlm-283	26	82	the	the	DET
ajlm-283	26	83	objective	objective	NOUN
ajlm-283	26	84	of	of	ADP
ajlm-283	26	85	this	this	DET
ajlm-283	26	86	study	study	NOUN
ajlm-283	26	87	was	be	AUX
ajlm-283	26	88	to	to	PART
ajlm-283	26	89	describe	describe	VERB
ajlm-283	26	90	the	the	DET
ajlm-283	26	91	prevalence	prevalence	NOUN
ajlm-283	26	92	of	of	ADP
ajlm-283	26	93	hbv	hbv	NOUN
ajlm-283	26	94	infection	infection	NOUN
ajlm-283	26	95	amongst	amongst	ADP
ajlm-283	26	96	hiv	hiv	PROPN
ajlm-283	26	97	-	-	PUNCT
ajlm-283	26	98	positive	positive	ADJ
ajlm-283	26	99	and	and	CCONJ
ajlm-283	26	100	hiv	hiv	NOUN
ajlm-283	26	101	-	-	PUNCT
ajlm-283	26	102	negative	negative	ADJ
ajlm-283	26	103	infants	infant	NOUN
ajlm-283	26	104	(	(	PUNCT
ajlm-283	26	105	aged	age	VERB
ajlm-283	26	106	between	between	ADP
ajlm-283	26	107	6	6	NUM
ajlm-283	26	108	weeks	week	NOUN
ajlm-283	26	109	and	and	CCONJ
ajlm-283	26	110	18	18	NUM
ajlm-283	26	111	months	month	NOUN
ajlm-283	26	112	)	)	PUNCT
ajlm-283	26	113	tested	test	VERB
ajlm-283	26	114	for	for	ADP
ajlm-283	26	115	early	early	ADJ
ajlm-283	26	116	-	-	PUNCT
ajlm-283	26	117	infant	infant	NOUN
ajlm-283	26	118	diagnosis	diagnosis	NOUN
ajlm-283	26	119	of	of	ADP
ajlm-283	26	120	hiv	hiv	PROPN
ajlm-283	26	121	in	in	ADP
ajlm-283	26	122	kwazulu	kwazulu	NOUN
ajlm-283	26	123	-	-	PUNCT
ajlm-283	26	124	natal	natal	NOUN
ajlm-283	26	125	by	by	ADP
ajlm-283	26	126	detecting	detect	VERB
ajlm-283	26	127	hbv	hbv	NOUN
ajlm-283	26	128	dna	dna	PROPN
ajlm-283	26	129	using	use	VERB
ajlm-283	26	130	polymerase	polymerase	NOUN
ajlm-283	26	131	chain	chain	NOUN
ajlm-283	26	132	reaction	reaction	NOUN
ajlm-283	26	133	(	(	PUNCT
ajlm-283	26	134	pcr	pcr	NOUN
ajlm-283	26	135	)	)	PUNCT
ajlm-283	26	136	in	in	ADP
ajlm-283	26	137	dbs	dbs	NOUN
ajlm-283	26	138	samples	sample	NOUN
ajlm-283	26	139	.	.	PUNCT
ajlm-283	27	1	we	we	PRON
ajlm-283	27	2	also	also	ADV
ajlm-283	27	3	evaluated	evaluate	VERB
ajlm-283	27	4	whether	whether	SCONJ
ajlm-283	27	5	the	the	DET
ajlm-283	27	6	prevalence	prevalence	NOUN
ajlm-283	27	7	of	of	ADP
ajlm-283	27	8	hbv	hbv	NOUN
ajlm-283	27	9	in	in	ADP
ajlm-283	27	10	this	this	DET
ajlm-283	27	11	population	population	NOUN
ajlm-283	27	12	group	group	NOUN
ajlm-283	27	13	was	be	AUX
ajlm-283	27	14	influenced	influence	VERB
ajlm-283	27	15	by	by	ADP
ajlm-283	27	16	hiv	hiv	PROPN
ajlm-283	27	17	co	co	NOUN
ajlm-283	27	18	-	-	NOUN
ajlm-283	27	19	infection	infection	NOUN
ajlm-283	27	20	.	.	PUNCT
ajlm-283	28	1	research	research	NOUN
ajlm-283	28	2	method	method	NOUN
ajlm-283	28	3	and	and	CCONJ
ajlm-283	28	4	design	design	VERB
ajlm-283	28	5	ethical	ethical	ADJ
ajlm-283	28	6	considerations	consideration	NOUN
ajlm-283	28	7	ethical	ethical	ADJ
ajlm-283	28	8	approval	approval	NOUN
ajlm-283	28	9	was	be	AUX
ajlm-283	28	10	obtained	obtain	VERB
ajlm-283	28	11	from	from	ADP
ajlm-283	28	12	the	the	DET
ajlm-283	28	13	biomedical	biomedical	ADJ
ajlm-283	28	14	research	research	NOUN
ajlm-283	28	15	and	and	CCONJ
ajlm-283	28	16	ethics	ethic	NOUN
ajlm-283	28	17	committee	committee	PROPN
ajlm-283	28	18	(	(	PUNCT
ajlm-283	28	19	brec	brec	PROPN
ajlm-283	28	20	)	)	PUNCT
ajlm-283	28	21	of	of	ADP
ajlm-283	28	22	the	the	DET
ajlm-283	28	23	university	university	PROPN
ajlm-283	28	24	of	of	ADP
ajlm-283	28	25	kwazulu	kwazulu	PROPN
ajlm-283	28	26	-	-	PUNCT
ajlm-283	28	27	natal	natal	NOUN
ajlm-283	28	28	(	(	PUNCT
ajlm-283	28	29	be243/010	be243/010	PROPN
ajlm-283	28	30	)	)	PUNCT
ajlm-283	28	31	.	.	PUNCT
ajlm-283	29	1	the	the	DET
ajlm-283	29	2	samples	sample	NOUN
ajlm-283	29	3	were	be	AUX
ajlm-283	29	4	sequentially	sequentially	ADV
ajlm-283	29	5	selected	select	VERB
ajlm-283	29	6	from	from	ADP
ajlm-283	29	7	those	those	PRON
ajlm-283	29	8	discarded	discard	VERB
ajlm-283	29	9	and	and	CCONJ
ajlm-283	29	10	anonymised	anonymise	VERB
ajlm-283	29	11	.	.	PUNCT
ajlm-283	30	1	study	study	NOUN
ajlm-283	30	2	population	population	NOUN
ajlm-283	30	3	and	and	CCONJ
ajlm-283	30	4	design	design	VERB
ajlm-283	30	5	this	this	DET
ajlm-283	30	6	retrospective	retrospective	ADJ
ajlm-283	30	7	cross	cross	ADJ
ajlm-283	30	8	-	-	ADJ
ajlm-283	30	9	sectional	sectional	ADJ
ajlm-283	30	10	study	study	NOUN
ajlm-283	30	11	was	be	AUX
ajlm-283	30	12	conducted	conduct	VERB
ajlm-283	30	13	in	in	ADP
ajlm-283	30	14	the	the	DET
ajlm-283	30	15	department	department	NOUN
ajlm-283	30	16	of	of	ADP
ajlm-283	30	17	virology	virology	NOUN
ajlm-283	30	18	at	at	ADP
ajlm-283	30	19	inkosi	inkosi	PROPN
ajlm-283	30	20	albert	albert	PROPN
ajlm-283	30	21	luthuli	luthuli	PROPN
ajlm-283	30	22	central	central	PROPN
ajlm-283	30	23	hospital	hospital	NOUN
ajlm-283	30	24	,	,	PUNCT
ajlm-283	30	25	located	locate	VERB
ajlm-283	30	26	in	in	ADP
ajlm-283	30	27	the	the	DET
ajlm-283	30	28	city	city	NOUN
ajlm-283	30	29	of	of	ADP
ajlm-283	30	30	durban	durban	PROPN
ajlm-283	30	31	,	,	PUNCT
ajlm-283	30	32	kwazulu	kwazulu	NOUN
ajlm-283	30	33	-	-	PUNCT
ajlm-283	30	34	natal	natal	ADJ
ajlm-283	30	35	,	,	PUNCT
ajlm-283	30	36	south	south	PROPN
ajlm-283	30	37	africa	africa	PROPN
ajlm-283	30	38	.	.	PUNCT
ajlm-283	31	1	the	the	DET
ajlm-283	31	2	department	department	PROPN
ajlm-283	31	3	of	of	ADP
ajlm-283	31	4	virology	virology	NOUN
ajlm-283	31	5	is	be	AUX
ajlm-283	31	6	an	an	DET
ajlm-283	31	7	academic	academic	ADJ
ajlm-283	31	8	referral	referral	NOUN
ajlm-283	31	9	laboratory	laboratory	NOUN
ajlm-283	31	10	that	that	PRON
ajlm-283	31	11	offers	offer	VERB
ajlm-283	31	12	diagnostic	diagnostic	ADJ
ajlm-283	31	13	virology	virology	NOUN
ajlm-283	31	14	services	service	NOUN
ajlm-283	31	15	to	to	ADP
ajlm-283	31	16	the	the	DET
ajlm-283	31	17	entire	entire	ADJ
ajlm-283	31	18	kwazulu	kwazulu	VERB
ajlm-283	31	19	-	-	PUNCT
ajlm-283	31	20	natal	natal	ADJ
ajlm-283	31	21	province	province	NOUN
ajlm-283	31	22	and	and	CCONJ
ajlm-283	31	23	is	be	AUX
ajlm-283	31	24	a	a	DET
ajlm-283	31	25	laboratory	laboratory	NOUN
ajlm-283	31	26	of	of	ADP
ajlm-283	31	27	the	the	DET
ajlm-283	31	28	national	national	PROPN
ajlm-283	31	29	health	health	PROPN
ajlm-283	31	30	laboratory	laboratory	PROPN
ajlm-283	31	31	service	service	NOUN
ajlm-283	31	32	.	.	PUNCT
ajlm-283	32	1	approximately	approximately	ADV
ajlm-283	32	2	9000	9000	NUM
ajlm-283	32	3	dbs	dbs	NOUN
ajlm-283	32	4	samples	sample	NOUN
ajlm-283	32	5	are	be	AUX
ajlm-283	32	6	received	receive	VERB
ajlm-283	32	7	by	by	ADP
ajlm-283	32	8	the	the	DET
ajlm-283	32	9	laboratory	laboratory	NOUN
ajlm-283	32	10	per	per	ADP
ajlm-283	32	11	month	month	NOUN
ajlm-283	32	12	for	for	ADP
ajlm-283	32	13	routine	routine	ADJ
ajlm-283	32	14	diagnostic	diagnostic	ADJ
ajlm-283	32	15	detection	detection	NOUN
ajlm-283	32	16	of	of	ADP
ajlm-283	32	17	hiv	hiv	PROPN
ajlm-283	32	18	using	use	VERB
ajlm-283	32	19	a	a	DET
ajlm-283	32	20	commercial	commercial	ADJ
ajlm-283	32	21	kit	kit	NOUN
ajlm-283	32	22	,	,	PUNCT
ajlm-283	32	23	namely	namely	ADV
ajlm-283	32	24	the	the	DET
ajlm-283	32	25	hiv	hiv	PROPN
ajlm-283	32	26	dna	dna	PROPN
ajlm-283	32	27	pcr	pcr	PROPN
ajlm-283	32	28	cobas	cobas	PROPN
ajlm-283	32	29	®	®	PROPN
ajlm-283	32	30	ampliprep	ampliprep	PROPN
ajlm-283	32	31	/	/	SYM
ajlm-283	32	32	cobas	cobas	ADJ
ajlm-283	32	33	taqman	taqman	NOUN
ajlm-283	32	34	®	®	NOUN
ajlm-283	32	35	hiv-1	hiv-1	X
ajlm-283	32	36	qualitative	qualitative	ADJ
ajlm-283	32	37	test	test	NOUN
ajlm-283	32	38	(	(	PUNCT
ajlm-283	32	39	roche	roche	X
ajlm-283	32	40	molecular	molecular	ADJ
ajlm-283	32	41	systems	systems	PROPN
ajlm-283	32	42	,	,	PUNCT
ajlm-283	32	43	inc	inc	PROPN
ajlm-283	32	44	.	.	PROPN
ajlm-283	32	45	,	,	PUNCT
ajlm-283	32	46	branchburg	branchburg	PROPN
ajlm-283	32	47	,	,	PUNCT
ajlm-283	32	48	new	new	PROPN
ajlm-283	32	49	jersey	jersey	PROPN
ajlm-283	32	50	,	,	PUNCT
ajlm-283	32	51	united	united	PROPN
ajlm-283	32	52	states	states	PROPN
ajlm-283	32	53	)	)	PUNCT
ajlm-283	32	54	.	.	PUNCT
ajlm-283	33	1	the	the	DET
ajlm-283	33	2	study	study	NOUN
ajlm-283	33	3	samples	sample	NOUN
ajlm-283	33	4	were	be	AUX
ajlm-283	33	5	randomly	randomly	ADV
ajlm-283	33	6	selected	select	VERB
ajlm-283	33	7	from	from	ADP
ajlm-283	33	8	residual	residual	ADJ
ajlm-283	33	9	samples	sample	NOUN
ajlm-283	33	10	scheduled	schedule	VERB
ajlm-283	33	11	to	to	PART
ajlm-283	33	12	be	be	AUX
ajlm-283	33	13	discarded	discard	VERB
ajlm-283	33	14	after	after	ADP
ajlm-283	33	15	testing	test	VERB
ajlm-283	33	16	for	for	ADP
ajlm-283	33	17	early	early	ADJ
ajlm-283	33	18	-	-	PUNCT
ajlm-283	33	19	infant	infant	NOUN
ajlm-283	33	20	diagnosis	diagnosis	NOUN
ajlm-283	33	21	of	of	ADP
ajlm-283	33	22	hiv	hiv	PROPN
ajlm-283	33	23	.	.	PUNCT
ajlm-283	34	1	samples	sample	NOUN
ajlm-283	34	2	with	with	ADP
ajlm-283	34	3	a	a	DET
ajlm-283	34	4	full	full	ADJ
ajlm-283	34	5	blood	blood	NOUN
ajlm-283	34	6	spot	spot	NOUN
ajlm-283	34	7	from	from	ADP
ajlm-283	34	8	infants	infant	NOUN
ajlm-283	34	9	aged	age	VERB
ajlm-283	34	10	18	18	NUM
ajlm-283	34	11	months	month	NOUN
ajlm-283	34	12	or	or	CCONJ
ajlm-283	34	13	younger	young	ADJ
ajlm-283	34	14	were	be	AUX
ajlm-283	34	15	included	include	VERB
ajlm-283	34	16	for	for	ADP
ajlm-283	34	17	hbv	hbv	NOUN
ajlm-283	34	18	testing	testing	NOUN
ajlm-283	34	19	.	.	PUNCT
ajlm-283	35	1	samples	sample	NOUN
ajlm-283	35	2	with	with	ADP
ajlm-283	35	3	inadequate	inadequate	ADJ
ajlm-283	35	4	blood	blood	NOUN
ajlm-283	35	5	spots	spot	NOUN
ajlm-283	35	6	or	or	CCONJ
ajlm-283	35	7	from	from	ADP
ajlm-283	35	8	patients	patient	NOUN
ajlm-283	35	9	aged	age	VERB
ajlm-283	35	10	older	old	ADJ
ajlm-283	35	11	than	than	ADP
ajlm-283	35	12	18	18	NUM
ajlm-283	35	13	months	month	NOUN
ajlm-283	35	14	were	be	AUX
ajlm-283	35	15	excluded	exclude	VERB
ajlm-283	35	16	.	.	PUNCT
ajlm-283	36	1	once	once	SCONJ
ajlm-283	36	2	the	the	DET
ajlm-283	36	3	hiv	hiv	PROPN
ajlm-283	36	4	results	result	NOUN
ajlm-283	36	5	and	and	CCONJ
ajlm-283	36	6	age	age	NOUN
ajlm-283	36	7	were	be	AUX
ajlm-283	36	8	recorded	record	VERB
ajlm-283	36	9	,	,	PUNCT
ajlm-283	36	10	the	the	DET
ajlm-283	36	11	samples	sample	NOUN
ajlm-283	36	12	were	be	AUX
ajlm-283	36	13	anonymised	anonymise	VERB
ajlm-283	36	14	and	and	CCONJ
ajlm-283	36	15	given	give	VERB
ajlm-283	36	16	unique	unique	ADJ
ajlm-283	36	17	study	study	NOUN
ajlm-283	36	18	numbers	number	NOUN
ajlm-283	36	19	.	.	PUNCT
ajlm-283	37	1	the	the	DET
ajlm-283	37	2	study	study	NOUN
ajlm-283	37	3	samples	sample	NOUN
ajlm-283	37	4	were	be	AUX
ajlm-283	37	5	collected	collect	VERB
ajlm-283	37	6	over	over	ADP
ajlm-283	37	7	a	a	DET
ajlm-283	37	8	six	six	NUM
ajlm-283	37	9	-	-	PUNCT
ajlm-283	37	10	month	month	NOUN
ajlm-283	37	11	period	period	NOUN
ajlm-283	37	12	(	(	PUNCT
ajlm-283	37	13	july	july	PROPN
ajlm-283	37	14	2011	2011	NUM
ajlm-283	37	15	to	to	ADP
ajlm-283	37	16	december	december	PROPN
ajlm-283	37	17	2011	2011	NUM
ajlm-283	37	18	)	)	PUNCT
ajlm-283	37	19	.	.	PUNCT
ajlm-283	38	1	the	the	DET
ajlm-283	38	2	samples	sample	NOUN
ajlm-283	38	3	were	be	AUX
ajlm-283	38	4	stored	store	VERB
ajlm-283	38	5	in	in	ADP
ajlm-283	38	6	individual	individual	ADJ
ajlm-283	38	7	plastic	plastic	NOUN
ajlm-283	38	8	packets	packet	NOUN
ajlm-283	38	9	with	with	ADP
ajlm-283	38	10	desiccant	desiccant	NOUN
ajlm-283	38	11	at	at	ADP
ajlm-283	38	12	room	room	NOUN
ajlm-283	38	13	temperature	temperature	NOUN
ajlm-283	38	14	until	until	SCONJ
ajlm-283	38	15	tested	test	VERB
ajlm-283	38	16	for	for	ADP
ajlm-283	38	17	hbv	hbv	NOUN
ajlm-283	38	18	using	use	VERB
ajlm-283	38	19	the	the	DET
ajlm-283	38	20	nested	nested	ADJ
ajlm-283	38	21	pcr	pcr	ADJ
ajlm-283	38	22	method	method	NOUN
ajlm-283	38	23	.	.	PUNCT
ajlm-283	39	1	the	the	DET
ajlm-283	39	2	sample	sample	NOUN
ajlm-283	39	3	size	size	NOUN
ajlm-283	39	4	for	for	ADP
ajlm-283	39	5	the	the	DET
ajlm-283	39	6	number	number	NOUN
ajlm-283	39	7	of	of	ADP
ajlm-283	39	8	hiv	hiv	PROPN
ajlm-283	39	9	-	-	PUNCT
ajlm-283	39	10	positive	positive	ADJ
ajlm-283	39	11	and	and	CCONJ
ajlm-283	39	12	hiv	hiv	NOUN
ajlm-283	39	13	-	-	PUNCT
ajlm-283	39	14	negative	negative	ADJ
ajlm-283	39	15	samples	sample	NOUN
ajlm-283	39	16	was	be	AUX
ajlm-283	39	17	calculated	calculate	VERB
ajlm-283	39	18	using	use	VERB
ajlm-283	39	19	an	an	DET
ajlm-283	39	20	hiv	hiv	PROPN
ajlm-283	39	21	prevalence	prevalence	NOUN
ajlm-283	39	22	of	of	ADP
ajlm-283	39	23	29.3	29.3	NUM
ajlm-283	39	24	%	%	NOUN
ajlm-283	39	25	,	,	PUNCT
ajlm-283	39	26	as	as	SCONJ
ajlm-283	39	27	reported	report	VERB
ajlm-283	39	28	in	in	ADP
ajlm-283	39	29	the	the	DET
ajlm-283	39	30	south	south	ADJ
ajlm-283	39	31	african	african	ADJ
ajlm-283	39	32	annual	annual	ADJ
ajlm-283	39	33	national	national	ADJ
ajlm-283	39	34	surveillance	surveillance	NOUN
ajlm-283	39	35	in	in	ADP
ajlm-283	39	36	antenatal	antenatal	ADJ
ajlm-283	39	37	clinics	clinic	NOUN
ajlm-283	39	38	report	report	NOUN
ajlm-283	39	39	of	of	ADP
ajlm-283	39	40	2008.12	2008.12	NUM
ajlm-283	39	41	the	the	DET
ajlm-283	39	42	sample	sample	NOUN
ajlm-283	39	43	size	size	NOUN
ajlm-283	39	44	of	of	ADP
ajlm-283	39	45	322	322	NUM
ajlm-283	39	46	was	be	AUX
ajlm-283	39	47	based	base	VERB
ajlm-283	39	48	on	on	ADP
ajlm-283	39	49	an	an	DET
ajlm-283	39	50	estimated	estimate	VERB
ajlm-283	39	51	250	250	NUM
ajlm-283	39	52	000	000	NUM
ajlm-283	39	53	live	live	ADJ
ajlm-283	39	54	births	birth	NOUN
ajlm-283	39	55	in	in	ADP
ajlm-283	39	56	kwazulu	kwazulu	PROPN
ajlm-283	39	57	-	-	PUNCT
ajlm-283	39	58	natal21	natal21	NOUN
ajlm-283	39	59	and	and	CCONJ
ajlm-283	39	60	allowed	allow	VERB
ajlm-283	39	61	for	for	ADP
ajlm-283	39	62	a	a	DET
ajlm-283	39	63	confidence	confidence	NOUN
ajlm-283	39	64	interval	interval	NOUN
ajlm-283	39	65	(	(	PUNCT
ajlm-283	39	66	ci	ci	NOUN
ajlm-283	39	67	)	)	PUNCT
ajlm-283	39	68	of	of	ADP
ajlm-283	39	69	95	95	NUM
ajlm-283	39	70	%	%	NOUN
ajlm-283	39	71	for	for	ADP
ajlm-283	39	72	a	a	DET
ajlm-283	39	73	population	population	NOUN
ajlm-283	39	74	epidemiological	epidemiological	ADJ
ajlm-283	39	75	survey	survey	NOUN
ajlm-283	39	76	,	,	PUNCT
ajlm-283	39	77	as	as	SCONJ
ajlm-283	39	78	calculated	calculate	VERB
ajlm-283	39	79	using	use	VERB
ajlm-283	39	80	epi	epi	NOUN
ajlm-283	39	81	info	info	NOUN
ajlm-283	39	82	™	™	PROPN
ajlm-283	39	83	,	,	PUNCT
ajlm-283	39	84	version	version	NOUN
ajlm-283	39	85	3.5.1	3.5.1	NUM
ajlm-283	39	86	(	(	PUNCT
ajlm-283	39	87	centers	center	NOUN
ajlm-283	39	88	for	for	ADP
ajlm-283	39	89	disease	disease	NOUN
ajlm-283	39	90	control	control	NOUN
ajlm-283	39	91	and	and	CCONJ
ajlm-283	39	92	prevention	prevention	NOUN
ajlm-283	39	93	,	,	PUNCT
ajlm-283	39	94	atlanta	atlanta	PROPN
ajlm-283	39	95	,	,	PUNCT
ajlm-283	39	96	georgia	georgia	PROPN
ajlm-283	39	97	,	,	PUNCT
ajlm-283	39	98	united	united	PROPN
ajlm-283	39	99	states	states	PROPN
ajlm-283	39	100	)	)	PUNCT
ajlm-283	39	101	.	.	PUNCT
ajlm-283	40	1	equal	equal	ADJ
ajlm-283	40	2	proportions	proportion	NOUN
ajlm-283	40	3	of	of	ADP
ajlm-283	40	4	hiv	hiv	PROPN
ajlm-283	40	5	-	-	PUNCT
ajlm-283	40	6	positive	positive	ADJ
ajlm-283	40	7	and	and	CCONJ
ajlm-283	40	8	hiv	hiv	NOUN
ajlm-283	40	9	-	-	PUNCT
ajlm-283	40	10	negative	negative	ADJ
ajlm-283	40	11	infant	infant	NOUN
ajlm-283	40	12	specimens	specimen	NOUN
ajlm-283	40	13	were	be	AUX
ajlm-283	40	14	included	include	VERB
ajlm-283	40	15	.	.	PUNCT
ajlm-283	41	1	laboratory	laboratory	NOUN
ajlm-283	41	2	methods	method	NOUN
ajlm-283	41	3	a	a	DET
ajlm-283	41	4	qualitative	qualitative	NOUN
ajlm-283	41	5	in	in	ADP
ajlm-283	41	6	-	-	PUNCT
ajlm-283	41	7	house	house	NOUN
ajlm-283	41	8	nested	nest	VERB
ajlm-283	41	9	pcr	pcr	PROPN
ajlm-283	41	10	method22	method22	NOUN
ajlm-283	41	11	was	be	AUX
ajlm-283	41	12	used	use	VERB
ajlm-283	41	13	for	for	ADP
ajlm-283	41	14	the	the	DET
ajlm-283	41	15	detection	detection	NOUN
ajlm-283	41	16	of	of	ADP
ajlm-283	41	17	hbv	hbv	NOUN
ajlm-283	41	18	dna	dna	PROPN
ajlm-283	41	19	in	in	ADP
ajlm-283	41	20	the	the	DET
ajlm-283	41	21	dbs	dbs	PROPN
ajlm-283	41	22	samples	sample	NOUN
ajlm-283	41	23	.	.	PUNCT
ajlm-283	42	1	the	the	DET
ajlm-283	42	2	primers	primer	NOUN
ajlm-283	42	3	(	(	PUNCT
ajlm-283	42	4	table	table	NOUN
ajlm-283	42	5	1	1	NUM
ajlm-283	42	6	)	)	PUNCT
ajlm-283	42	7	targeted	target	VERB
ajlm-283	42	8	the	the	DET
ajlm-283	42	9	surface	surface	NOUN
ajlm-283	42	10	gene	gene	NOUN
ajlm-283	42	11	of	of	ADP
ajlm-283	42	12	the	the	DET
ajlm-283	42	13	hbv	hbv	NOUN
ajlm-283	42	14	genome	genome	NOUN
ajlm-283	42	15	.	.	PUNCT
ajlm-283	43	1	the	the	DET
ajlm-283	43	2	first	first	ADJ
ajlm-283	43	3	outer	outer	ADJ
ajlm-283	43	4	set	set	NOUN
ajlm-283	43	5	of	of	ADP
ajlm-283	43	6	primers	primer	NOUN
ajlm-283	43	7	was	be	AUX
ajlm-283	43	8	used	use	VERB
ajlm-283	43	9	to	to	PART
ajlm-283	43	10	amplify	amplify	VERB
ajlm-283	43	11	the	the	DET
ajlm-283	43	12	entire	entire	ADJ
ajlm-283	43	13	coding	code	VERB
ajlm-283	43	14	region	region	NOUN
ajlm-283	43	15	for	for	ADP
ajlm-283	43	16	the	the	DET
ajlm-283	43	17	large	large	ADJ
ajlm-283	43	18	-	-	PUNCT
ajlm-283	43	19	surface	surface	NOUN
ajlm-283	43	20	antigen	antigen	ADJ
ajlm-283	43	21	gene	gene	NOUN
ajlm-283	43	22	of	of	ADP
ajlm-283	43	23	the	the	DET
ajlm-283	43	24	hbv	hbv	NOUN
ajlm-283	43	25	genome	genome	NOUN
ajlm-283	43	26	,	,	PUNCT
ajlm-283	43	27	which	which	PRON
ajlm-283	43	28	incorporated	incorporate	VERB
ajlm-283	43	29	the	the	DET
ajlm-283	43	30	middle	middle	ADJ
ajlm-283	43	31	-	-	PUNCT
ajlm-283	43	32	surface	surface	NOUN
ajlm-283	43	33	antigen	antigen	NOUN
ajlm-283	43	34	and	and	CCONJ
ajlm-283	43	35	the	the	DET
ajlm-283	43	36	small	small	ADJ
ajlm-283	43	37	-	-	PUNCT
ajlm-283	43	38	surface	surface	NOUN
ajlm-283	43	39	antigen	antigen	NOUN
ajlm-283	43	40	.	.	PUNCT
ajlm-283	44	1	the	the	DET
ajlm-283	44	2	nested	nested	ADJ
ajlm-283	44	3	primers	primer	NOUN
ajlm-283	44	4	amplified	amplify	VERB
ajlm-283	44	5	the	the	DET
ajlm-283	44	6	pres2	pres2	NOUN
ajlm-283	44	7	region	region	NOUN
ajlm-283	44	8	and	and	CCONJ
ajlm-283	44	9	most	most	ADJ
ajlm-283	44	10	of	of	ADP
ajlm-283	44	11	the	the	DET
ajlm-283	44	12	surface	surface	NOUN
ajlm-283	44	13	antigen	antigen	ADV
ajlm-283	44	14	.	.	PUNCT
ajlm-283	45	1	details	detail	NOUN
ajlm-283	45	2	of	of	ADP
ajlm-283	45	3	this	this	DET
ajlm-283	45	4	method	method	NOUN
ajlm-283	45	5	have	have	AUX
ajlm-283	45	6	been	be	AUX
ajlm-283	45	7	published	publish	VERB
ajlm-283	45	8	previously.23	previously.23	NOUN
ajlm-283	45	9	table	table	NOUN
ajlm-283	45	10	1	1	NUM
ajlm-283	45	11	:	:	PUNCT
ajlm-283	45	12	 	 	SPACE
ajlm-283	45	13	pcr	pcr	ADJ
ajlm-283	45	14	primers	primer	NOUN
ajlm-283	45	15	used	use	VERB
ajlm-283	45	16	for	for	ADP
ajlm-283	45	17	detection	detection	NOUN
ajlm-283	45	18	of	of	ADP
ajlm-283	45	19	hbv	hbv	PROPN
ajlm-283	45	20	dna	dna	PROPN
ajlm-283	45	21	.	.	PUNCT
ajlm-283	46	1	nucleic	nucleic	ADJ
ajlm-283	46	2	acid	acid	NOUN
ajlm-283	46	3	extraction	extraction	NOUN
ajlm-283	46	4	was	be	AUX
ajlm-283	46	5	achieved	achieve	VERB
ajlm-283	46	6	using	use	VERB
ajlm-283	46	7	the	the	DET
ajlm-283	46	8	magna	magna	PROPN
ajlm-283	46	9	pure	pure	ADJ
ajlm-283	46	10	lc	lc	PROPN
ajlm-283	46	11	™	™	ADJ
ajlm-283	46	12	dna	dna	NOUN
ajlm-283	46	13	isolation	isolation	NOUN
ajlm-283	46	14	kit	kit	NOUN
ajlm-283	46	15	iii	iii	NOUN
ajlm-283	46	16	on	on	ADP
ajlm-283	46	17	the	the	DET
ajlm-283	46	18	roche	roche	PROPN
ajlm-283	46	19	magna	magna	PROPN
ajlm-283	46	20	pure	pure	ADJ
ajlm-283	46	21	™	™	PROPN
ajlm-283	46	22	lc	lc	PROPN
ajlm-283	46	23	instrument	instrument	NOUN
ajlm-283	46	24	(	(	PUNCT
ajlm-283	46	25	roche	roche	X
ajlm-283	46	26	molecular	molecular	ADJ
ajlm-283	46	27	diagnostics	diagnostic	NOUN
ajlm-283	46	28	,	,	PUNCT
ajlm-283	46	29	mannheim	mannheim	PROPN
ajlm-283	46	30	,	,	PUNCT
ajlm-283	46	31	germany	germany	PROPN
ajlm-283	46	32	)	)	PUNCT
ajlm-283	46	33	.	.	PUNCT
ajlm-283	47	1	a	a	DET
ajlm-283	47	2	pre	pre	ADJ
ajlm-283	47	3	-	-	ADJ
ajlm-283	47	4	extraction	extraction	NOUN
ajlm-283	47	5	step	step	NOUN
ajlm-283	47	6	was	be	AUX
ajlm-283	47	7	performed24	performed24	NOUN
ajlm-283	47	8	as	as	ADP
ajlm-283	47	9	a	a	DET
ajlm-283	47	10	modification	modification	NOUN
ajlm-283	47	11	to	to	ADP
ajlm-283	47	12	the	the	DET
ajlm-283	47	13	manufacturer	manufacturer	NOUN
ajlm-283	47	14	’s	’s	PART
ajlm-283	47	15	protocol	protocol	NOUN
ajlm-283	47	16	for	for	ADP
ajlm-283	47	17	dbs	dbs	PROPN
ajlm-283	47	18	extraction	extraction	NOUN
ajlm-283	47	19	.	.	PUNCT
ajlm-283	48	1	a	a	DET
ajlm-283	48	2	whole	whole	ADJ
ajlm-283	48	3	-	-	PUNCT
ajlm-283	48	4	blood	blood	NOUN
ajlm-283	48	5	spot	spot	NOUN
ajlm-283	48	6	containing	contain	VERB
ajlm-283	48	7	approximately	approximately	ADV
ajlm-283	48	8	50	50	NUM
ajlm-283	48	9	µl	µl	NOUN
ajlm-283	48	10	of	of	ADP
ajlm-283	48	11	dried	dry	VERB
ajlm-283	48	12	blood	blood	NOUN
ajlm-283	48	13	was	be	AUX
ajlm-283	48	14	cut	cut	VERB
ajlm-283	48	15	from	from	ADP
ajlm-283	48	16	the	the	DET
ajlm-283	48	17	filter	filter	NOUN
ajlm-283	48	18	paper	paper	NOUN
ajlm-283	48	19	and	and	CCONJ
ajlm-283	48	20	added	add	VERB
ajlm-283	48	21	into	into	ADP
ajlm-283	48	22	a	a	DET
ajlm-283	48	23	300	300	NUM
ajlm-283	48	24	µl	µl	ADP
ajlm-283	48	25	mixture	mixture	NOUN
ajlm-283	48	26	of	of	ADP
ajlm-283	48	27	lysis	lysis	NOUN
ajlm-283	48	28	buffer	buffer	NOUN
ajlm-283	48	29	with	with	ADP
ajlm-283	48	30	proteinase	proteinase	PROPN
ajlm-283	48	31	k	k	PROPN
ajlm-283	48	32	and	and	CCONJ
ajlm-283	48	33	elution	elution	NOUN
ajlm-283	48	34	buffer	buffer	NOUN
ajlm-283	48	35	in	in	ADP
ajlm-283	48	36	a	a	DET
ajlm-283	48	37	1	1	NUM
ajlm-283	48	38	-	-	PUNCT
ajlm-283	48	39	ml	ml	NOUN
ajlm-283	48	40	microtube	microtube	NOUN
ajlm-283	48	41	.	.	PUNCT
ajlm-283	49	1	the	the	DET
ajlm-283	49	2	tubes	tube	NOUN
ajlm-283	49	3	were	be	AUX
ajlm-283	49	4	incubated	incubate	VERB
ajlm-283	49	5	on	on	ADP
ajlm-283	49	6	a	a	DET
ajlm-283	49	7	heating	heating	NOUN
ajlm-283	49	8	block	block	NOUN
ajlm-283	49	9	for	for	ADP
ajlm-283	49	10	10	10	NUM
ajlm-283	49	11	min	min	NOUN
ajlm-283	49	12	at	at	ADP
ajlm-283	49	13	65	65	NUM
ajlm-283	49	14	°	°	NOUN
ajlm-283	49	15	c	c	NOUN
ajlm-283	49	16	and	and	CCONJ
ajlm-283	49	17	another	another	DET
ajlm-283	49	18	10	10	NUM
ajlm-283	49	19	min	min	NOUN
ajlm-283	49	20	at	at	ADP
ajlm-283	49	21	95	95	NUM
ajlm-283	49	22	°	°	ADP
ajlm-283	49	23	c	c	NOUN
ajlm-283	49	24	,	,	PUNCT
ajlm-283	49	25	then	then	ADV
ajlm-283	49	26	centrifuged	centrifuge	VERB
ajlm-283	49	27	at	at	ADP
ajlm-283	49	28	1500	1500	NUM
ajlm-283	49	29	g	g	NOUN
ajlm-283	49	30	for	for	ADP
ajlm-283	49	31	3	3	NUM
ajlm-283	49	32	minutes	minute	NOUN
ajlm-283	49	33	.	.	PUNCT
ajlm-283	50	1	a	a	DET
ajlm-283	50	2	200-µl	200-µl	NUM
ajlm-283	50	3	lysate	lysate	NOUN
ajlm-283	50	4	was	be	AUX
ajlm-283	50	5	then	then	ADV
ajlm-283	50	6	transferred	transfer	VERB
ajlm-283	50	7	for	for	ADP
ajlm-283	50	8	automated	automate	VERB
ajlm-283	50	9	nucleic	nucleic	ADJ
ajlm-283	50	10	acid	acid	NOUN
ajlm-283	50	11	extraction	extraction	NOUN
ajlm-283	50	12	.	.	PUNCT
ajlm-283	51	1	amplification	amplification	NOUN
ajlm-283	51	2	was	be	AUX
ajlm-283	51	3	carried	carry	VERB
ajlm-283	51	4	out	out	ADP
ajlm-283	51	5	using	use	VERB
ajlm-283	51	6	the	the	DET
ajlm-283	51	7	genamp	genamp	ADJ
ajlm-283	51	8	9700	9700	NUM
ajlm-283	51	9	™	™	ADJ
ajlm-283	51	10	thermocycler	thermocycler	NOUN
ajlm-283	51	11	(	(	PUNCT
ajlm-283	51	12	applied	apply	VERB
ajlm-283	51	13	biosystems	biosystem	NOUN
ajlm-283	51	14	™	™	NOUN
ajlm-283	51	15	,	,	PUNCT
ajlm-283	51	16	life	life	NOUN
ajlm-283	51	17	technologies	technology	NOUN
ajlm-283	51	18	,	,	PUNCT
ajlm-283	51	19	carlsbad	carlsbad	PROPN
ajlm-283	51	20	,	,	PUNCT
ajlm-283	51	21	california	california	PROPN
ajlm-283	51	22	,	,	PUNCT
ajlm-283	51	23	united	united	PROPN
ajlm-283	51	24	states	states	PROPN
ajlm-283	51	25	)	)	PUNCT
ajlm-283	51	26	.	.	PUNCT
ajlm-283	52	1	the	the	DET
ajlm-283	52	2	master	master	NOUN
ajlm-283	52	3	mix	mix	VERB
ajlm-283	52	4	reagents	reagent	NOUN
ajlm-283	52	5	for	for	ADP
ajlm-283	52	6	both	both	DET
ajlm-283	52	7	pcr	pcr	ADJ
ajlm-283	52	8	rounds	round	NOUN
ajlm-283	52	9	were	be	AUX
ajlm-283	52	10	prepared	prepare	VERB
ajlm-283	52	11	in	in	ADP
ajlm-283	52	12	a	a	DET
ajlm-283	52	13	separate	separate	ADJ
ajlm-283	52	14	clean	clean	ADJ
ajlm-283	52	15	laboratory	laboratory	NOUN
ajlm-283	52	16	and	and	CCONJ
ajlm-283	52	17	kept	keep	VERB
ajlm-283	52	18	on	on	ADP
ajlm-283	52	19	an	an	DET
ajlm-283	52	20	ice	ice	NOUN
ajlm-283	52	21	block	block	NOUN
ajlm-283	52	22	to	to	PART
ajlm-283	52	23	prevent	prevent	VERB
ajlm-283	52	24	nonspecific	nonspecific	ADJ
ajlm-283	52	25	reactions	reaction	NOUN
ajlm-283	52	26	and	and	CCONJ
ajlm-283	52	27	minimise	minimise	VERB
ajlm-283	52	28	the	the	DET
ajlm-283	52	29	formation	formation	NOUN
ajlm-283	52	30	of	of	ADP
ajlm-283	52	31	primer	primer	NOUN
ajlm-283	52	32	dimers	dimer	NOUN
ajlm-283	52	33	.	.	PUNCT
ajlm-283	53	1	the	the	DET
ajlm-283	53	2	first	first	ADJ
ajlm-283	53	3	-	-	PUNCT
ajlm-283	53	4	round	round	NOUN
ajlm-283	53	5	cycling	cycling	NOUN
ajlm-283	53	6	programme	programme	NOUN
ajlm-283	53	7	had	have	VERB
ajlm-283	53	8	36	36	NUM
ajlm-283	53	9	cycles	cycle	NOUN
ajlm-283	53	10	and	and	CCONJ
ajlm-283	53	11	dilution	dilution	NOUN
ajlm-283	53	12	of	of	ADP
ajlm-283	53	13	the	the	DET
ajlm-283	53	14	first	first	ADJ
ajlm-283	53	15	-	-	PUNCT
ajlm-283	53	16	round	round	NOUN
ajlm-283	53	17	pcr	pcr	ADJ
ajlm-283	53	18	products	product	NOUN
ajlm-283	53	19	and	and	CCONJ
ajlm-283	53	20	addition	addition	NOUN
ajlm-283	53	21	to	to	ADP
ajlm-283	53	22	the	the	DET
ajlm-283	53	23	nested	nest	VERB
ajlm-283	53	24	master	master	NOUN
ajlm-283	53	25	mix	mix	NOUN
ajlm-283	53	26	were	be	AUX
ajlm-283	53	27	performed	perform	VERB
ajlm-283	53	28	in	in	ADP
ajlm-283	53	29	a	a	DET
ajlm-283	53	30	biosafety	biosafety	NOUN
ajlm-283	53	31	cabinet	cabinet	NOUN
ajlm-283	53	32	to	to	PART
ajlm-283	53	33	minimise	minimise	VERB
ajlm-283	53	34	the	the	DET
ajlm-283	53	35	inherent	inherent	ADJ
ajlm-283	53	36	contamination	contamination	NOUN
ajlm-283	53	37	risk	risk	NOUN
ajlm-283	53	38	of	of	ADP
ajlm-283	53	39	the	the	DET
ajlm-283	53	40	nested	nested	ADJ
ajlm-283	53	41	pcr	pcr	ADJ
ajlm-283	53	42	method	method	NOUN
ajlm-283	53	43	.	.	PUNCT
ajlm-283	54	1	each	each	DET
ajlm-283	54	2	run	run	NOUN
ajlm-283	54	3	contained	contain	VERB
ajlm-283	54	4	one	one	NUM
ajlm-283	54	5	negative	negative	ADJ
ajlm-283	54	6	and	and	CCONJ
ajlm-283	54	7	one	one	NUM
ajlm-283	54	8	positive	positive	ADJ
ajlm-283	54	9	control	control	NOUN
ajlm-283	54	10	.	.	PUNCT
ajlm-283	55	1	owing	owe	VERB
ajlm-283	55	2	to	to	ADP
ajlm-283	55	3	the	the	DET
ajlm-283	55	4	efficacy	efficacy	NOUN
ajlm-283	55	5	of	of	ADP
ajlm-283	55	6	the	the	DET
ajlm-283	55	7	nested	nested	ADJ
ajlm-283	55	8	pcr	pcr	NOUN
ajlm-283	55	9	,	,	PUNCT
ajlm-283	55	10	the	the	DET
ajlm-283	55	11	first	first	ADJ
ajlm-283	55	12	-	-	PUNCT
ajlm-283	55	13	round	round	NOUN
ajlm-283	55	14	products	product	NOUN
ajlm-283	55	15	were	be	AUX
ajlm-283	55	16	diluted	dilute	VERB
ajlm-283	55	17	in	in	ADP
ajlm-283	55	18	a	a	DET
ajlm-283	55	19	1:2	1:2	NUM
ajlm-283	55	20	ratio	ratio	NOUN
ajlm-283	55	21	to	to	ADP
ajlm-283	55	22	minimise	minimise	NOUN
ajlm-283	55	23	background	background	NOUN
ajlm-283	55	24	on	on	ADP
ajlm-283	55	25	the	the	DET
ajlm-283	55	26	agarose	agarose	NOUN
ajlm-283	55	27	gel	gel	NOUN
ajlm-283	55	28	and	and	CCONJ
ajlm-283	55	29	increase	increase	VERB
ajlm-283	55	30	efficacy	efficacy	NOUN
ajlm-283	55	31	of	of	ADP
ajlm-283	55	32	the	the	DET
ajlm-283	55	33	pcr	pcr	NOUN
ajlm-283	55	34	.	.	PUNCT
ajlm-283	56	1	after	after	SCONJ
ajlm-283	56	2	a	a	DET
ajlm-283	56	3	further	further	ADJ
ajlm-283	56	4	36	36	NUM
ajlm-283	56	5	cycles	cycle	NOUN
ajlm-283	56	6	of	of	ADP
ajlm-283	56	7	nested	nested	ADJ
ajlm-283	56	8	pcr	pcr	NOUN
ajlm-283	56	9	,	,	PUNCT
ajlm-283	56	10	a	a	DET
ajlm-283	56	11	fragment	fragment	NOUN
ajlm-283	56	12	of	of	ADP
ajlm-283	56	13	approximately	approximately	ADV
ajlm-283	56	14	780	780	NUM
ajlm-283	56	15	bp	bp	NOUN
ajlm-283	56	16	was	be	AUX
ajlm-283	56	17	visualised	visualise	VERB
ajlm-283	56	18	using	use	VERB
ajlm-283	56	19	1	1	NUM
ajlm-283	56	20	%	%	NOUN
ajlm-283	56	21	agarose	agarose	NOUN
ajlm-283	56	22	gel	gel	NOUN
ajlm-283	56	23	electrophoresis	electrophoresis	NOUN
ajlm-283	56	24	.	.	PUNCT
ajlm-283	57	1	a	a	DET
ajlm-283	57	2	100	100	NUM
ajlm-283	57	3	-	-	PUNCT
ajlm-283	57	4	bp	bp	NOUN
ajlm-283	57	5	dna	dna	PROPN
ajlm-283	57	6	molecular	molecular	ADJ
ajlm-283	57	7	weight	weight	NOUN
ajlm-283	57	8	marker	marker	NOUN
ajlm-283	57	9	xiv	xiv	PROPN
ajlm-283	58	1	(	(	PUNCT
ajlm-283	58	2	roche	roche	X
ajlm-283	58	3	molecular	molecular	ADJ
ajlm-283	58	4	diagnostics	diagnostic	NOUN
ajlm-283	58	5	,	,	PUNCT
ajlm-283	58	6	mannheim	mannheim	PROPN
ajlm-283	58	7	,	,	PUNCT
ajlm-283	58	8	germany	germany	PROPN
ajlm-283	58	9	)	)	PUNCT
ajlm-283	58	10	was	be	AUX
ajlm-283	58	11	used	use	VERB
ajlm-283	58	12	to	to	PART
ajlm-283	58	13	identify	identify	VERB
ajlm-283	58	14	the	the	DET
ajlm-283	58	15	desired	desire	VERB
ajlm-283	58	16	amplicon	amplicon	NOUN
ajlm-283	58	17	size	size	NOUN
ajlm-283	58	18	.	.	PUNCT
ajlm-283	59	1	data	datum	NOUN
ajlm-283	59	2	analysis	analysis	NOUN
ajlm-283	59	3	and	and	CCONJ
ajlm-283	59	4	statistical	statistical	ADJ
ajlm-283	59	5	methods	method	NOUN
ajlm-283	59	6	data	datum	NOUN
ajlm-283	59	7	were	be	AUX
ajlm-283	59	8	analysed	analyse	VERB
ajlm-283	59	9	using	use	VERB
ajlm-283	59	10	spss	spss	PROPN
ajlm-283	59	11	®	®	NOUN
ajlm-283	59	12	,	,	PUNCT
ajlm-283	59	13	version	version	NOUN
ajlm-283	59	14	22	22	NUM
ajlm-283	59	15	(	(	PUNCT
ajlm-283	59	16	ibm	ibm	PROPN
ajlm-283	59	17	®	®	PROPN
ajlm-283	59	18	inc	inc	PROPN
ajlm-283	59	19	.	.	PROPN
ajlm-283	59	20	,	,	PUNCT
ajlm-283	59	21	armonk	armonk	PROPN
ajlm-283	59	22	,	,	PUNCT
ajlm-283	59	23	new	new	PROPN
ajlm-283	59	24	york	york	PROPN
ajlm-283	59	25	,	,	PUNCT
ajlm-283	59	26	united	united	PROPN
ajlm-283	59	27	states	states	PROPN
ajlm-283	59	28	)	)	PUNCT
ajlm-283	59	29	.	.	PUNCT
ajlm-283	60	1	statistical	statistical	ADJ
ajlm-283	60	2	differences	difference	NOUN
ajlm-283	60	3	in	in	ADP
ajlm-283	60	4	the	the	DET
ajlm-283	60	5	prevalence	prevalence	NOUN
ajlm-283	60	6	of	of	ADP
ajlm-283	60	7	hbv	hbv	NOUN
ajlm-283	60	8	between	between	ADP
ajlm-283	60	9	the	the	DET
ajlm-283	60	10	hiv	hiv	PROPN
ajlm-283	60	11	-	-	PUNCT
ajlm-283	60	12	positive	positive	ADJ
ajlm-283	60	13	and	and	CCONJ
ajlm-283	60	14	hiv	hiv	NOUN
ajlm-283	60	15	-	-	PUNCT
ajlm-283	60	16	negative	negative	ADJ
ajlm-283	60	17	samples	sample	NOUN
ajlm-283	60	18	were	be	AUX
ajlm-283	60	19	calculated	calculate	VERB
ajlm-283	60	20	using	use	VERB
ajlm-283	60	21	the	the	DET
ajlm-283	60	22	pearson	pearson	PROPN
ajlm-283	60	23	chi	chi	PROPN
ajlm-283	60	24	-	-	PUNCT
ajlm-283	60	25	square	square	PROPN
ajlm-283	60	26	test	test	NOUN
ajlm-283	60	27	.	.	PUNCT
ajlm-283	61	1	further	further	ADJ
ajlm-283	61	2	analysis	analysis	NOUN
ajlm-283	61	3	of	of	ADP
ajlm-283	61	4	the	the	DET
ajlm-283	61	5	influence	influence	NOUN
ajlm-283	61	6	of	of	ADP
ajlm-283	61	7	sex	sex	NOUN
ajlm-283	61	8	and	and	CCONJ
ajlm-283	61	9	age	age	NOUN
ajlm-283	61	10	on	on	ADP
ajlm-283	61	11	the	the	DET
ajlm-283	61	12	prevalence	prevalence	NOUN
ajlm-283	61	13	of	of	ADP
ajlm-283	61	14	hbv	hbv	NOUN
ajlm-283	61	15	was	be	AUX
ajlm-283	61	16	conducted	conduct	VERB
ajlm-283	61	17	using	use	VERB
ajlm-283	61	18	stratified	stratified	ADJ
ajlm-283	61	19	analysis	analysis	NOUN
ajlm-283	61	20	.	.	PUNCT
ajlm-283	62	1	a	a	DET
ajlm-283	62	2	p	p	NOUN
ajlm-283	62	3	-	-	PUNCT
ajlm-283	62	4	value	value	NOUN
ajlm-283	62	5	of	of	ADP
ajlm-283	62	6	<	<	X
ajlm-283	62	7	0.05	0.05	NUM
ajlm-283	62	8	was	be	AUX
ajlm-283	62	9	regarded	regard	VERB
ajlm-283	62	10	as	as	ADP
ajlm-283	62	11	statistically	statistically	ADV
ajlm-283	62	12	significant	significant	ADJ
ajlm-283	62	13	.	.	PUNCT
ajlm-283	63	1	cis	cis	NOUN
ajlm-283	63	2	were	be	AUX
ajlm-283	63	3	calculated	calculate	VERB
ajlm-283	63	4	by	by	ADP
ajlm-283	63	5	bootstrapping	bootstrappe	VERB
ajlm-283	63	6	,	,	PUNCT
ajlm-283	63	7	using	use	VERB
ajlm-283	63	8	the	the	DET
ajlm-283	63	9	default	default	NOUN
ajlm-283	63	10	options	option	NOUN
ajlm-283	63	11	in	in	ADP
ajlm-283	63	12	spss	spss	PROPN
ajlm-283	63	13	®	®	PROPN
ajlm-283	63	14	.	.	PUNCT
ajlm-283	64	1	results	result	NOUN
ajlm-283	64	2	amongst	amongst	ADP
ajlm-283	64	3	the	the	DET
ajlm-283	64	4	161	161	NUM
ajlm-283	64	5	samples	sample	NOUN
ajlm-283	64	6	from	from	ADP
ajlm-283	64	7	hiv	hiv	NOUN
ajlm-283	64	8	-	-	PUNCT
ajlm-283	64	9	positive	positive	ADJ
ajlm-283	64	10	infants	infant	NOUN
ajlm-283	64	11	and	and	CCONJ
ajlm-283	64	12	161	161	NUM
ajlm-283	64	13	samples	sample	NOUN
ajlm-283	64	14	from	from	ADP
ajlm-283	64	15	hiv	hiv	PROPN
ajlm-283	64	16	-	-	PUNCT
ajlm-283	64	17	negative	negative	ADJ
ajlm-283	64	18	infants	infant	NOUN
ajlm-283	64	19	,	,	PUNCT
ajlm-283	64	20	the	the	DET
ajlm-283	64	21	overall	overall	ADJ
ajlm-283	64	22	prevalence	prevalence	NOUN
ajlm-283	64	23	of	of	ADP
ajlm-283	64	24	hbv	hbv	NOUN
ajlm-283	64	25	was	be	AUX
ajlm-283	64	26	10	10	NUM
ajlm-283	64	27	%	%	NOUN
ajlm-283	64	28	(	(	PUNCT
ajlm-283	64	29	table	table	NOUN
ajlm-283	64	30	2	2	NUM
ajlm-283	64	31	)	)	PUNCT
ajlm-283	64	32	.	.	PUNCT
ajlm-283	65	1	amongst	amongst	ADP
ajlm-283	65	2	the	the	DET
ajlm-283	65	3	hiv	hiv	PROPN
ajlm-283	65	4	-	-	PUNCT
ajlm-283	65	5	positive	positive	ADJ
ajlm-283	65	6	infants	infant	NOUN
ajlm-283	65	7	,	,	PUNCT
ajlm-283	65	8	21	21	NUM
ajlm-283	65	9	tested	test	VERB
ajlm-283	65	10	positive	positive	ADJ
ajlm-283	65	11	for	for	ADP
ajlm-283	65	12	hbv	hbv	NOUN
ajlm-283	65	13	compared	compare	VERB
ajlm-283	65	14	with	with	ADP
ajlm-283	65	15	12	12	NUM
ajlm-283	65	16	hiv	hiv	PROPN
ajlm-283	65	17	-	-	PUNCT
ajlm-283	65	18	negative	negative	ADJ
ajlm-283	65	19	infants	infant	NOUN
ajlm-283	65	20	who	who	PRON
ajlm-283	65	21	tested	test	VERB
ajlm-283	65	22	positive	positive	ADJ
ajlm-283	65	23	for	for	ADP
ajlm-283	65	24	hbv	hbv	NOUN
ajlm-283	65	25	.	.	PUNCT
ajlm-283	66	1	the	the	DET
ajlm-283	66	2	proportion	proportion	NOUN
ajlm-283	66	3	of	of	ADP
ajlm-283	66	4	hbv	hbv	NOUN
ajlm-283	66	5	infection	infection	NOUN
ajlm-283	66	6	amongst	amongst	ADP
ajlm-283	66	7	hiv	hiv	PROPN
ajlm-283	66	8	-	-	PUNCT
ajlm-283	66	9	positive	positive	ADJ
ajlm-283	66	10	infants	infant	NOUN
ajlm-283	66	11	was	be	AUX
ajlm-283	66	12	found	find	VERB
ajlm-283	66	13	to	to	PART
ajlm-283	66	14	be	be	AUX
ajlm-283	66	15	marginally	marginally	ADV
ajlm-283	66	16	higher	high	ADJ
ajlm-283	66	17	than	than	ADP
ajlm-283	66	18	amongst	amongst	ADP
ajlm-283	66	19	hiv	hiv	PROPN
ajlm-283	66	20	-	-	PUNCT
ajlm-283	66	21	negative	negative	ADJ
ajlm-283	66	22	infants	infant	NOUN
ajlm-283	66	23	(	(	PUNCT
ajlm-283	66	24	13.0	13.0	NUM
ajlm-283	66	25	%	%	NOUN
ajlm-283	66	26	,	,	PUNCT
ajlm-283	66	27	95	95	NUM
ajlm-283	66	28	%	%	NOUN
ajlm-283	66	29	ci	ci	NOUN
ajlm-283	66	30	:	:	PUNCT
ajlm-283	66	31	6.8–19.9	6.8–19.9	NOUN
ajlm-283	66	32	for	for	ADP
ajlm-283	66	33	hiv	hiv	NOUN
ajlm-283	66	34	-	-	PUNCT
ajlm-283	66	35	positive	positive	ADJ
ajlm-283	66	36	infants	infant	NOUN
ajlm-283	66	37	vs	vs	ADP
ajlm-283	66	38	7.5	7.5	NUM
ajlm-283	66	39	%	%	NOUN
ajlm-283	66	40	,	,	PUNCT
ajlm-283	66	41	95	95	NUM
ajlm-283	66	42	%	%	NOUN
ajlm-283	66	43	ci	ci	NOUN
ajlm-283	66	44	:	:	PUNCT
ajlm-283	66	45	2.5–13.7	2.5–13.7	NOUN
ajlm-283	66	46	for	for	ADP
ajlm-283	66	47	hiv	hiv	NOUN
ajlm-283	66	48	-	-	PUNCT
ajlm-283	66	49	negative	negative	ADJ
ajlm-283	66	50	infants	infant	NOUN
ajlm-283	66	51	;	;	PUNCT
ajlm-283	66	52	p	p	X
ajlm-283	66	53	=	=	NOUN
ajlm-283	66	54	0.098	0.098	NUM
ajlm-283	66	55	)	)	PUNCT
ajlm-283	66	56	.	.	PUNCT
ajlm-283	67	1	the	the	DET
ajlm-283	67	2	observed	observe	VERB
ajlm-283	67	3	difference	difference	NOUN
ajlm-283	67	4	in	in	ADP
ajlm-283	67	5	hbv	hbv	NOUN
ajlm-283	67	6	infection	infection	NOUN
ajlm-283	67	7	between	between	ADP
ajlm-283	67	8	boys	boy	NOUN
ajlm-283	67	9	and	and	CCONJ
ajlm-283	67	10	girls	girl	NOUN
ajlm-283	67	11	(	(	PUNCT
ajlm-283	67	12	table	table	NOUN
ajlm-283	67	13	3	3	NUM
ajlm-283	67	14	)	)	PUNCT
ajlm-283	67	15	was	be	AUX
ajlm-283	67	16	not	not	PART
ajlm-283	67	17	found	find	VERB
ajlm-283	67	18	to	to	PART
ajlm-283	67	19	be	be	AUX
ajlm-283	67	20	statistically	statistically	ADV
ajlm-283	67	21	significant	significant	ADJ
ajlm-283	67	22	(	(	PUNCT
ajlm-283	67	23	p	p	X
ajlm-283	67	24	=	=	NOUN
ajlm-283	67	25	0.33	0.33	NUM
ajlm-283	67	26	)	)	PUNCT
ajlm-283	67	27	.	.	PUNCT
ajlm-283	68	1	further	further	ADJ
ajlm-283	68	2	analysis	analysis	NOUN
ajlm-283	68	3	by	by	ADP
ajlm-283	68	4	age	age	NOUN
ajlm-283	68	5	categories	category	NOUN
ajlm-283	68	6	showed	show	VERB
ajlm-283	68	7	approximately	approximately	ADV
ajlm-283	68	8	equal	equal	ADJ
ajlm-283	68	9	proportions	proportion	NOUN
ajlm-283	68	10	of	of	ADP
ajlm-283	68	11	hbv	hbv	NOUN
ajlm-283	68	12	infection	infection	NOUN
ajlm-283	68	13	amongst	amongst	ADP
ajlm-283	68	14	all	all	DET
ajlm-283	68	15	categories	category	NOUN
ajlm-283	68	16	for	for	ADP
ajlm-283	68	17	infants	infant	NOUN
ajlm-283	68	18	aged	age	VERB
ajlm-283	68	19	52	52	NUM
ajlm-283	68	20	weeks	week	NOUN
ajlm-283	68	21	or	or	CCONJ
ajlm-283	68	22	younger	young	ADJ
ajlm-283	68	23	,	,	PUNCT
ajlm-283	68	24	with	with	ADP
ajlm-283	68	25	the	the	DET
ajlm-283	68	26	exception	exception	NOUN
ajlm-283	68	27	that	that	PRON
ajlm-283	68	28	all	all	DET
ajlm-283	68	29	samples	sample	NOUN
ajlm-283	68	30	from	from	ADP
ajlm-283	68	31	infants	infant	NOUN
ajlm-283	68	32	aged	age	VERB
ajlm-283	68	33	53	53	NUM
ajlm-283	68	34	weeks	week	NOUN
ajlm-283	68	35	or	or	CCONJ
ajlm-283	68	36	older	old	ADJ
ajlm-283	68	37	were	be	AUX
ajlm-283	68	38	negative	negative	ADJ
ajlm-283	68	39	for	for	ADP
ajlm-283	68	40	hbv	hbv	NOUN
ajlm-283	68	41	(	(	PUNCT
ajlm-283	68	42	table	table	NOUN
ajlm-283	68	43	4	4	NUM
ajlm-283	68	44	)	)	PUNCT
ajlm-283	68	45	.	.	PUNCT
ajlm-283	69	1	the	the	DET
ajlm-283	69	2	chi	chi	NOUN
ajlm-283	69	3	-	-	PUNCT
ajlm-283	69	4	squared	square	VERB
ajlm-283	69	5	test	test	NOUN
ajlm-283	69	6	showed	show	VERB
ajlm-283	69	7	that	that	SCONJ
ajlm-283	69	8	there	there	PRON
ajlm-283	69	9	were	be	VERB
ajlm-283	69	10	no	no	DET
ajlm-283	69	11	differences	difference	NOUN
ajlm-283	69	12	in	in	ADP
ajlm-283	69	13	hbv	hbv	NOUN
ajlm-283	69	14	infection	infection	NOUN
ajlm-283	69	15	across	across	ADP
ajlm-283	69	16	all	all	DET
ajlm-283	69	17	age	age	NOUN
ajlm-283	69	18	categories	category	NOUN
ajlm-283	69	19	(	(	PUNCT
ajlm-283	69	20	p	p	X
ajlm-283	69	21	=	=	NOUN
ajlm-283	69	22	0.73	0.73	NUM
ajlm-283	69	23	)	)	PUNCT
ajlm-283	69	24	.	.	PUNCT
ajlm-283	70	1	table	table	NOUN
ajlm-283	70	2	2	2	NUM
ajlm-283	70	3	:	:	PUNCT
ajlm-283	70	4	 	 	SPACE
ajlm-283	70	5	prevalence	prevalence	NOUN
ajlm-283	70	6	of	of	ADP
ajlm-283	70	7	hbv	hbv	NOUN
ajlm-283	70	8	infection	infection	NOUN
ajlm-283	70	9	amongst	amongst	ADP
ajlm-283	70	10	hiv	hiv	PROPN
ajlm-283	70	11	-	-	PUNCT
ajlm-283	70	12	positive	positive	ADJ
ajlm-283	70	13	and	and	CCONJ
ajlm-283	70	14	hiv	hiv	NOUN
ajlm-283	70	15	-	-	PUNCT
ajlm-283	70	16	negative	negative	ADJ
ajlm-283	70	17	infants	infant	NOUN
ajlm-283	70	18	,	,	PUNCT
ajlm-283	70	19	kwazulu	kwazulu	NOUN
ajlm-283	70	20	-	-	PUNCT
ajlm-283	70	21	natal	natal	ADJ
ajlm-283	70	22	,	,	PUNCT
ajlm-283	70	23	south	south	PROPN
ajlm-283	70	24	africa	africa	PROPN
ajlm-283	70	25	(	(	PUNCT
ajlm-283	70	26	july	july	PROPN
ajlm-283	70	27	2011	2011	NUM
ajlm-283	70	28	to	to	ADP
ajlm-283	70	29	december	december	PROPN
ajlm-283	70	30	2011).†	2011).†	NUM
ajlm-283	70	31	table	table	NOUN
ajlm-283	70	32	3	3	NUM
ajlm-283	70	33	:	:	PUNCT
ajlm-283	70	34	 	 	SPACE
ajlm-283	70	35	hbv	hbv	NOUN
ajlm-283	70	36	infection	infection	NOUN
ajlm-283	70	37	amongst	amongst	ADP
ajlm-283	70	38	hiv	hiv	PROPN
ajlm-283	70	39	-	-	PUNCT
ajlm-283	70	40	positive	positive	ADJ
ajlm-283	70	41	and	and	CCONJ
ajlm-283	70	42	hiv	hiv	NOUN
ajlm-283	70	43	-	-	PUNCT
ajlm-283	70	44	negative	negative	ADJ
ajlm-283	70	45	infants	infant	NOUN
ajlm-283	70	46	stratified	stratify	VERB
ajlm-283	70	47	by	by	ADP
ajlm-283	70	48	sex	sex	NOUN
ajlm-283	70	49	,	,	PUNCT
ajlm-283	70	50	kwazulu	kwazulu	NOUN
ajlm-283	70	51	-	-	PUNCT
ajlm-283	70	52	natal	natal	ADJ
ajlm-283	70	53	,	,	PUNCT
ajlm-283	70	54	south	south	PROPN
ajlm-283	70	55	africa	africa	PROPN
ajlm-283	70	56	(	(	PUNCT
ajlm-283	70	57	july	july	PROPN
ajlm-283	70	58	2011	2011	NUM
ajlm-283	70	59	to	to	ADP
ajlm-283	70	60	december	december	PROPN
ajlm-283	70	61	2011	2011	NUM
ajlm-283	70	62	)	)	PUNCT
ajlm-283	70	63	.	.	PUNCT
ajlm-283	71	1	table	table	NOUN
ajlm-283	71	2	4	4	NUM
ajlm-283	71	3	:	:	PUNCT
ajlm-283	71	4	 	 	SPACE
ajlm-283	71	5	hbv	hbv	NOUN
ajlm-283	71	6	infection	infection	NOUN
ajlm-283	71	7	amongst	amongst	ADP
ajlm-283	71	8	hiv	hiv	PROPN
ajlm-283	71	9	-	-	PUNCT
ajlm-283	71	10	positive	positive	ADJ
ajlm-283	71	11	and	and	CCONJ
ajlm-283	71	12	hiv	hiv	NOUN
ajlm-283	71	13	-	-	PUNCT
ajlm-283	71	14	negative	negative	ADJ
ajlm-283	71	15	infants	infant	NOUN
ajlm-283	71	16	stratified	stratify	VERB
ajlm-283	71	17	by	by	ADP
ajlm-283	71	18	age	age	NOUN
ajlm-283	71	19	,	,	PUNCT
ajlm-283	71	20	kwazulu	kwazulu	NOUN
ajlm-283	71	21	-	-	PUNCT
ajlm-283	71	22	natal	natal	ADJ
ajlm-283	71	23	,	,	PUNCT
ajlm-283	71	24	south	south	PROPN
ajlm-283	71	25	africa	africa	PROPN
ajlm-283	71	26	(	(	PUNCT
ajlm-283	71	27	july	july	PROPN
ajlm-283	71	28	2011	2011	NUM
ajlm-283	71	29	to	to	ADP
ajlm-283	71	30	december	december	PROPN
ajlm-283	71	31	2011).†	2011).†	NUM
ajlm-283	71	32	discussion	discussion	NOUN
ajlm-283	71	33	from	from	ADP
ajlm-283	71	34	this	this	DET
ajlm-283	71	35	cohort	cohort	NOUN
ajlm-283	71	36	of	of	ADP
ajlm-283	71	37	samples	sample	NOUN
ajlm-283	71	38	referred	refer	VERB
ajlm-283	71	39	to	to	ADP
ajlm-283	71	40	an	an	DET
ajlm-283	71	41	academic	academic	ADJ
ajlm-283	71	42	laboratory	laboratory	NOUN
ajlm-283	71	43	for	for	ADP
ajlm-283	71	44	routine	routine	ADJ
ajlm-283	71	45	early	early	ADJ
ajlm-283	71	46	-	-	PUNCT
ajlm-283	71	47	infant	infant	NOUN
ajlm-283	71	48	diagnosis	diagnosis	NOUN
ajlm-283	71	49	of	of	ADP
ajlm-283	71	50	hiv	hiv	PROPN
ajlm-283	71	51	,	,	PUNCT
ajlm-283	71	52	we	we	PRON
ajlm-283	71	53	found	find	VERB
ajlm-283	71	54	a	a	DET
ajlm-283	71	55	10	10	NUM
ajlm-283	71	56	%	%	NOUN
ajlm-283	71	57	prevalence	prevalence	NOUN
ajlm-283	71	58	of	of	ADP
ajlm-283	71	59	hbv	hbv	NOUN
ajlm-283	71	60	infection	infection	NOUN
ajlm-283	71	61	for	for	ADP
ajlm-283	71	62	a	a	DET
ajlm-283	71	63	sub	sub	NOUN
ajlm-283	71	64	-	-	NOUN
ajlm-283	71	65	population	population	NOUN
ajlm-283	71	66	of	of	ADP
ajlm-283	71	67	infants	infant	NOUN
ajlm-283	71	68	of	of	ADP
ajlm-283	71	69	the	the	DET
ajlm-283	71	70	kwazulu	kwazulu	ADJ
ajlm-283	71	71	-	-	PUNCT
ajlm-283	71	72	natal	natal	ADJ
ajlm-283	71	73	province	province	NOUN
ajlm-283	71	74	of	of	ADP
ajlm-283	71	75	south	south	PROPN
ajlm-283	71	76	africa	africa	PROPN
ajlm-283	71	77	.	.	PUNCT
ajlm-283	72	1	the	the	DET
ajlm-283	72	2	world	world	PROPN
ajlm-283	72	3	health	health	PROPN
ajlm-283	72	4	organization	organization	NOUN
ajlm-283	72	5	(	(	PUNCT
ajlm-283	72	6	who	who	PRON
ajlm-283	72	7	)	)	PUNCT
ajlm-283	72	8	categorises	categorise	VERB
ajlm-283	72	9	sub	sub	ADJ
ajlm-283	72	10	-	-	ADJ
ajlm-283	72	11	saharan	saharan	ADJ
ajlm-283	72	12	africa	africa	PROPN
ajlm-283	72	13	as	as	ADP
ajlm-283	72	14	highly	highly	ADV
ajlm-283	72	15	endemic	endemic	ADJ
ajlm-283	72	16	for	for	ADP
ajlm-283	72	17	hbv	hbv	NOUN
ajlm-283	72	18	,	,	PUNCT
ajlm-283	72	19	with	with	ADP
ajlm-283	72	20	a	a	DET
ajlm-283	72	21	prevalence	prevalence	NOUN
ajlm-283	72	22	of	of	ADP
ajlm-283	72	23	more	more	ADJ
ajlm-283	72	24	than	than	ADP
ajlm-283	72	25	8%.25	8%.25	NUM
ajlm-283	72	26	exposure	exposure	NOUN
ajlm-283	72	27	to	to	ADP
ajlm-283	72	28	hbv	hbv	NOUN
ajlm-283	72	29	in	in	ADP
ajlm-283	72	30	different	different	ADJ
ajlm-283	72	31	regions	region	NOUN
ajlm-283	72	32	of	of	ADP
ajlm-283	72	33	the	the	DET
ajlm-283	72	34	african	african	ADJ
ajlm-283	72	35	continent	continent	NOUN
ajlm-283	72	36	is	be	AUX
ajlm-283	72	37	variable	variable	ADJ
ajlm-283	72	38	,	,	PUNCT
ajlm-283	72	39	as	as	SCONJ
ajlm-283	72	40	evidenced	evidence	VERB
ajlm-283	72	41	by	by	ADP
ajlm-283	72	42	the	the	DET
ajlm-283	72	43	prevalence	prevalence	NOUN
ajlm-283	72	44	of	of	ADP
ajlm-283	72	45	antibodies	antibody	NOUN
ajlm-283	72	46	to	to	ADP
ajlm-283	72	47	the	the	DET
ajlm-283	72	48	hbv	hbv	NOUN
ajlm-283	72	49	core	core	NOUN
ajlm-283	72	50	antibody	antibody	NOUN
ajlm-283	72	51	(	(	PUNCT
ajlm-283	72	52	anti	anti	ADJ
ajlm-283	72	53	-	-	NOUN
ajlm-283	72	54	hbc	hbc	ADJ
ajlm-283	72	55	)	)	PUNCT
ajlm-283	72	56	.	.	PUNCT
ajlm-283	73	1	anti	anti	ADJ
ajlm-283	73	2	-	-	ADJ
ajlm-283	73	3	hbc	hbc	ADJ
ajlm-283	73	4	prevalence	prevalence	NOUN
ajlm-283	73	5	in	in	ADP
ajlm-283	73	6	western	western	PROPN
ajlm-283	73	7	africa	africa	PROPN
ajlm-283	73	8	has	have	AUX
ajlm-283	73	9	been	be	AUX
ajlm-283	73	10	reported	report	VERB
ajlm-283	73	11	to	to	PART
ajlm-283	73	12	exceed	exceed	VERB
ajlm-283	73	13	85	85	NUM
ajlm-283	73	14	%	%	NOUN
ajlm-283	73	15	,	,	PUNCT
ajlm-283	73	16	whereas	whereas	SCONJ
ajlm-283	73	17	the	the	DET
ajlm-283	73	18	prevalence	prevalence	NOUN
ajlm-283	73	19	in	in	ADP
ajlm-283	73	20	eastern	eastern	PROPN
ajlm-283	73	21	africa	africa	PROPN
ajlm-283	73	22	is	be	AUX
ajlm-283	73	23	reported	report	VERB
ajlm-283	73	24	to	to	PART
ajlm-283	73	25	range	range	VERB
ajlm-283	73	26	from	from	ADP
ajlm-283	73	27	65	65	NUM
ajlm-283	73	28	%	%	NOUN
ajlm-283	73	29	to	to	PART
ajlm-283	73	30	85	85	NUM
ajlm-283	73	31	%	%	NOUN
ajlm-283	73	32	,	,	PUNCT
ajlm-283	73	33	with	with	SCONJ
ajlm-283	73	34	rural	rural	ADJ
ajlm-283	73	35	areas	area	NOUN
ajlm-283	73	36	showing	show	VERB
ajlm-283	73	37	a	a	DET
ajlm-283	73	38	higher	high	ADJ
ajlm-283	73	39	prevalence	prevalence	NOUN
ajlm-283	73	40	than	than	ADP
ajlm-283	73	41	urban	urban	ADJ
ajlm-283	73	42	areas.26	areas.26	PROPN
ajlm-283	73	43	a	a	DET
ajlm-283	73	44	systematic	systematic	ADJ
ajlm-283	73	45	review	review	NOUN
ajlm-283	73	46	of	of	ADP
ajlm-283	73	47	global	global	ADJ
ajlm-283	73	48	epidemiology	epidemiology	NOUN
ajlm-283	73	49	of	of	ADP
ajlm-283	73	50	hbv	hbv	NOUN
ajlm-283	73	51	over	over	ADP
ajlm-283	73	52	a	a	DET
ajlm-283	73	53	27	27	NUM
ajlm-283	73	54	-	-	PUNCT
ajlm-283	73	55	year	year	NOUN
ajlm-283	73	56	period	period	NOUN
ajlm-283	73	57	(	(	PUNCT
ajlm-283	73	58	1980–2007	1980–2007	NUM
ajlm-283	73	59	)	)	PUNCT
ajlm-283	73	60	showed	show	VERB
ajlm-283	73	61	a	a	DET
ajlm-283	73	62	decrease	decrease	NOUN
ajlm-283	73	63	in	in	ADP
ajlm-283	73	64	hbv	hbv	NOUN
ajlm-283	73	65	prevalence	prevalence	NOUN
ajlm-283	73	66	in	in	ADP
ajlm-283	73	67	southern	southern	PROPN
ajlm-283	73	68	africa	africa	PROPN
ajlm-283	73	69	,	,	PUNCT
ajlm-283	73	70	from	from	ADP
ajlm-283	73	71	around	around	ADP
ajlm-283	73	72	7	7	NUM
ajlm-283	73	73	%	%	NOUN
ajlm-283	73	74	in	in	ADP
ajlm-283	73	75	1990	1990	NUM
ajlm-283	73	76	to	to	PART
ajlm-283	73	77	just	just	ADV
ajlm-283	73	78	under	under	ADP
ajlm-283	73	79	4	4	NUM
ajlm-283	73	80	%	%	NOUN
ajlm-283	73	81	in	in	ADP
ajlm-283	73	82	2005.2	2005.2	NUM
ajlm-283	73	83	south	south	ADJ
ajlm-283	73	84	africa	africa	PROPN
ajlm-283	73	85	has	have	AUX
ajlm-283	73	86	also	also	ADV
ajlm-283	73	87	been	be	AUX
ajlm-283	73	88	shown	show	VERB
ajlm-283	73	89	to	to	PART
ajlm-283	73	90	have	have	VERB
ajlm-283	73	91	a	a	DET
ajlm-283	73	92	variable	variable	ADJ
ajlm-283	73	93	hbv	hbv	NOUN
ajlm-283	73	94	seroprevalence	seroprevalence	NOUN
ajlm-283	73	95	between	between	ADP
ajlm-283	73	96	the	the	DET
ajlm-283	73	97	different	different	ADJ
ajlm-283	73	98	provinces	province	NOUN
ajlm-283	73	99	,	,	PUNCT
ajlm-283	73	100	with	with	ADP
ajlm-283	73	101	rural	rural	ADJ
ajlm-283	73	102	south	south	ADJ
ajlm-283	73	103	african	african	ADJ
ajlm-283	73	104	regions	region	NOUN
ajlm-283	73	105	being	be	AUX
ajlm-283	73	106	reported	report	VERB
ajlm-283	73	107	to	to	PART
ajlm-283	73	108	have	have	VERB
ajlm-283	73	109	a	a	DET
ajlm-283	73	110	higher	high	ADJ
ajlm-283	73	111	prevalence	prevalence	NOUN
ajlm-283	73	112	than	than	ADP
ajlm-283	73	113	their	their	PRON
ajlm-283	73	114	urban	urban	ADJ
ajlm-283	73	115	counterparts.27	counterparts.27	NOUN
ajlm-283	73	116	in	in	ADP
ajlm-283	73	117	the	the	DET
ajlm-283	73	118	pre	pre	ADJ
ajlm-283	73	119	-	-	ADJ
ajlm-283	73	120	immunisation	immunisation	ADJ
ajlm-283	73	121	era	era	NOUN
ajlm-283	73	122	,	,	PUNCT
ajlm-283	73	123	hepatitis	hepatitis	PROPN
ajlm-283	73	124	b	b	PROPN
ajlm-283	73	125	surface	surface	NOUN
ajlm-283	73	126	antigenaemia	antigenaemia	PROPN
ajlm-283	73	127	was	be	AUX
ajlm-283	73	128	reported	report	VERB
ajlm-283	73	129	to	to	PART
ajlm-283	73	130	range	range	VERB
ajlm-283	73	131	from	from	ADP
ajlm-283	73	132	10	10	NUM
ajlm-283	73	133	%	%	NOUN
ajlm-283	73	134	amongst	amongst	ADP
ajlm-283	73	135	urban	urban	ADJ
ajlm-283	73	136	children	child	NOUN
ajlm-283	73	137	to	to	ADP
ajlm-283	73	138	18.5	18.5	NUM
ajlm-283	73	139	%	%	NOUN
ajlm-283	73	140	amongst	amongst	ADP
ajlm-283	73	141	rural	rural	ADJ
ajlm-283	73	142	children	child	NOUN
ajlm-283	73	143	in	in	ADP
ajlm-283	73	144	kwazulu	kwazulu	PROPN
ajlm-283	73	145	-	-	PUNCT
ajlm-283	73	146	natal.13	natal.13	VERB
ajlm-283	73	147	a	a	DET
ajlm-283	73	148	retrospective	retrospective	ADJ
ajlm-283	73	149	database	database	NOUN
ajlm-283	73	150	analysis	analysis	NOUN
ajlm-283	73	151	conducted	conduct	VERB
ajlm-283	73	152	for	for	ADP
ajlm-283	73	153	a	a	DET
ajlm-283	73	154	nine	nine	NUM
ajlm-283	73	155	-	-	PUNCT
ajlm-283	73	156	year	year	NOUN
ajlm-283	73	157	period	period	NOUN
ajlm-283	73	158	(	(	PUNCT
ajlm-283	73	159	2002	2002	NUM
ajlm-283	73	160	to	to	ADP
ajlm-283	73	161	2010	2010	NUM
ajlm-283	73	162	)	)	PUNCT
ajlm-283	73	163	in	in	ADP
ajlm-283	73	164	a	a	DET
ajlm-283	73	165	reference	reference	NOUN
ajlm-283	73	166	laboratory	laboratory	NOUN
ajlm-283	73	167	in	in	ADP
ajlm-283	73	168	kwazulu	kwazulu	PROPN
ajlm-283	73	169	-	-	PUNCT
ajlm-283	73	170	natal	natal	NOUN
ajlm-283	73	171	estimated	estimate	VERB
ajlm-283	73	172	the	the	DET
ajlm-283	73	173	overall	overall	ADJ
ajlm-283	73	174	seroprevalence	seroprevalence	NOUN
ajlm-283	73	175	of	of	ADP
ajlm-283	73	176	hepatitis	hepatitis	PROPN
ajlm-283	73	177	b	b	PROPN
ajlm-283	73	178	surface	surface	NOUN
ajlm-283	73	179	antigen	antigen	ADV
ajlm-283	73	180	in	in	ADP
ajlm-283	73	181	all	all	DET
ajlm-283	73	182	age	age	NOUN
ajlm-283	73	183	groups	group	NOUN
ajlm-283	73	184	to	to	PART
ajlm-283	73	185	be	be	AUX
ajlm-283	73	186	12.05%.27	12.05%.27	NUM
ajlm-283	73	187	our	our	PRON
ajlm-283	73	188	finding	finding	NOUN
ajlm-283	73	189	of	of	ADP
ajlm-283	73	190	a	a	DET
ajlm-283	73	191	10	10	NUM
ajlm-283	73	192	%	%	NOUN
ajlm-283	73	193	prevalence	prevalence	NOUN
ajlm-283	73	194	in	in	ADP
ajlm-283	73	195	this	this	DET
ajlm-283	73	196	infant	infant	NOUN
ajlm-283	73	197	cohort	cohort	NOUN
ajlm-283	73	198	is	be	AUX
ajlm-283	73	199	clinically	clinically	ADV
ajlm-283	73	200	significant	significant	ADJ
ajlm-283	73	201	.	.	PUNCT
ajlm-283	74	1	although	although	SCONJ
ajlm-283	74	2	previously	previously	ADV
ajlm-283	74	3	hbv	hbv	NOUN
ajlm-283	74	4	prevalence	prevalence	NOUN
ajlm-283	74	5	has	have	AUX
ajlm-283	74	6	been	be	AUX
ajlm-283	74	7	mostly	mostly	ADV
ajlm-283	74	8	reported	report	VERB
ajlm-283	74	9	using	use	VERB
ajlm-283	74	10	serological	serological	ADJ
ajlm-283	74	11	markers	marker	NOUN
ajlm-283	74	12	,	,	PUNCT
ajlm-283	74	13	the	the	DET
ajlm-283	74	14	use	use	NOUN
ajlm-283	74	15	of	of	ADP
ajlm-283	74	16	hbv	hbv	NOUN
ajlm-283	74	17	dna	dna	PROPN
ajlm-283	74	18	as	as	ADP
ajlm-283	74	19	a	a	DET
ajlm-283	74	20	screening	screening	NOUN
ajlm-283	74	21	tool	tool	NOUN
ajlm-283	74	22	can	can	AUX
ajlm-283	74	23	identify	identify	VERB
ajlm-283	74	24	even	even	ADV
ajlm-283	74	25	occult	occult	NOUN
ajlm-283	74	26	infections	infection	NOUN
ajlm-283	74	27	.	.	PUNCT
ajlm-283	75	1	occult	occult	NOUN
ajlm-283	75	2	hbv	hbv	NOUN
ajlm-283	75	3	infection	infection	NOUN
ajlm-283	75	4	is	be	AUX
ajlm-283	75	5	defined	define	VERB
ajlm-283	75	6	as	as	ADP
ajlm-283	75	7	the	the	DET
ajlm-283	75	8	presence	presence	NOUN
ajlm-283	75	9	of	of	ADP
ajlm-283	75	10	hbv	hbv	PROPN
ajlm-283	75	11	dna	dna	PROPN
ajlm-283	75	12	without	without	ADP
ajlm-283	75	13	hepatitis	hepatitis	PROPN
ajlm-283	75	14	b	b	PROPN
ajlm-283	75	15	surface	surface	NOUN
ajlm-283	75	16	antigen	antigen	ADV
ajlm-283	75	17	outside	outside	ADP
ajlm-283	75	18	the	the	DET
ajlm-283	75	19	acute	acute	NOUN
ajlm-283	75	20	-	-	PUNCT
ajlm-283	75	21	phase	phase	NOUN
ajlm-283	75	22	window	window	NOUN
ajlm-283	75	23	period	period	NOUN
ajlm-283	75	24	.	.	PUNCT
ajlm-283	76	1	most	most	ADJ
ajlm-283	76	2	hbv	hbv	NOUN
ajlm-283	76	3	infections	infection	NOUN
ajlm-283	76	4	in	in	ADP
ajlm-283	76	5	endemic	endemic	ADJ
ajlm-283	76	6	areas	area	NOUN
ajlm-283	76	7	,	,	PUNCT
ajlm-283	76	8	including	include	VERB
ajlm-283	76	9	sub	sub	ADJ
ajlm-283	76	10	-	-	ADJ
ajlm-283	76	11	saharan	saharan	ADJ
ajlm-283	76	12	africa	africa	PROPN
ajlm-283	76	13	,	,	PUNCT
ajlm-283	76	14	are	be	AUX
ajlm-283	76	15	thought	think	VERB
ajlm-283	76	16	to	to	PART
ajlm-283	76	17	be	be	AUX
ajlm-283	76	18	due	due	ADJ
ajlm-283	76	19	to	to	ADP
ajlm-283	76	20	transmissions	transmission	NOUN
ajlm-283	76	21	in	in	ADP
ajlm-283	76	22	the	the	DET
ajlm-283	76	23	perinatal	perinatal	ADJ
ajlm-283	76	24	period	period	NOUN
ajlm-283	76	25	and	and	CCONJ
ajlm-283	76	26	early	early	ADJ
ajlm-283	76	27	childhood.28,29	childhood.28,29	NOUN
ajlm-283	76	28	the	the	DET
ajlm-283	76	29	high	high	ADJ
ajlm-283	76	30	prevalence	prevalence	NOUN
ajlm-283	76	31	of	of	ADP
ajlm-283	76	32	hbv	hbv	NOUN
ajlm-283	76	33	infection	infection	NOUN
ajlm-283	76	34	amongst	amongst	ADP
ajlm-283	76	35	infants	infant	NOUN
ajlm-283	76	36	in	in	ADP
ajlm-283	76	37	this	this	DET
ajlm-283	76	38	study	study	NOUN
ajlm-283	76	39	affirmed	affirm	VERB
ajlm-283	76	40	this	this	DET
ajlm-283	76	41	assertion	assertion	NOUN
ajlm-283	76	42	.	.	PUNCT
ajlm-283	77	1	studies	study	NOUN
ajlm-283	77	2	on	on	ADP
ajlm-283	77	3	the	the	DET
ajlm-283	77	4	natural	natural	ADJ
ajlm-283	77	5	progression	progression	NOUN
ajlm-283	77	6	of	of	ADP
ajlm-283	77	7	hbv	hbv	NOUN
ajlm-283	77	8	infection	infection	NOUN
ajlm-283	77	9	have	have	AUX
ajlm-283	77	10	shown	show	VERB
ajlm-283	77	11	that	that	SCONJ
ajlm-283	77	12	perinatally	perinatally	ADV
ajlm-283	77	13	acquired	acquire	VERB
ajlm-283	77	14	infections	infection	NOUN
ajlm-283	77	15	progress	progress	VERB
ajlm-283	77	16	to	to	PART
ajlm-283	77	17	chronic	chronic	VERB
ajlm-283	77	18	hepatitis	hepatitis	PROPN
ajlm-283	77	19	b	b	PROPN
ajlm-283	77	20	,	,	PUNCT
ajlm-283	77	21	which	which	PRON
ajlm-283	77	22	is	be	AUX
ajlm-283	77	23	worrying	worry	VERB
ajlm-283	77	24	for	for	ADP
ajlm-283	77	25	vaccination	vaccination	NOUN
ajlm-283	77	26	efforts.31	efforts.31	NOUN
ajlm-283	77	27	our	our	PRON
ajlm-283	77	28	study	study	NOUN
ajlm-283	77	29	specifically	specifically	ADV
ajlm-283	77	30	considered	consider	VERB
ajlm-283	77	31	hbv	hbv	NOUN
ajlm-283	77	32	rates	rate	NOUN
ajlm-283	77	33	amongst	amongst	ADP
ajlm-283	77	34	hiv	hiv	PROPN
ajlm-283	77	35	-	-	PUNCT
ajlm-283	77	36	positive	positive	ADJ
ajlm-283	77	37	and	and	CCONJ
ajlm-283	77	38	hiv	hiv	NOUN
ajlm-283	77	39	-	-	PUNCT
ajlm-283	77	40	negative	negative	ADJ
ajlm-283	77	41	infants	infant	NOUN
ajlm-283	77	42	and	and	CCONJ
ajlm-283	77	43	therefore	therefore	ADV
ajlm-283	77	44	differs	differ	VERB
ajlm-283	77	45	from	from	ADP
ajlm-283	77	46	previous	previous	ADJ
ajlm-283	77	47	studies	study	NOUN
ajlm-283	77	48	conducted	conduct	VERB
ajlm-283	77	49	in	in	ADP
ajlm-283	77	50	the	the	DET
ajlm-283	77	51	pre	pre	PROPN
ajlm-283	77	52	-	-	ADJ
ajlm-283	77	53	hiv	hiv	ADJ
ajlm-283	77	54	epidemic	epidemic	NOUN
ajlm-283	77	55	era.4,13	era.4,13	NOUN
ajlm-283	77	56	further	far	ADV
ajlm-283	77	57	,	,	PUNCT
ajlm-283	77	58	in	in	ADP
ajlm-283	77	59	the	the	DET
ajlm-283	77	60	hiv	hiv	PROPN
ajlm-283	77	61	era	era	NOUN
ajlm-283	77	62	,	,	PUNCT
ajlm-283	77	63	higher	high	ADJ
ajlm-283	77	64	prevalences	prevalence	NOUN
ajlm-283	77	65	of	of	ADP
ajlm-283	77	66	hbv	hbv	NOUN
ajlm-283	77	67	have	have	AUX
ajlm-283	77	68	been	be	AUX
ajlm-283	77	69	reported	report	VERB
ajlm-283	77	70	amongst	amongst	ADP
ajlm-283	77	71	hiv	hiv	PROPN
ajlm-283	77	72	-	-	PUNCT
ajlm-283	77	73	positive	positive	ADJ
ajlm-283	77	74	adults7,8,9,10	adults7,8,9,10	NOUN
ajlm-283	77	75	owing	owe	VERB
ajlm-283	77	76	to	to	ADP
ajlm-283	77	77	shared	share	VERB
ajlm-283	77	78	routes	route	NOUN
ajlm-283	77	79	of	of	ADP
ajlm-283	77	80	transmission	transmission	NOUN
ajlm-283	77	81	.	.	PUNCT
ajlm-283	78	1	however	however	ADV
ajlm-283	78	2	,	,	PUNCT
ajlm-283	78	3	the	the	DET
ajlm-283	78	4	observed	observed	ADJ
ajlm-283	78	5	prevalence	prevalence	NOUN
ajlm-283	78	6	of	of	ADP
ajlm-283	78	7	hbv	hbv	NOUN
ajlm-283	78	8	amongst	amongst	ADP
ajlm-283	78	9	hiv	hiv	PROPN
ajlm-283	78	10	-	-	PUNCT
ajlm-283	78	11	positive	positive	ADJ
ajlm-283	78	12	infants	infant	NOUN
ajlm-283	78	13	in	in	ADP
ajlm-283	78	14	our	our	PRON
ajlm-283	78	15	study	study	NOUN
ajlm-283	78	16	was	be	AUX
ajlm-283	78	17	not	not	PART
ajlm-283	78	18	statistically	statistically	ADV
ajlm-283	78	19	significant	significant	ADJ
ajlm-283	78	20	compared	compare	VERB
ajlm-283	78	21	with	with	ADP
ajlm-283	78	22	hiv	hiv	PROPN
ajlm-283	78	23	-	-	PUNCT
ajlm-283	78	24	negative	negative	ADJ
ajlm-283	78	25	infants	infant	NOUN
ajlm-283	78	26	,	,	PUNCT
ajlm-283	78	27	suggesting	suggest	VERB
ajlm-283	78	28	that	that	SCONJ
ajlm-283	78	29	high	high	ADJ
ajlm-283	78	30	hbv	hbv	NOUN
ajlm-283	78	31	infection	infection	NOUN
ajlm-283	78	32	rates	rate	NOUN
ajlm-283	78	33	may	may	AUX
ajlm-283	78	34	be	be	AUX
ajlm-283	78	35	independent	independent	ADJ
ajlm-283	78	36	of	of	ADP
ajlm-283	78	37	hiv	hiv	PROPN
ajlm-283	78	38	in	in	ADP
ajlm-283	78	39	infants	infant	NOUN
ajlm-283	78	40	.	.	PUNCT
ajlm-283	79	1	similar	similar	ADJ
ajlm-283	79	2	findings	finding	NOUN
ajlm-283	79	3	have	have	AUX
ajlm-283	79	4	been	be	AUX
ajlm-283	79	5	reported	report	VERB
ajlm-283	79	6	by	by	ADP
ajlm-283	79	7	studies	study	NOUN
ajlm-283	79	8	of	of	ADP
ajlm-283	79	9	pregnant	pregnant	ADJ
ajlm-283	79	10	women	woman	NOUN
ajlm-283	79	11	in	in	ADP
ajlm-283	79	12	south	south	ADJ
ajlm-283	79	13	africa.11,30	africa.11,30	NOUN
ajlm-283	79	14	analysis	analysis	NOUN
ajlm-283	79	15	of	of	ADP
ajlm-283	79	16	data	datum	NOUN
ajlm-283	79	17	following	follow	VERB
ajlm-283	79	18	age	age	NOUN
ajlm-283	79	19	stratification	stratification	NOUN
ajlm-283	79	20	showed	show	VERB
ajlm-283	79	21	an	an	DET
ajlm-283	79	22	equivalent	equivalent	ADJ
ajlm-283	79	23	distribution	distribution	NOUN
ajlm-283	79	24	of	of	ADP
ajlm-283	79	25	hbv	hbv	NOUN
ajlm-283	79	26	infection	infection	NOUN
ajlm-283	79	27	,	,	PUNCT
ajlm-283	79	28	with	with	ADP
ajlm-283	79	29	almost	almost	ADV
ajlm-283	79	30	10	10	NUM
ajlm-283	79	31	%	%	NOUN
ajlm-283	79	32	of	of	ADP
ajlm-283	79	33	infections	infection	NOUN
ajlm-283	79	34	observed	observe	VERB
ajlm-283	79	35	amongst	amongst	ADP
ajlm-283	79	36	infants	infant	NOUN
ajlm-283	79	37	aged	age	VERB
ajlm-283	79	38	6	6	NUM
ajlm-283	79	39	weeks	week	NOUN
ajlm-283	79	40	or	or	CCONJ
ajlm-283	79	41	younger	young	ADJ
ajlm-283	79	42	,	,	PUNCT
ajlm-283	79	43	suggesting	suggest	VERB
ajlm-283	79	44	congenital	congenital	ADJ
ajlm-283	79	45	infection	infection	NOUN
ajlm-283	79	46	in	in	ADP
ajlm-283	79	47	this	this	DET
ajlm-283	79	48	sub	sub	NOUN
ajlm-283	79	49	-	-	NOUN
ajlm-283	79	50	group	group	NOUN
ajlm-283	79	51	.	.	PUNCT
ajlm-283	80	1	routine	routine	ADJ
ajlm-283	80	2	screening	screening	NOUN
ajlm-283	80	3	of	of	ADP
ajlm-283	80	4	pregnant	pregnant	ADJ
ajlm-283	80	5	women	woman	NOUN
ajlm-283	80	6	for	for	ADP
ajlm-283	80	7	hbv	hbv	NOUN
ajlm-283	80	8	infection	infection	NOUN
ajlm-283	80	9	is	be	AUX
ajlm-283	80	10	still	still	ADV
ajlm-283	80	11	not	not	PART
ajlm-283	80	12	policy	policy	NOUN
ajlm-283	80	13	in	in	ADP
ajlm-283	80	14	the	the	DET
ajlm-283	80	15	south	south	ADJ
ajlm-283	80	16	african	african	ADJ
ajlm-283	80	17	public	public	ADJ
ajlm-283	80	18	health	health	NOUN
ajlm-283	80	19	care	care	NOUN
ajlm-283	80	20	sector	sector	NOUN
ajlm-283	80	21	.	.	PUNCT
ajlm-283	81	1	the	the	DET
ajlm-283	81	2	recommended	recommend	VERB
ajlm-283	81	3	treatment	treatment	NOUN
ajlm-283	81	4	for	for	ADP
ajlm-283	81	5	infants	infant	NOUN
ajlm-283	81	6	exposed	expose	VERB
ajlm-283	81	7	to	to	ADP
ajlm-283	81	8	hbv	hbv	NOUN
ajlm-283	81	9	in	in	ADP
ajlm-283	81	10	utero	utero	PROPN
ajlm-283	81	11	is	be	AUX
ajlm-283	81	12	the	the	DET
ajlm-283	81	13	administration	administration	NOUN
ajlm-283	81	14	of	of	ADP
ajlm-283	81	15	the	the	DET
ajlm-283	81	16	hbv	hbv	NOUN
ajlm-283	81	17	vaccine	vaccine	NOUN
ajlm-283	81	18	and	and	CCONJ
ajlm-283	81	19	hbv	hbv	NOUN
ajlm-283	81	20	-	-	PUNCT
ajlm-283	81	21	specific	specific	ADJ
ajlm-283	81	22	immunoglobulin	immunoglobulin	NOUN
ajlm-283	81	23	at	at	ADP
ajlm-283	81	24	birth.32	birth.32	ADP
ajlm-283	81	25	the	the	DET
ajlm-283	81	26	availability	availability	NOUN
ajlm-283	81	27	of	of	ADP
ajlm-283	81	28	hbv	hbv	NOUN
ajlm-283	81	29	vaccine	vaccine	NOUN
ajlm-283	81	30	and	and	CCONJ
ajlm-283	81	31	hbv	hbv	NOUN
ajlm-283	81	32	-	-	PUNCT
ajlm-283	81	33	specific	specific	ADJ
ajlm-283	81	34	immunoglobulin	immunoglobulin	NOUN
ajlm-283	81	35	for	for	ADP
ajlm-283	81	36	passive	passive	ADJ
ajlm-283	81	37	active	active	ADJ
ajlm-283	81	38	immunisation	immunisation	NOUN
ajlm-283	81	39	at	at	ADP
ajlm-283	81	40	birth	birth	NOUN
ajlm-283	81	41	remains	remain	VERB
ajlm-283	81	42	a	a	DET
ajlm-283	81	43	challenge	challenge	NOUN
ajlm-283	81	44	in	in	ADP
ajlm-283	81	45	most	most	ADJ
ajlm-283	81	46	south	south	ADJ
ajlm-283	81	47	african	african	ADJ
ajlm-283	81	48	obstetric	obstetric	ADJ
ajlm-283	81	49	units.33	units.33	NOUN
ajlm-283	81	50	the	the	DET
ajlm-283	81	51	who	who	PRON
ajlm-283	81	52	recommends	recommend	VERB
ajlm-283	81	53	hbv	hbv	NOUN
ajlm-283	81	54	vaccination	vaccination	NOUN
ajlm-283	81	55	within	within	ADP
ajlm-283	81	56	24	24	NUM
ajlm-283	81	57	hours	hour	NOUN
ajlm-283	81	58	of	of	ADP
ajlm-283	81	59	birth	birth	NOUN
ajlm-283	81	60	.	.	PUNCT
ajlm-283	82	1	providing	provide	VERB
ajlm-283	82	2	this	this	DET
ajlm-283	82	3	birth	birth	NOUN
ajlm-283	82	4	dose	dose	NOUN
ajlm-283	82	5	is	be	AUX
ajlm-283	82	6	feasible	feasible	ADJ
ajlm-283	82	7	within	within	ADP
ajlm-283	82	8	the	the	DET
ajlm-283	82	9	south	south	ADJ
ajlm-283	82	10	african	african	ADJ
ajlm-283	82	11	immunisation	immunisation	NOUN
ajlm-283	82	12	schedule	schedule	NOUN
ajlm-283	82	13	,	,	PUNCT
ajlm-283	82	14	as	as	SCONJ
ajlm-283	82	15	other	other	ADJ
ajlm-283	82	16	vaccines	vaccine	NOUN
ajlm-283	82	17	are	be	AUX
ajlm-283	82	18	currently	currently	ADV
ajlm-283	82	19	given	give	VERB
ajlm-283	82	20	at	at	ADP
ajlm-283	82	21	birth	birth	NOUN
ajlm-283	82	22	.	.	PUNCT
ajlm-283	83	1	we	we	PRON
ajlm-283	83	2	propose	propose	VERB
ajlm-283	83	3	that	that	SCONJ
ajlm-283	83	4	the	the	DET
ajlm-283	83	5	birth	birth	NOUN
ajlm-283	83	6	dose	dose	NOUN
ajlm-283	83	7	of	of	ADP
ajlm-283	83	8	hbv	hbv	NOUN
ajlm-283	83	9	vaccination	vaccination	NOUN
ajlm-283	83	10	,	,	PUNCT
ajlm-283	83	11	which	which	PRON
ajlm-283	83	12	has	have	AUX
ajlm-283	83	13	been	be	AUX
ajlm-283	83	14	shown	show	VERB
ajlm-283	83	15	to	to	PART
ajlm-283	83	16	reduce	reduce	VERB
ajlm-283	83	17	early	early	ADJ
ajlm-283	83	18	perinatal	perinatal	ADJ
ajlm-283	83	19	transmission,34	transmission,34	NOUN
ajlm-283	83	20	should	should	AUX
ajlm-283	83	21	be	be	AUX
ajlm-283	83	22	considered	consider	VERB
ajlm-283	83	23	as	as	ADP
ajlm-283	83	24	part	part	NOUN
ajlm-283	83	25	of	of	ADP
ajlm-283	83	26	the	the	DET
ajlm-283	83	27	expanded	expand	VERB
ajlm-283	83	28	programme	programme	NOUN
ajlm-283	83	29	on	on	ADP
ajlm-283	83	30	immunisation	immunisation	NOUN
ajlm-283	83	31	in	in	ADP
ajlm-283	83	32	south	south	PROPN
ajlm-283	83	33	africa	africa	PROPN
ajlm-283	83	34	.	.	PUNCT
ajlm-283	84	1	limitations	limitation	NOUN
ajlm-283	84	2	of	of	ADP
ajlm-283	84	3	the	the	DET
ajlm-283	84	4	study	study	NOUN
ajlm-283	84	5	testing	testing	NOUN
ajlm-283	84	6	was	be	AUX
ajlm-283	84	7	conducted	conduct	VERB
ajlm-283	84	8	on	on	ADP
ajlm-283	84	9	residual	residual	ADJ
ajlm-283	84	10	samples	sample	NOUN
ajlm-283	84	11	that	that	PRON
ajlm-283	84	12	were	be	AUX
ajlm-283	84	13	referred	refer	VERB
ajlm-283	84	14	for	for	ADP
ajlm-283	84	15	early	early	ADJ
ajlm-283	84	16	-	-	PUNCT
ajlm-283	84	17	infant	infant	NOUN
ajlm-283	84	18	diagnosis	diagnosis	NOUN
ajlm-283	84	19	of	of	ADP
ajlm-283	84	20	hiv	hiv	PROPN
ajlm-283	84	21	,	,	PUNCT
ajlm-283	84	22	which	which	PRON
ajlm-283	84	23	may	may	AUX
ajlm-283	84	24	have	have	AUX
ajlm-283	84	25	created	create	VERB
ajlm-283	84	26	a	a	DET
ajlm-283	84	27	bias	bias	NOUN
ajlm-283	84	28	towards	towards	ADP
ajlm-283	84	29	infants	infant	NOUN
ajlm-283	84	30	who	who	PRON
ajlm-283	84	31	had	have	AUX
ajlm-283	84	32	been	be	AUX
ajlm-283	84	33	exposed	expose	VERB
ajlm-283	84	34	to	to	ADP
ajlm-283	84	35	hiv	hiv	PROPN
ajlm-283	84	36	in	in	ADP
ajlm-283	84	37	utero	utero	PROPN
ajlm-283	84	38	,	,	PUNCT
ajlm-283	84	39	impacting	impact	VERB
ajlm-283	84	40	the	the	DET
ajlm-283	84	41	generalizability	generalizability	NOUN
ajlm-283	84	42	of	of	ADP
ajlm-283	84	43	our	our	PRON
ajlm-283	84	44	findings	finding	NOUN
ajlm-283	84	45	to	to	ADP
ajlm-283	84	46	the	the	DET
ajlm-283	84	47	broader	broad	ADJ
ajlm-283	84	48	population	population	NOUN
ajlm-283	84	49	of	of	ADP
ajlm-283	84	50	all	all	DET
ajlm-283	84	51	infants	infant	NOUN
ajlm-283	84	52	in	in	ADP
ajlm-283	84	53	kwazulu	kwazulu	PROPN
ajlm-283	84	54	-	-	PUNCT
ajlm-283	84	55	natal	natal	ADJ
ajlm-283	84	56	province	province	NOUN
ajlm-283	84	57	of	of	ADP
ajlm-283	84	58	south	south	PROPN
ajlm-283	84	59	africa	africa	PROPN
ajlm-283	84	60	.	.	PUNCT
ajlm-283	85	1	in	in	ADP
ajlm-283	85	2	addition	addition	NOUN
ajlm-283	85	3	,	,	PUNCT
ajlm-283	85	4	no	no	DET
ajlm-283	85	5	follow	follow	NOUN
ajlm-283	85	6	-	-	PUNCT
ajlm-283	85	7	up	up	NOUN
ajlm-283	85	8	was	be	AUX
ajlm-283	85	9	conducted	conduct	VERB
ajlm-283	85	10	to	to	PART
ajlm-283	85	11	confirm	confirm	VERB
ajlm-283	85	12	chronic	chronic	ADJ
ajlm-283	85	13	hbv	hbv	NOUN
ajlm-283	85	14	infection	infection	NOUN
ajlm-283	85	15	.	.	PUNCT
ajlm-283	86	1	finally	finally	ADV
ajlm-283	86	2	,	,	PUNCT
ajlm-283	86	3	the	the	DET
ajlm-283	86	4	sample	sample	NOUN
ajlm-283	86	5	size	size	NOUN
ajlm-283	86	6	of	of	ADP
ajlm-283	86	7	our	our	PRON
ajlm-283	86	8	study	study	NOUN
ajlm-283	86	9	was	be	AUX
ajlm-283	86	10	relatively	relatively	ADV
ajlm-283	86	11	small	small	ADJ
ajlm-283	86	12	limiting	limit	VERB
ajlm-283	86	13	the	the	DET
ajlm-283	86	14	statistical	statistical	ADJ
ajlm-283	86	15	power	power	NOUN
ajlm-283	86	16	to	to	PART
ajlm-283	86	17	detect	detect	VERB
ajlm-283	86	18	differences	difference	NOUN
ajlm-283	86	19	between	between	ADP
ajlm-283	86	20	hiv	hiv	PROPN
ajlm-283	86	21	-	-	PUNCT
ajlm-283	86	22	positive	positive	ADJ
ajlm-283	86	23	and	and	CCONJ
ajlm-283	86	24	hiv	hiv	NOUN
ajlm-283	86	25	-	-	PUNCT
ajlm-283	86	26	negative	negative	ADJ
ajlm-283	86	27	infants	infant	NOUN
ajlm-283	86	28	.	.	PUNCT
ajlm-283	87	1	conclusion	conclusion	NOUN
ajlm-283	87	2	this	this	DET
ajlm-283	87	3	study	study	NOUN
ajlm-283	87	4	found	find	VERB
ajlm-283	87	5	a	a	DET
ajlm-283	87	6	clinically	clinically	ADV
ajlm-283	87	7	significant	significant	ADJ
ajlm-283	87	8	prevalence	prevalence	NOUN
ajlm-283	87	9	of	of	ADP
ajlm-283	87	10	hbv	hbv	NOUN
ajlm-283	87	11	infection	infection	NOUN
ajlm-283	87	12	(	(	PUNCT
ajlm-283	87	13	10	10	NUM
ajlm-283	87	14	%	%	NOUN
ajlm-283	87	15	)	)	PUNCT
ajlm-283	87	16	amongst	amongst	ADP
ajlm-283	87	17	a	a	DET
ajlm-283	87	18	sample	sample	NOUN
ajlm-283	87	19	of	of	ADP
ajlm-283	87	20	hiv	hiv	PROPN
ajlm-283	87	21	-	-	PUNCT
ajlm-283	87	22	positive	positive	ADJ
ajlm-283	87	23	and	and	CCONJ
ajlm-283	87	24	hiv	hiv	NOUN
ajlm-283	87	25	-	-	PUNCT
ajlm-283	87	26	negative	negative	ADJ
ajlm-283	87	27	infants	infant	NOUN
ajlm-283	87	28	in	in	ADP
ajlm-283	87	29	kwazulu	kwazulu	NOUN
ajlm-283	87	30	-	-	PUNCT
ajlm-283	87	31	natal	natal	ADJ
ajlm-283	87	32	,	,	PUNCT
ajlm-283	87	33	south	south	PROPN
ajlm-283	87	34	africa	africa	PROPN
ajlm-283	87	35	.	.	PUNCT
ajlm-283	88	1	the	the	DET
ajlm-283	88	2	difference	difference	NOUN
ajlm-283	88	3	in	in	ADP
ajlm-283	88	4	hbv	hbv	NOUN
ajlm-283	88	5	prevalence	prevalence	NOUN
ajlm-283	88	6	between	between	ADP
ajlm-283	88	7	the	the	DET
ajlm-283	88	8	two	two	NUM
ajlm-283	88	9	groups	group	NOUN
ajlm-283	88	10	of	of	ADP
ajlm-283	88	11	infants	infant	NOUN
ajlm-283	88	12	was	be	AUX
ajlm-283	88	13	not	not	PART
ajlm-283	88	14	statistically	statistically	ADV
ajlm-283	88	15	significant	significant	ADJ
ajlm-283	88	16	,	,	PUNCT
ajlm-283	88	17	suggesting	suggest	VERB
ajlm-283	88	18	that	that	SCONJ
ajlm-283	88	19	hbv	hbv	NOUN
ajlm-283	88	20	infection	infection	NOUN
ajlm-283	88	21	amongst	amongst	ADP
ajlm-283	88	22	children	child	NOUN
ajlm-283	88	23	in	in	ADP
ajlm-283	88	24	this	this	DET
ajlm-283	88	25	region	region	NOUN
ajlm-283	88	26	may	may	AUX
ajlm-283	88	27	be	be	AUX
ajlm-283	88	28	a	a	DET
ajlm-283	88	29	problem	problem	NOUN
ajlm-283	88	30	independent	independent	ADJ
ajlm-283	88	31	of	of	ADP
ajlm-283	88	32	hiv	hiv	PROPN
ajlm-283	88	33	.	.	PUNCT
ajlm-283	89	1	acknowledgements	acknowledgement	NOUN
ajlm-283	89	2	competing	compete	VERB
ajlm-283	89	3	interests	interest	NOUN
ajlm-283	89	4	the	the	DET
ajlm-283	89	5	authors	author	NOUN
ajlm-283	89	6	declare	declare	VERB
ajlm-283	89	7	that	that	SCONJ
ajlm-283	89	8	they	they	PRON
ajlm-283	89	9	have	have	VERB
ajlm-283	89	10	no	no	DET
ajlm-283	89	11	financial	financial	ADJ
ajlm-283	89	12	or	or	CCONJ
ajlm-283	89	13	personal	personal	ADJ
ajlm-283	89	14	relationship(s	relationship(s	NOUN
ajlm-283	89	15	)	)	PUNCT
ajlm-283	89	16	that	that	PRON
ajlm-283	89	17	may	may	AUX
ajlm-283	89	18	have	have	AUX
ajlm-283	89	19	inappropriately	inappropriately	ADV
ajlm-283	89	20	influenced	influence	VERB
ajlm-283	89	21	them	they	PRON
ajlm-283	89	22	in	in	ADP
ajlm-283	89	23	writing	write	VERB
ajlm-283	89	24	this	this	DET
ajlm-283	89	25	article	article	NOUN
ajlm-283	89	26	.	.	PUNCT
ajlm-283	90	1	sources	source	NOUN
ajlm-283	90	2	of	of	ADP
ajlm-283	90	3	support	support	NOUN
ajlm-283	90	4	the	the	DET
ajlm-283	90	5	authors	author	NOUN
ajlm-283	90	6	would	would	AUX
ajlm-283	90	7	like	like	VERB
ajlm-283	90	8	to	to	PART
ajlm-283	90	9	thank	thank	VERB
ajlm-283	90	10	the	the	DET
ajlm-283	90	11	national	national	PROPN
ajlm-283	90	12	health	health	PROPN
ajlm-283	90	13	laboratory	laboratory	PROPN
ajlm-283	90	14	service	service	PROPN
ajlm-283	90	15	research	research	NOUN
ajlm-283	90	16	trust	trust	NOUN
ajlm-283	90	17	for	for	ADP
ajlm-283	90	18	funding	fund	VERB
ajlm-283	90	19	this	this	DET
ajlm-283	90	20	research	research	NOUN
ajlm-283	90	21	.	.	PUNCT
ajlm-283	91	1	authors	author	NOUN
ajlm-283	91	2	’	’	PART
ajlm-283	91	3	contributions	contribution	NOUN
ajlm-283	91	4	n.m	n.m	PROPN
ajlm-283	91	5	.	.	PROPN
ajlm-283	91	6	was	be	AUX
ajlm-283	91	7	the	the	DET
ajlm-283	91	8	project	project	NOUN
ajlm-283	91	9	leader	leader	NOUN
ajlm-283	91	10	and	and	CCONJ
ajlm-283	91	11	was	be	AUX
ajlm-283	91	12	responsible	responsible	ADJ
ajlm-283	91	13	for	for	ADP
ajlm-283	91	14	performing	perform	VERB
ajlm-283	91	15	all	all	DET
ajlm-283	91	16	laboratory	laboratory	NOUN
ajlm-283	91	17	tests	test	NOUN
ajlm-283	91	18	and	and	CCONJ
ajlm-283	91	19	drafting	draft	VERB
ajlm-283	91	20	the	the	DET
ajlm-283	91	21	manuscript	manuscript	NOUN
ajlm-283	91	22	.	.	PUNCT
ajlm-283	92	1	r.p	r.p	PROPN
ajlm-283	92	2	.	.	PROPN
ajlm-283	92	3	was	be	AUX
ajlm-283	92	4	responsible	responsible	ADJ
ajlm-283	92	5	for	for	ADP
ajlm-283	92	6	the	the	DET
ajlm-283	92	7	study	study	NOUN
ajlm-283	92	8	design	design	NOUN
ajlm-283	92	9	and	and	CCONJ
ajlm-283	92	10	statistical	statistical	ADJ
ajlm-283	92	11	analysis	analysis	NOUN
ajlm-283	92	12	.	.	PUNCT
ajlm-283	93	1	p.m.	p.m.	PROPN
ajlm-283	93	2	was	be	AUX
ajlm-283	93	3	involved	involve	VERB
ajlm-283	93	4	during	during	ADP
ajlm-283	93	5	study	study	NOUN
ajlm-283	93	6	conceptualisation	conceptualisation	NOUN
ajlm-283	93	7	and	and	CCONJ
ajlm-283	93	8	review	review	NOUN
ajlm-283	93	9	of	of	ADP
ajlm-283	93	10	the	the	DET
ajlm-283	93	11	manuscript	manuscript	NOUN
ajlm-283	93	12	.	.	PUNCT
ajlm-283	94	1	all	all	DET
ajlm-283	94	2	authors	author	NOUN
ajlm-283	94	3	are	be	AUX
ajlm-283	94	4	affiliated	affiliate	VERB
ajlm-283	94	5	with	with	ADP
ajlm-283	94	6	the	the	DET
ajlm-283	94	7	national	national	PROPN
ajlm-283	94	8	health	health	PROPN
ajlm-283	94	9	laboratory	laboratory	PROPN
ajlm-283	94	10	service	service	NOUN
ajlm-283	94	11	at	at	ADP
ajlm-283	94	12	the	the	DET
ajlm-283	94	13	inkosi	inkosi	PROPN
ajlm-283	94	14	albert	albert	PROPN
ajlm-283	94	15	luthuli	luthuli	PROPN
ajlm-283	94	16	central	central	PROPN
ajlm-283	94	17	hospital	hospital	NOUN
ajlm-283	94	18	,	,	PUNCT
ajlm-283	94	19	university	university	NOUN
ajlm-283	94	20	of	of	ADP
ajlm-283	94	21	kwazulu	kwazulu	PROPN
ajlm-283	94	22	-	-	PUNCT
ajlm-283	94	23	natal	natal	ADJ
ajlm-283	94	24	,	,	PUNCT
ajlm-283	94	25	south	south	PROPN
ajlm-283	94	26	africa	africa	PROPN
ajlm-283	94	27	.	.	PUNCT
ajlm-283	95	1	references	reference	NOUN
ajlm-283	95	2	lavanchy	lavanchy	PROPN
ajlm-283	95	3	d.	d.	PROPN
ajlm-283	95	4	hepatitis	hepatitis	PROPN
ajlm-283	95	5	b	b	PROPN
ajlm-283	95	6	virus	virus	PROPN
ajlm-283	95	7	epidemiology	epidemiology	NOUN
ajlm-283	95	8	,	,	PUNCT
ajlm-283	95	9	disease	disease	NOUN
ajlm-283	95	10	burden	burden	NOUN
ajlm-283	95	11	,	,	PUNCT
ajlm-283	95	12	treatment	treatment	NOUN
ajlm-283	95	13	,	,	PUNCT
ajlm-283	95	14	and	and	CCONJ
ajlm-283	95	15	current	current	ADJ
ajlm-283	95	16	and	and	CCONJ
ajlm-283	95	17	emerging	emerge	VERB
ajlm-283	95	18	prevention	prevention	NOUN
ajlm-283	95	19	and	and	CCONJ
ajlm-283	95	20	control	control	NOUN
ajlm-283	95	21	measures	measure	NOUN
ajlm-283	95	22	.	.	PUNCT
ajlm-283	96	1	j	j	PROPN
ajlm-283	96	2	viral	viral	ADJ
ajlm-283	96	3	hepat	hepat	NOUN
ajlm-283	96	4	.	.	PUNCT
ajlm-283	97	1	2004;11(2):97–107	2004;11(2):97–107	NUM
ajlm-283	97	2	.	.	PUNCT
ajlm-283	98	1	http://dx.doi.org/10.1046/j.1365-2893.2003.00487.x	http://dx.doi.org/10.1046/j.1365-2893.2003.00487.x	X
ajlm-283	98	2	ott	ott	PROPN
ajlm-283	98	3	jj	jj	PROPN
ajlm-283	98	4	,	,	PUNCT
ajlm-283	98	5	stevens	stevens	PROPN
ajlm-283	98	6	ga	ga	PROPN
ajlm-283	98	7	,	,	PUNCT
ajlm-283	98	8	groeger	groeger	PROPN
ajlm-283	98	9	j	j	PROPN
ajlm-283	98	10	,	,	PUNCT
ajlm-283	98	11	wiersma	wiersma	PROPN
ajlm-283	98	12	st	st	PROPN
ajlm-283	98	13	.	.	PROPN
ajlm-283	98	14	global	global	ADJ
ajlm-283	98	15	epidemiology	epidemiology	NOUN
ajlm-283	98	16	of	of	ADP
ajlm-283	98	17	hepatitis	hepatitis	PROPN
ajlm-283	98	18	b	b	PROPN
ajlm-283	98	19	virus	virus	NOUN
ajlm-283	98	20	infection	infection	NOUN
ajlm-283	98	21	:	:	PUNCT
ajlm-283	98	22	new	new	ADJ
ajlm-283	98	23	estimates	estimate	NOUN
ajlm-283	98	24	of	of	ADP
ajlm-283	98	25	age	age	NOUN
ajlm-283	98	26	-	-	PUNCT
ajlm-283	98	27	specific	specific	ADJ
ajlm-283	98	28	hbsag	hbsag	ADJ
ajlm-283	98	29	seroprevalence	seroprevalence	NOUN
ajlm-283	98	30	and	and	CCONJ
ajlm-283	98	31	endemicity	endemicity	NOUN
ajlm-283	98	32	.	.	PUNCT
ajlm-283	99	1	vaccine	vaccine	NOUN
ajlm-283	99	2	.	.	PUNCT
ajlm-283	100	1	2012;30(12):2212–2219	2012;30(12):2212–2219	NUM
ajlm-283	100	2	.	.	PUNCT
ajlm-283	101	1	http://dx.doi.org/10.1016/j.vaccine.2011.12.116	http://dx.doi.org/10.1016/j.vaccine.2011.12.116	ADP
ajlm-283	101	2	abdool	abdool	NOUN
ajlm-283	101	3	karim	karim	PROPN
ajlm-283	101	4	s	s	PROPN
ajlm-283	101	5	,	,	PUNCT
ajlm-283	101	6	thejpal	thejpal	ADJ
ajlm-283	101	7	r	r	NOUN
ajlm-283	101	8	,	,	PUNCT
ajlm-283	101	9	singh	singh	PROPN
ajlm-283	101	10	b.	b.	PROPN
ajlm-283	101	11	high	high	ADJ
ajlm-283	101	12	prevalence	prevalence	NOUN
ajlm-283	101	13	of	of	ADP
ajlm-283	101	14	hepatitis	hepatitis	PROPN
ajlm-283	101	15	b	b	PROPN
ajlm-283	101	16	virus	virus	NOUN
ajlm-283	101	17	infection	infection	NOUN
ajlm-283	101	18	in	in	ADP
ajlm-283	101	19	rural	rural	ADJ
ajlm-283	101	20	black	black	ADJ
ajlm-283	101	21	adults	adult	NOUN
ajlm-283	101	22	in	in	ADP
ajlm-283	101	23	mseleni	mseleni	ADJ
ajlm-283	101	24	,	,	PUNCT
ajlm-283	101	25	south	south	PROPN
ajlm-283	101	26	africa	africa	PROPN
ajlm-283	101	27	.	.	PUNCT
ajlm-283	102	1	am	be	AUX
ajlm-283	102	2	j	j	PROPN
ajlm-283	102	3	public	public	ADJ
ajlm-283	102	4	health	health	NOUN
ajlm-283	102	5	.	.	PUNCT
ajlm-283	103	1	1989;79(7):893–894	1989;79(7):893–894	NUM
ajlm-283	103	2	.	.	NOUN
ajlm-283	103	3	http://dx.doi.org/10.2105/ajph.79.7.893	http://dx.doi.org/10.2105/ajph.79.7.893	NOUN
ajlm-283	103	4	vardas	vardas	PROPN
ajlm-283	103	5	e	e	X
ajlm-283	103	6	,	,	PUNCT
ajlm-283	103	7	mathai	mathai	PROPN
ajlm-283	103	8	m	m	PROPN
ajlm-283	103	9	,	,	PUNCT
ajlm-283	103	10	blaauw	blaauw	NOUN
ajlm-283	103	11	d	d	NOUN
ajlm-283	103	12	,	,	PUNCT
ajlm-283	103	13	mcanerney	mcanerney	PROPN
ajlm-283	103	14	j	j	PROPN
ajlm-283	103	15	,	,	PUNCT
ajlm-283	103	16	coppin	coppin	PROPN
ajlm-283	103	17	a	a	PRON
ajlm-283	103	18	,	,	PUNCT
ajlm-283	103	19	sim	sim	ADJ
ajlm-283	103	20	j.	j.	PROPN
ajlm-283	103	21	preimmunization	preimmunization	PROPN
ajlm-283	103	22	epidemiology	epidemiology	NOUN
ajlm-283	103	23	of	of	ADP
ajlm-283	103	24	hepatitis	hepatitis	PROPN
ajlm-283	103	25	b	b	PROPN
ajlm-283	103	26	virus	virus	NOUN
ajlm-283	103	27	infection	infection	NOUN
ajlm-283	103	28	in	in	ADP
ajlm-283	103	29	south	south	ADJ
ajlm-283	103	30	african	african	ADJ
ajlm-283	103	31	children	child	NOUN
ajlm-283	103	32	.	.	PUNCT
ajlm-283	104	1	j	j	PROPN
ajlm-283	104	2	med	med	PROPN
ajlm-283	104	3	virol	virol	NOUN
ajlm-283	104	4	.	.	PUNCT
ajlm-283	105	1	1999;58(2):111–115	1999;58(2):111–115	X
ajlm-283	105	2	.	.	PUNCT
ajlm-283	106	1	http://dx.doi.org/10.1002/(sici)1096-9071(199906)58:2<111::aid-jmv2>3.0.co;2-b	http://dx.doi.org/10.1002/(sici)1096-9071(199906)58:2<111::aid-jmv2>3.0.co;2-b	PROPN
ajlm-283	106	2	tsebe	tsebe	PROPN
ajlm-283	106	3	kv	kv	PROPN
ajlm-283	106	4	,	,	PUNCT
ajlm-283	106	5	burnett	burnett	PROPN
ajlm-283	106	6	rj	rj	PROPN
ajlm-283	106	7	,	,	PUNCT
ajlm-283	106	8	hlungwani	hlungwani	PROPN
ajlm-283	106	9	np	np	INTJ
ajlm-283	106	10	,	,	PUNCT
ajlm-283	106	11	sibara	sibara	PROPN
ajlm-283	106	12	mm	mm	PROPN
ajlm-283	106	13	,	,	PUNCT
ajlm-283	106	14	venter	venter	PROPN
ajlm-283	106	15	pa	pa	PROPN
ajlm-283	106	16	,	,	PUNCT
ajlm-283	106	17	mphahlele	mphahlele	PROPN
ajlm-283	106	18	mj	mj	PROPN
ajlm-283	106	19	.	.	PUNCT
ajlm-283	107	1	the	the	DET
ajlm-283	107	2	first	first	ADJ
ajlm-283	107	3	five	five	NUM
ajlm-283	107	4	years	year	NOUN
ajlm-283	107	5	of	of	ADP
ajlm-283	107	6	universal	universal	ADJ
ajlm-283	107	7	hepatitis	hepatitis	PROPN
ajlm-283	107	8	b	b	PROPN
ajlm-283	107	9	vaccination	vaccination	NOUN
ajlm-283	107	10	in	in	ADP
ajlm-283	107	11	south	south	PROPN
ajlm-283	107	12	africa	africa	PROPN
ajlm-283	107	13	:	:	PUNCT
ajlm-283	107	14	evidence	evidence	NOUN
ajlm-283	107	15	for	for	ADP
ajlm-283	107	16	elimination	elimination	NOUN
ajlm-283	107	17	of	of	ADP
ajlm-283	107	18	hbsag	hbsag	ADJ
ajlm-283	107	19	carriage	carriage	NOUN
ajlm-283	107	20	in	in	ADP
ajlm-283	107	21	under	under	ADP
ajlm-283	107	22	5	5	NUM
ajlm-283	107	23	-	-	PUNCT
ajlm-283	107	24	year	year	NOUN
ajlm-283	107	25	-	-	PUNCT
ajlm-283	107	26	olds	old	NOUN
ajlm-283	107	27	.	.	PUNCT
ajlm-283	108	1	vaccine	vaccine	NOUN
ajlm-283	108	2	.	.	PUNCT
ajlm-283	109	1	2001;19(28	2001;19(28	NUM
ajlm-283	109	2	-	-	NOUN
ajlm-283	109	3	29):3919–3926	29):3919–3926	NOUN
ajlm-283	109	4	.	.	PUNCT
ajlm-283	110	1	http://dx.doi.org/10.1016/s0264-410x(01)00120-7	http://dx.doi.org/10.1016/s0264-410x(01)00120-7	PROPN
ajlm-283	110	2	simani	simani	PROPN
ajlm-283	110	3	oe	oe	PROPN
ajlm-283	110	4	,	,	PUNCT
ajlm-283	110	5	leroux	leroux	NOUN
ajlm-283	110	6	-	-	PUNCT
ajlm-283	110	7	roels	roel	NOUN
ajlm-283	110	8	g	g	NOUN
ajlm-283	110	9	,	,	PUNCT
ajlm-283	110	10	françois	françois	PROPN
ajlm-283	110	11	g	g	PROPN
ajlm-283	110	12	,	,	PUNCT
ajlm-283	110	13	burnett	burnett	PROPN
ajlm-283	110	14	rj	rj	PROPN
ajlm-283	110	15	,	,	PUNCT
ajlm-283	110	16	meheus	meheus	PROPN
ajlm-283	110	17	a	a	PROPN
ajlm-283	110	18	,	,	PUNCT
ajlm-283	110	19	mphahlele	mphahlele	PROPN
ajlm-283	110	20	mj	mj	PROPN
ajlm-283	110	21	.	.	PROPN
ajlm-283	110	22	reduced	reduce	VERB
ajlm-283	110	23	detection	detection	NOUN
ajlm-283	110	24	and	and	CCONJ
ajlm-283	110	25	levels	level	NOUN
ajlm-283	110	26	of	of	ADP
ajlm-283	110	27	protective	protective	ADJ
ajlm-283	110	28	antibodies	antibody	NOUN
ajlm-283	110	29	to	to	ADP
ajlm-283	110	30	hepatitis	hepatitis	PROPN
ajlm-283	110	31	b	b	PROPN
ajlm-283	110	32	vaccine	vaccine	NOUN
ajlm-283	110	33	in	in	ADP
ajlm-283	110	34	under	under	ADP
ajlm-283	110	35	2	2	NUM
ajlm-283	110	36	-	-	PUNCT
ajlm-283	110	37	year	year	NOUN
ajlm-283	110	38	-	-	PUNCT
ajlm-283	110	39	old	old	ADJ
ajlm-283	110	40	hiv	hiv	PROPN
ajlm-283	110	41	positive	positive	ADJ
ajlm-283	110	42	south	south	ADJ
ajlm-283	110	43	african	african	ADJ
ajlm-283	110	44	children	child	NOUN
ajlm-283	110	45	at	at	ADP
ajlm-283	110	46	a	a	DET
ajlm-283	110	47	paediatric	paediatric	ADJ
ajlm-283	110	48	outpatient	outpatient	NOUN
ajlm-283	110	49	clinic	clinic	NOUN
ajlm-283	110	50	.	.	PUNCT
ajlm-283	111	1	vaccine	vaccine	NOUN
ajlm-283	111	2	.	.	PUNCT
ajlm-283	112	1	2009;27(1):146–151	2009;27(1):146–151	X
ajlm-283	112	2	.	.	PUNCT
ajlm-283	113	1	http://dx.doi.org/10.1016/j.vaccine.2008.10.004	http://dx.doi.org/10.1016/j.vaccine.2008.10.004	PROPN
ajlm-283	113	2	scharschmidt	scharschmidt	PROPN
ajlm-283	113	3	bf	bf	PROPN
ajlm-283	113	4	,	,	PUNCT
ajlm-283	113	5	held	hold	VERB
ajlm-283	113	6	mj	mj	PROPN
ajlm-283	113	7	,	,	PUNCT
ajlm-283	113	8	hollander	hollander	PROPN
ajlm-283	113	9	hh	hh	PROPN
ajlm-283	113	10	,	,	PUNCT
ajlm-283	113	11	read	read	VERB
ajlm-283	113	12	ae	ae	PROPN
ajlm-283	113	13	,	,	PUNCT
ajlm-283	113	14	lavine	lavine	PROPN
ajlm-283	113	15	je	je	PROPN
ajlm-283	113	16	,	,	PUNCT
ajlm-283	113	17	veereman	veereman	PROPN
ajlm-283	113	18	g	g	PROPN
ajlm-283	113	19	,	,	PUNCT
ajlm-283	113	20	et	et	PROPN
ajlm-283	113	21	al	al	PROPN
ajlm-283	113	22	.	.	PUNCT
ajlm-283	114	1	hepatitis	hepatitis	PROPN
ajlm-283	114	2	b	b	PROPN
ajlm-283	114	3	in	in	ADP
ajlm-283	114	4	patients	patient	NOUN
ajlm-283	114	5	with	with	ADP
ajlm-283	114	6	hiv	hiv	PROPN
ajlm-283	114	7	infection	infection	NOUN
ajlm-283	114	8	:	:	PUNCT
ajlm-283	114	9	relationship	relationship	NOUN
ajlm-283	114	10	to	to	ADP
ajlm-283	114	11	aids	aid	NOUN
ajlm-283	114	12	and	and	CCONJ
ajlm-283	114	13	patient	patient	ADJ
ajlm-283	114	14	survival	survival	NOUN
ajlm-283	114	15	.	.	PUNCT
ajlm-283	115	1	ann	ann	PROPN
ajlm-283	115	2	intern	intern	PROPN
ajlm-283	115	3	med	med	PROPN
ajlm-283	115	4	.	.	PUNCT
ajlm-283	116	1	1992;117(10):837–838	1992;117(10):837–838	X
ajlm-283	116	2	.	.	PUNCT
ajlm-283	117	1	http://dx.doi.org/10.7326/0003-4819-117-10-837	http://dx.doi.org/10.7326/0003-4819-117-10-837	PROPN
ajlm-283	117	2	horvath	horvath	PROPN
ajlm-283	117	3	j	j	PROPN
ajlm-283	117	4	,	,	PUNCT
ajlm-283	117	5	raffanti	raffanti	PROPN
ajlm-283	117	6	sp	sp	PROPN
ajlm-283	117	7	.	.	PROPN
ajlm-283	117	8	clinical	clinical	ADJ
ajlm-283	117	9	aspects	aspect	NOUN
ajlm-283	117	10	of	of	ADP
ajlm-283	117	11	the	the	DET
ajlm-283	117	12	interactions	interaction	NOUN
ajlm-283	117	13	between	between	ADP
ajlm-283	117	14	human	human	ADJ
ajlm-283	117	15	immunodeficiency	immunodeficiency	NOUN
ajlm-283	117	16	virus	virus	NOUN
ajlm-283	117	17	and	and	CCONJ
ajlm-283	117	18	the	the	DET
ajlm-283	117	19	hepatotropic	hepatotropic	NOUN
ajlm-283	117	20	viruses	virus	NOUN
ajlm-283	117	21	.	.	PUNCT
ajlm-283	118	1	clin	clin	PROPN
ajlm-283	118	2	infect	infect	PROPN
ajlm-283	118	3	dis	dis	PROPN
ajlm-283	118	4	.	.	PUNCT
ajlm-283	119	1	1994;18(3):339–347	1994;18(3):339–347	NUM
ajlm-283	119	2	.	.	PUNCT
ajlm-283	120	1	http://dx.doi.org/10.1093/clinids/18.3.339	http://dx.doi.org/10.1093/clinids/18.3.339	PROPN
ajlm-283	120	2	burnett	burnett	PROPN
ajlm-283	120	3	rj	rj	PROPN
ajlm-283	120	4	,	,	PUNCT
ajlm-283	120	5	ngobeni	ngobeni	NOUN
ajlm-283	120	6	jm	jm	PROPN
ajlm-283	120	7	,	,	PUNCT
ajlm-283	120	8	françois	françois	PROPN
ajlm-283	120	9	g	g	PROPN
ajlm-283	120	10	,	,	PUNCT
ajlm-283	120	11	hoosen	hoosen	NOUN
ajlm-283	120	12	aa	aa	NOUN
ajlm-283	120	13	,	,	PUNCT
ajlm-283	120	14	leroux	leroux	NOUN
ajlm-283	120	15	-	-	PUNCT
ajlm-283	120	16	roels	roel	NOUN
ajlm-283	120	17	g	g	NOUN
ajlm-283	120	18	,	,	PUNCT
ajlm-283	120	19	meheus	meheus	PROPN
ajlm-283	120	20	a	a	PROPN
ajlm-283	120	21	,	,	PUNCT
ajlm-283	120	22	et	et	PROPN
ajlm-283	120	23	al	al	PROPN
ajlm-283	120	24	.	.	PROPN
ajlm-283	120	25	increased	increase	VERB
ajlm-283	120	26	exposure	exposure	NOUN
ajlm-283	120	27	to	to	ADP
ajlm-283	120	28	hepatitis	hepatitis	PROPN
ajlm-283	120	29	b	b	PROPN
ajlm-283	120	30	virus	virus	NOUN
ajlm-283	120	31	infection	infection	NOUN
ajlm-283	120	32	in	in	ADP
ajlm-283	120	33	hiv	hiv	PROPN
ajlm-283	120	34	-	-	PUNCT
ajlm-283	120	35	positive	positive	ADJ
ajlm-283	120	36	south	south	ADJ
ajlm-283	120	37	african	african	ADJ
ajlm-283	120	38	antenatal	antenatal	ADJ
ajlm-283	120	39	women	woman	NOUN
ajlm-283	120	40	.	.	PUNCT
ajlm-283	121	1	int	int	PROPN
ajlm-283	121	2	j	j	PROPN
ajlm-283	121	3	std	std	X
ajlm-283	121	4	aids	aids	PROPN
ajlm-283	121	5	.	.	PUNCT
ajlm-283	122	1	2007;18(3):152–156	2007;18(3):152–156	PROPN
ajlm-283	122	2	.	.	PROPN
ajlm-283	122	3	http://dx.doi.org/10.1258/095646207780132523	http://dx.doi.org/10.1258/095646207780132523	PROPN
ajlm-283	122	4	burnett	burnett	PROPN
ajlm-283	122	5	rj	rj	PROPN
ajlm-283	122	6	,	,	PUNCT
ajlm-283	122	7	françois	françois	PROPN
ajlm-283	122	8	g	g	PROPN
ajlm-283	122	9	,	,	PUNCT
ajlm-283	122	10	kew	kew	PROPN
ajlm-283	122	11	mc	mc	PROPN
ajlm-283	122	12	,	,	PUNCT
ajlm-283	122	13	leroux	leroux	NOUN
ajlm-283	122	14	-	-	PUNCT
ajlm-283	122	15	roels	roel	NOUN
ajlm-283	122	16	g	g	NOUN
ajlm-283	122	17	,	,	PUNCT
ajlm-283	122	18	meheus	meheus	PROPN
ajlm-283	122	19	a	a	PROPN
ajlm-283	122	20	,	,	PUNCT
ajlm-283	122	21	hoosen	hoosen	NOUN
ajlm-283	122	22	aa	aa	NOUN
ajlm-283	122	23	,	,	PUNCT
ajlm-283	122	24	et	et	PROPN
ajlm-283	122	25	al	al	PROPN
ajlm-283	122	26	.	.	PUNCT
ajlm-283	123	1	hepatitis	hepatitis	PROPN
ajlm-283	123	2	b	b	PROPN
ajlm-283	123	3	virus	virus	NOUN
ajlm-283	123	4	and	and	CCONJ
ajlm-283	123	5	human	human	ADJ
ajlm-283	123	6	immunodeficiency	immunodeficiency	NOUN
ajlm-283	123	7	virus	virus	NOUN
ajlm-283	123	8	co	co	NOUN
ajlm-283	123	9	-	-	NOUN
ajlm-283	123	10	infection	infection	NOUN
ajlm-283	123	11	in	in	ADP
ajlm-283	123	12	sub	sub	ADJ
ajlm-283	123	13	-	-	ADJ
ajlm-283	123	14	saharan	saharan	ADJ
ajlm-283	123	15	africa	africa	PROPN
ajlm-283	123	16	:	:	PUNCT
ajlm-283	123	17	a	a	DET
ajlm-283	123	18	call	call	NOUN
ajlm-283	123	19	for	for	ADP
ajlm-283	123	20	further	further	ADJ
ajlm-283	123	21	investigation	investigation	NOUN
ajlm-283	123	22	.	.	PUNCT
ajlm-283	124	1	liver	liver	NOUN
ajlm-283	124	2	int	int	NOUN
ajlm-283	124	3	.	.	PUNCT
ajlm-283	125	1	2005;25(2):201–213	2005;25(2):201–213	X
ajlm-283	125	2	.	.	PUNCT
ajlm-283	126	1	http://dx.doi.org/10.1111/j.1478-3231.2005.01054.x	http://dx.doi.org/10.1111/j.1478-3231.2005.01054.x	PROPN
ajlm-283	126	2	andersson	andersson	PROPN
ajlm-283	126	3	mi	mi	PROPN
ajlm-283	126	4	,	,	PUNCT
ajlm-283	126	5	maponga	maponga	PROPN
ajlm-283	126	6	tg	tg	PROPN
ajlm-283	126	7	,	,	PUNCT
ajlm-283	126	8	ijaz	ijaz	PROPN
ajlm-283	126	9	s	s	PROPN
ajlm-283	126	10	,	,	PUNCT
ajlm-283	126	11	barnes	barnes	PROPN
ajlm-283	126	12	j	j	PROPN
ajlm-283	126	13	,	,	PUNCT
ajlm-283	126	14	theron	theron	PROPN
ajlm-283	126	15	gb	gb	PROPN
ajlm-283	126	16	,	,	PUNCT
ajlm-283	126	17	meredith	meredith	PROPN
ajlm-283	126	18	sa	sa	PROPN
ajlm-283	126	19	,	,	PUNCT
ajlm-283	126	20	et	et	PROPN
ajlm-283	126	21	al	al	PROPN
ajlm-283	126	22	.	.	PUNCT
ajlm-283	127	1	the	the	DET
ajlm-283	127	2	epidemiology	epidemiology	NOUN
ajlm-283	127	3	of	of	ADP
ajlm-283	127	4	hepatitis	hepatitis	PROPN
ajlm-283	127	5	b	b	PROPN
ajlm-283	127	6	virus	virus	NOUN
ajlm-283	127	7	infection	infection	NOUN
ajlm-283	127	8	in	in	ADP
ajlm-283	127	9	hiv	hiv	PROPN
ajlm-283	127	10	-	-	PUNCT
ajlm-283	127	11	infected	infect	VERB
ajlm-283	127	12	and	and	CCONJ
ajlm-283	127	13	hiv	hiv	PROPN
ajlm-283	127	14	-	-	PUNCT
ajlm-283	127	15	uninfected	uninfected	ADJ
ajlm-283	127	16	pregnant	pregnant	ADJ
ajlm-283	127	17	women	woman	NOUN
ajlm-283	127	18	in	in	ADP
ajlm-283	127	19	the	the	DET
ajlm-283	127	20	western	western	ADJ
ajlm-283	127	21	cape	cape	NOUN
ajlm-283	127	22	,	,	PUNCT
ajlm-283	127	23	south	south	PROPN
ajlm-283	127	24	africa	africa	PROPN
ajlm-283	127	25	.	.	PUNCT
ajlm-283	128	1	vaccine	vaccine	NOUN
ajlm-283	128	2	.	.	PUNCT
ajlm-283	129	1	2013;31(47):5579–5584	2013;31(47):5579–5584	X
ajlm-283	129	2	.	.	PUNCT
ajlm-283	129	3	http://dx.doi.org/10.1016/j.vaccine.2013.08.028	http://dx.doi.org/10.1016/j.vaccine.2013.08.028	PROPN
ajlm-283	129	4	department	department	PROPN
ajlm-283	129	5	of	of	ADP
ajlm-283	129	6	health	health	NOUN
ajlm-283	129	7	.	.	PUNCT
ajlm-283	130	1	the	the	DET
ajlm-283	130	2	2008	2008	NUM
ajlm-283	130	3	national	national	ADJ
ajlm-283	130	4	antenatal	antenatal	ADJ
ajlm-283	130	5	sentinel	sentinel	PROPN
ajlm-283	130	6	hiv	hiv	PROPN
ajlm-283	130	7	&	&	CCONJ
ajlm-283	130	8	syphilis	syphilis	PROPN
ajlm-283	130	9	prevalence	prevalence	NOUN
ajlm-283	130	10	survey	survey	NOUN
ajlm-283	130	11	in	in	ADP
ajlm-283	130	12	south	south	PROPN
ajlm-283	130	13	africa	africa	PROPN
ajlm-283	130	14	.	.	PUNCT
ajlm-283	131	1	pretoria	pretoria	PROPN
ajlm-283	131	2	:	:	PUNCT
ajlm-283	131	3	national	national	PROPN
ajlm-283	131	4	department	department	PROPN
ajlm-283	131	5	of	of	ADP
ajlm-283	131	6	health	health	NOUN
ajlm-283	131	7	;	;	PUNCT
ajlm-283	131	8	2009	2009	NUM
ajlm-283	131	9	.	.	PUNCT
ajlm-283	132	1	abdool	abdool	NOUN
ajlm-283	132	2	karim	karim	PROPN
ajlm-283	132	3	ss	ss	PROPN
ajlm-283	132	4	,	,	PUNCT
ajlm-283	132	5	coovadia	coovadia	PROPN
ajlm-283	132	6	hm	hm	PROPN
ajlm-283	132	7	,	,	PUNCT
ajlm-283	132	8	windsor	windsor	PROPN
ajlm-283	132	9	i	i	PROPN
ajlm-283	132	10	m	m	PROPN
ajlm-283	132	11	,	,	PUNCT
ajlm-283	132	12	thejpal	thejpal	ADJ
ajlm-283	132	13	r	r	NOUN
ajlm-283	132	14	,	,	PUNCT
ajlm-283	132	15	van	van	PROPN
ajlm-283	132	16	den	den	PROPN
ajlm-283	132	17	ende	ende	PROPN
ajlm-283	132	18	j	j	PROPN
ajlm-283	132	19	,	,	PUNCT
ajlm-283	132	20	fouche	fouche	PROPN
ajlm-283	132	21	a.	a.	NOUN
ajlm-283	132	22	the	the	DET
ajlm-283	132	23	prevalence	prevalence	NOUN
ajlm-283	132	24	and	and	CCONJ
ajlm-283	132	25	transmission	transmission	NOUN
ajlm-283	132	26	of	of	ADP
ajlm-283	132	27	hepatitis	hepatitis	PROPN
ajlm-283	132	28	b	b	PROPN
ajlm-283	132	29	virus	virus	NOUN
ajlm-283	132	30	infection	infection	NOUN
ajlm-283	132	31	in	in	ADP
ajlm-283	132	32	urban	urban	ADJ
ajlm-283	132	33	,	,	PUNCT
ajlm-283	132	34	rural	rural	ADJ
ajlm-283	132	35	and	and	CCONJ
ajlm-283	132	36	institutionalized	institutionalize	VERB
ajlm-283	132	37	black	black	ADJ
ajlm-283	132	38	children	child	NOUN
ajlm-283	132	39	of	of	ADP
ajlm-283	132	40	natal	natal	NOUN
ajlm-283	132	41	/	/	SYM
ajlm-283	132	42	kwazulu	kwazulu	PROPN
ajlm-283	132	43	,	,	PUNCT
ajlm-283	132	44	south	south	PROPN
ajlm-283	132	45	africa	africa	PROPN
ajlm-283	132	46	.	.	PUNCT
ajlm-283	133	1	int	int	PROPN
ajlm-283	133	2	j	j	PROPN
ajlm-283	133	3	epidemiol	epidemiol	PROPN
ajlm-283	133	4	.	.	PUNCT
ajlm-283	134	1	1988;17(1):168–173	1988;17(1):168–173	X
ajlm-283	134	2	.	.	PUNCT
ajlm-283	135	1	http://dx.doi.org/10.1093/ije/17.1.168	http://dx.doi.org/10.1093/ije/17.1.168	PROPN
ajlm-283	135	2	chotun	chotun	PROPN
ajlm-283	135	3	n	n	PROPN
ajlm-283	135	4	,	,	PUNCT
ajlm-283	135	5	nel	nel	PROPN
ajlm-283	135	6	e	e	NOUN
ajlm-283	135	7	,	,	PUNCT
ajlm-283	135	8	cotton	cotton	NOUN
ajlm-283	135	9	mf	mf	NOUN
ajlm-283	135	10	,	,	PUNCT
ajlm-283	135	11	preiser	preiser	PROPN
ajlm-283	135	12	w	w	PROPN
ajlm-283	135	13	,	,	PUNCT
ajlm-283	135	14	andersson	andersson	PROPN
ajlm-283	135	15	mi	mi	PROPN
ajlm-283	135	16	.	.	PROPN
ajlm-283	135	17	hepatitis	hepatitis	PROPN
ajlm-283	135	18	b	b	PROPN
ajlm-283	135	19	virus	virus	NOUN
ajlm-283	135	20	infection	infection	NOUN
ajlm-283	135	21	in	in	ADP
ajlm-283	135	22	hiv	hiv	PROPN
ajlm-283	135	23	-	-	PUNCT
ajlm-283	135	24	exposed	expose	VERB
ajlm-283	135	25	infants	infant	NOUN
ajlm-283	135	26	in	in	ADP
ajlm-283	135	27	the	the	DET
ajlm-283	135	28	western	western	ADJ
ajlm-283	135	29	cape	cape	NOUN
ajlm-283	135	30	,	,	PUNCT
ajlm-283	135	31	south	south	PROPN
ajlm-283	135	32	africa	africa	PROPN
ajlm-283	135	33	.	.	PUNCT
ajlm-283	136	1	vaccine	vaccine	NOUN
ajlm-283	136	2	.	.	PUNCT
ajlm-283	137	1	2015;33(36	2015;33(36	NUM
ajlm-283	137	2	):	):	PUNCT
ajlm-283	137	3	4618–4622	4618–4622	NUM
ajlm-283	137	4	.	.	PUNCT
ajlm-283	138	1	http://dx.doi.org/10.1016/j.vaccine.2015.06.076	http://dx.doi.org/10.1016/j.vaccine.2015.06.076	NOUN
ajlm-283	138	2	guthrie	guthrie	NOUN
ajlm-283	138	3	r	r	NOUN
ajlm-283	138	4	,	,	PUNCT
ajlm-283	138	5	susi	susi	PROPN
ajlm-283	138	6	a.	a.	PROPN
ajlm-283	138	7	a	a	DET
ajlm-283	138	8	simple	simple	ADJ
ajlm-283	138	9	phenylalanine	phenylalanine	NOUN
ajlm-283	138	10	method	method	NOUN
ajlm-283	138	11	for	for	ADP
ajlm-283	138	12	detecting	detect	VERB
ajlm-283	138	13	phenylketonuria	phenylketonuria	NOUN
ajlm-283	138	14	in	in	ADP
ajlm-283	138	15	large	large	ADJ
ajlm-283	138	16	populations	population	NOUN
ajlm-283	138	17	of	of	ADP
ajlm-283	138	18	newborn	newborn	ADJ
ajlm-283	138	19	infants	infant	NOUN
ajlm-283	138	20	.	.	PUNCT
ajlm-283	139	1	pediatrics	pediatric	NOUN
ajlm-283	139	2	.	.	PUNCT
ajlm-283	140	1	1963;32:338–343	1963;32:338–343	NOUN
ajlm-283	140	2	.	.	PUNCT
ajlm-283	141	1	cassol	cassol	PROPN
ajlm-283	141	2	s	s	PROPN
ajlm-283	141	3	,	,	PUNCT
ajlm-283	141	4	salas	salas	PROPN
ajlm-283	141	5	t	t	PROPN
ajlm-283	141	6	,	,	PUNCT
ajlm-283	141	7	arella	arella	NOUN
ajlm-283	141	8	m	m	PROPN
ajlm-283	141	9	,	,	PUNCT
ajlm-283	141	10	neumann	neumann	PROPN
ajlm-283	141	11	p	p	PROPN
ajlm-283	141	12	,	,	PUNCT
ajlm-283	141	13	schechter	schechter	PROPN
ajlm-283	141	14	mt	mt	PROPN
ajlm-283	141	15	,	,	PUNCT
ajlm-283	141	16	o’shaughnessy	o’shaughnessy	ADJ
ajlm-283	141	17	m.	m.	NOUN
ajlm-283	141	18	use	use	NOUN
ajlm-283	141	19	of	of	ADP
ajlm-283	141	20	dried	dry	VERB
ajlm-283	141	21	blood	blood	NOUN
ajlm-283	141	22	spot	spot	NOUN
ajlm-283	141	23	specimens	specimen	NOUN
ajlm-283	141	24	in	in	ADP
ajlm-283	141	25	the	the	DET
ajlm-283	141	26	detection	detection	NOUN
ajlm-283	141	27	of	of	ADP
ajlm-283	141	28	human	human	ADJ
ajlm-283	141	29	immunodeficiency	immunodeficiency	NOUN
ajlm-283	141	30	virus	virus	NOUN
ajlm-283	141	31	type	type	NOUN
ajlm-283	141	32	1	1	NUM
ajlm-283	141	33	by	by	ADP
ajlm-283	141	34	the	the	DET
ajlm-283	141	35	polymerase	polymerase	NOUN
ajlm-283	141	36	chain	chain	NOUN
ajlm-283	141	37	reaction	reaction	NOUN
ajlm-283	141	38	.	.	PUNCT
ajlm-283	142	1	j	j	PROPN
ajlm-283	142	2	clin	clin	PROPN
ajlm-283	142	3	microbiol	microbiol	PROPN
ajlm-283	142	4	.	.	PUNCT
ajlm-283	143	1	1991;29(4):667–671	1991;29(4):667–671	PROPN
ajlm-283	143	2	.	.	PUNCT
ajlm-283	144	1	cassol	cassol	PROPN
ajlm-283	144	2	s	s	PROPN
ajlm-283	144	3	,	,	PUNCT
ajlm-283	144	4	salas	salas	PROPN
ajlm-283	144	5	t	t	PROPN
ajlm-283	144	6	,	,	PUNCT
ajlm-283	144	7	gill	gill	PROPN
ajlm-283	144	8	mj	mj	PROPN
ajlm-283	144	9	,	,	PUNCT
ajlm-283	144	10	montpetit	montpetit	PROPN
ajlm-283	144	11	m	m	PROPN
ajlm-283	144	12	,	,	PUNCT
ajlm-283	144	13	rudnik	rudnik	PROPN
ajlm-283	144	14	j	j	PROPN
ajlm-283	144	15	,	,	PUNCT
ajlm-283	144	16	sy	sy	PROPN
ajlm-283	144	17	ct	ct	PROPN
ajlm-283	144	18	,	,	PUNCT
ajlm-283	144	19	et	et	PROPN
ajlm-283	144	20	al	al	PROPN
ajlm-283	144	21	.	.	PROPN
ajlm-283	144	22	stability	stability	NOUN
ajlm-283	144	23	of	of	ADP
ajlm-283	144	24	dried	dry	VERB
ajlm-283	144	25	blood	blood	NOUN
ajlm-283	144	26	spot	spot	NOUN
ajlm-283	144	27	specimens	specimen	NOUN
ajlm-283	144	28	for	for	ADP
ajlm-283	144	29	detection	detection	NOUN
ajlm-283	144	30	of	of	ADP
ajlm-283	144	31	human	human	ADJ
ajlm-283	144	32	immunodeficiency	immunodeficiency	NOUN
ajlm-283	144	33	virus	virus	NOUN
ajlm-283	144	34	dna	dna	NOUN
ajlm-283	144	35	by	by	ADP
ajlm-283	144	36	polymerase	polymerase	NOUN
ajlm-283	144	37	chain	chain	NOUN
ajlm-283	144	38	reaction	reaction	NOUN
ajlm-283	144	39	.	.	PUNCT
ajlm-283	145	1	j	j	PROPN
ajlm-283	145	2	clin	clin	PROPN
ajlm-283	145	3	microbiol	microbiol	PROPN
ajlm-283	145	4	.	.	PUNCT
ajlm-283	146	1	1992;30(12):3039–3042	1992;30(12):3039–3042	NUM
ajlm-283	146	2	.	.	PUNCT
ajlm-283	147	1	sherman	sherman	PROPN
ajlm-283	147	2	gg	gg	PROPN
ajlm-283	147	3	,	,	PUNCT
ajlm-283	147	4	stevens	stevens	PROPN
ajlm-283	147	5	g	g	PROPN
ajlm-283	147	6	,	,	PUNCT
ajlm-283	147	7	jones	jones	PROPN
ajlm-283	147	8	sa	sa	PROPN
ajlm-283	147	9	,	,	PUNCT
ajlm-283	147	10	horsfield	horsfield	VERB
ajlm-283	147	11	p	p	PROPN
ajlm-283	147	12	,	,	PUNCT
ajlm-283	147	13	stevens	stevens	PROPN
ajlm-283	147	14	ws	ws	PROPN
ajlm-283	147	15	.	.	PUNCT
ajlm-283	148	1	dried	dry	VERB
ajlm-283	148	2	blood	blood	NOUN
ajlm-283	148	3	spots	spot	NOUN
ajlm-283	148	4	improve	improve	VERB
ajlm-283	148	5	access	access	NOUN
ajlm-283	148	6	to	to	ADP
ajlm-283	148	7	hiv	hiv	PROPN
ajlm-283	148	8	diagnosis	diagnosis	NOUN
ajlm-283	148	9	and	and	CCONJ
ajlm-283	148	10	care	care	VERB
ajlm-283	148	11	for	for	ADP
ajlm-283	148	12	infants	infant	NOUN
ajlm-283	148	13	in	in	ADP
ajlm-283	148	14	low	low	ADJ
ajlm-283	148	15	-	-	PUNCT
ajlm-283	148	16	resource	resource	NOUN
ajlm-283	148	17	settings	setting	NOUN
ajlm-283	148	18	.	.	PUNCT
ajlm-283	149	1	j	j	PROPN
ajlm-283	149	2	acquir	acquir	PROPN
ajlm-283	149	3	immune	immune	VERB
ajlm-283	149	4	defic	defic	ADJ
ajlm-283	149	5	syndr	syndr	NOUN
ajlm-283	149	6	.	.	PUNCT
ajlm-283	150	1	2005;38(5):615–617	2005;38(5):615–617	NUM
ajlm-283	150	2	.	.	PUNCT
ajlm-283	150	3	http://dx.doi.org/10.1097/01.qai.0000143604.71857.5d	http://dx.doi.org/10.1097/01.qai.0000143604.71857.5d	PROPN
ajlm-283	151	1	lira	lira	PROPN
ajlm-283	151	2	r	r	PROPN
ajlm-283	151	3	,	,	PUNCT
ajlm-283	151	4	maldonado	maldonado	PROPN
ajlm-283	151	5	-	-	PUNCT
ajlm-283	151	6	rodriguez	rodriguez	PROPN
ajlm-283	151	7	a	a	X
ajlm-283	151	8	,	,	PUNCT
ajlm-283	151	9	rojas	rojas	PROPN
ajlm-283	151	10	-	-	PUNCT
ajlm-283	151	11	montes	montes	PROPN
ajlm-283	151	12	o	o	NOUN
ajlm-283	151	13	,	,	PUNCT
ajlm-283	151	14	ruiz	ruiz	NOUN
ajlm-283	151	15	-	-	PUNCT
ajlm-283	151	16	tachiquin	tachiquin	NOUN
ajlm-283	151	17	m	m	PROPN
ajlm-283	151	18	,	,	PUNCT
ajlm-283	151	19	torres	torre	NOUN
ajlm-283	151	20	-	-	PUNCT
ajlm-283	151	21	ibarra	ibarra	NOUN
ajlm-283	151	22	r	r	NOUN
ajlm-283	151	23	,	,	PUNCT
ajlm-283	151	24	cano	cano	PROPN
ajlm-283	151	25	-	-	PUNCT
ajlm-283	151	26	dominguez	dominguez	PROPN
ajlm-283	151	27	c	c	PROPN
ajlm-283	151	28	,	,	PUNCT
ajlm-283	151	29	et	et	PROPN
ajlm-283	151	30	al	al	PROPN
ajlm-283	151	31	.	.	PUNCT
ajlm-283	151	32	use	use	NOUN
ajlm-283	151	33	of	of	ADP
ajlm-283	151	34	dried	dry	VERB
ajlm-283	151	35	blood	blood	NOUN
ajlm-283	151	36	samples	sample	NOUN
ajlm-283	151	37	for	for	ADP
ajlm-283	151	38	monitoring	monitor	VERB
ajlm-283	151	39	hepatitis	hepatitis	PROPN
ajlm-283	151	40	b	b	PROPN
ajlm-283	151	41	virus	virus	NOUN
ajlm-283	151	42	infection	infection	NOUN
ajlm-283	151	43	.	.	PUNCT
ajlm-283	152	1	virol	virol	PROPN
ajlm-283	152	2	j.	j.	PROPN
ajlm-283	152	3	2009;6(1):1	2009;6(1):1	PROPN
ajlm-283	152	4	.	.	PUNCT
ajlm-283	152	5	http://dx.doi.org/10.1186/1743-422x-6-153	http://dx.doi.org/10.1186/1743-422x-6-153	VERB
ajlm-283	152	6	villar	villar	PROPN
ajlm-283	152	7	lm	lm	PROPN
ajlm-283	152	8	,	,	PUNCT
ajlm-283	152	9	de	de	PROPN
ajlm-283	152	10	oliveira	oliveira	PROPN
ajlm-283	152	11	jc	jc	PROPN
ajlm-283	152	12	,	,	PUNCT
ajlm-283	152	13	cruz	cruz	PROPN
ajlm-283	152	14	hm	hm	PROPN
ajlm-283	152	15	,	,	PUNCT
ajlm-283	152	16	yoshida	yoshida	PROPN
ajlm-283	152	17	cf	cf	PROPN
ajlm-283	152	18	,	,	PUNCT
ajlm-283	152	19	lampe	lampe	X
ajlm-283	152	20	e	e	NOUN
ajlm-283	152	21	,	,	PUNCT
ajlm-283	152	22	lewis	lewis	PROPN
ajlm-283	152	23	-	-	PUNCT
ajlm-283	152	24	ximenez	ximenez	PROPN
ajlm-283	152	25	ll	ll	AUX
ajlm-283	152	26	.	.	PUNCT
ajlm-283	153	1	assessment	assessment	NOUN
ajlm-283	153	2	of	of	ADP
ajlm-283	153	3	dried	dry	VERB
ajlm-283	153	4	blood	blood	NOUN
ajlm-283	153	5	spot	spot	NOUN
ajlm-283	153	6	samples	sample	NOUN
ajlm-283	153	7	as	as	ADP
ajlm-283	153	8	a	a	DET
ajlm-283	153	9	simple	simple	ADJ
ajlm-283	153	10	method	method	NOUN
ajlm-283	153	11	for	for	ADP
ajlm-283	153	12	detection	detection	NOUN
ajlm-283	153	13	of	of	ADP
ajlm-283	153	14	hepatitis	hepatitis	PROPN
ajlm-283	153	15	b	b	PROPN
ajlm-283	153	16	virus	virus	NOUN
ajlm-283	153	17	markers	marker	NOUN
ajlm-283	153	18	.	.	PUNCT
ajlm-283	154	1	j	j	PROPN
ajlm-283	154	2	med	med	PROPN
ajlm-283	154	3	virol	virol	NOUN
ajlm-283	154	4	.	.	PUNCT
ajlm-283	155	1	2011;83(9):1522–1529	2011;83(9):1522–1529	NUM
ajlm-283	155	2	.	.	PUNCT
ajlm-283	156	1	http://dx.doi.org/10.1002/jmv.22138	http://dx.doi.org/10.1002/jmv.22138	PROPN
ajlm-283	156	2	statistics	statistics	PROPN
ajlm-283	156	3	south	south	PROPN
ajlm-283	156	4	africa	africa	PROPN
ajlm-283	156	5	.	.	PUNCT
ajlm-283	157	1	mid	mid	ADJ
ajlm-283	157	2	-	-	ADJ
ajlm-283	157	3	year	year	NOUN
ajlm-283	157	4	population	population	NOUN
ajlm-283	157	5	estimates	estimate	NOUN
ajlm-283	157	6	,	,	PUNCT
ajlm-283	157	7	2010	2010	NUM
ajlm-283	157	8	,	,	PUNCT
ajlm-283	157	9	pretoria	pretoria	PROPN
ajlm-283	157	10	:	:	PUNCT
ajlm-283	157	11	statistics	statistics	PROPN
ajlm-283	157	12	south	south	PROPN
ajlm-283	157	13	africa	africa	PROPN
ajlm-283	157	14	;	;	PUNCT
ajlm-283	157	15	2010	2010	NUM
ajlm-283	157	16	.	.	PUNCT
ajlm-283	158	1	bowyer	bowyer	PROPN
ajlm-283	158	2	s.	s.	PROPN
ajlm-283	158	3	molecular	molecular	ADJ
ajlm-283	158	4	characterization	characterization	NOUN
ajlm-283	158	5	of	of	ADP
ajlm-283	158	6	the	the	DET
ajlm-283	158	7	hepatitis	hepatitis	PROPN
ajlm-283	158	8	b	b	PROPN
ajlm-283	158	9	virus	virus	NOUN
ajlm-283	158	10	in	in	ADP
ajlm-283	158	11	south	south	PROPN
ajlm-283	158	12	africa	africa	PROPN
ajlm-283	159	1	[	[	X
ajlm-283	159	2	unpublished	unpublished	ADJ
ajlm-283	159	3	thesis	thesis	NOUN
ajlm-283	159	4	]	]	X
ajlm-283	159	5	.	.	PUNCT
ajlm-283	160	1	johannesburg	johannesburg	PROPN
ajlm-283	160	2	:	:	PUNCT
ajlm-283	160	3	university	university	NOUN
ajlm-283	160	4	of	of	ADP
ajlm-283	160	5	the	the	DET
ajlm-283	160	6	witwatersrand	witwatersrand	NOUN
ajlm-283	160	7	;	;	PUNCT
ajlm-283	160	8	2001	2001	NUM
ajlm-283	160	9	.	.	PUNCT
ajlm-283	161	1	bowyer	bowyer	PROPN
ajlm-283	161	2	sm	sm	PROPN
ajlm-283	161	3	,	,	PUNCT
ajlm-283	161	4	van	van	PROPN
ajlm-283	161	5	staden	staden	PROPN
ajlm-283	161	6	l	l	PROPN
ajlm-283	161	7	,	,	PUNCT
ajlm-283	161	8	kew	kew	PROPN
ajlm-283	161	9	mc	mc	PROPN
ajlm-283	161	10	,	,	PUNCT
ajlm-283	161	11	sim	sim	ADJ
ajlm-283	161	12	jg	jg	PROPN
ajlm-283	161	13	.	.	PUNCT
ajlm-283	162	1	a	a	DET
ajlm-283	162	2	unique	unique	ADJ
ajlm-283	162	3	segment	segment	NOUN
ajlm-283	162	4	of	of	ADP
ajlm-283	162	5	the	the	DET
ajlm-283	162	6	hepatitis	hepatitis	PROPN
ajlm-283	162	7	b	b	PROPN
ajlm-283	162	8	virus	virus	NOUN
ajlm-283	162	9	group	group	NOUN
ajlm-283	162	10	a	a	DET
ajlm-283	162	11	genotype	genotype	NOUN
ajlm-283	162	12	identified	identify	VERB
ajlm-283	162	13	in	in	ADP
ajlm-283	162	14	isolates	isolate	NOUN
ajlm-283	162	15	from	from	ADP
ajlm-283	162	16	south	south	PROPN
ajlm-283	162	17	africa	africa	PROPN
ajlm-283	162	18	.	.	PUNCT
ajlm-283	163	1	j	j	PROPN
ajlm-283	163	2	gen	gen	PROPN
ajlm-283	163	3	virol	virol	NOUN
ajlm-283	163	4	.	.	PUNCT
ajlm-283	164	1	1997;78(pt	1997;78(pt	NUM
ajlm-283	164	2	7):1719–1729	7):1719–1729	NUM
ajlm-283	164	3	.	.	PUNCT
ajlm-283	165	1	epub	epub	PROPN
ajlm-283	165	2	1997/07/01	1997/07/01	NOUN
ajlm-283	165	3	.	.	PUNCT
ajlm-283	166	1	http://dx.doi.org/10.1099/0022-1317-78-7-1719	http://dx.doi.org/10.1099/0022-1317-78-7-1719	PROPN
ajlm-283	166	2	patton	patton	PROPN
ajlm-283	166	3	jc	jc	PROPN
ajlm-283	166	4	,	,	PUNCT
ajlm-283	166	5	akkers	akker	NOUN
ajlm-283	166	6	e	e	PROPN
ajlm-283	166	7	,	,	PUNCT
ajlm-283	166	8	coovadia	coovadia	PROPN
ajlm-283	166	9	ah	ah	INTJ
ajlm-283	166	10	,	,	PUNCT
ajlm-283	166	11	meyers	meyers	PROPN
ajlm-283	166	12	tm	tm	PROPN
ajlm-283	166	13	,	,	PUNCT
ajlm-283	166	14	stevens	stevens	PROPN
ajlm-283	166	15	ws	ws	PROPN
ajlm-283	166	16	,	,	PUNCT
ajlm-283	166	17	sherman	sherman	PROPN
ajlm-283	166	18	gg	gg	PROPN
ajlm-283	166	19	.	.	PUNCT
ajlm-283	167	1	evaluation	evaluation	NOUN
ajlm-283	167	2	of	of	ADP
ajlm-283	167	3	dried	dry	VERB
ajlm-283	167	4	whole	whole	ADJ
ajlm-283	167	5	blood	blood	NOUN
ajlm-283	167	6	spots	spot	NOUN
ajlm-283	167	7	obtained	obtain	VERB
ajlm-283	167	8	by	by	ADP
ajlm-283	167	9	heel	heel	NOUN
ajlm-283	167	10	or	or	CCONJ
ajlm-283	167	11	finger	finger	NOUN
ajlm-283	167	12	stick	stick	NOUN
ajlm-283	167	13	as	as	ADP
ajlm-283	167	14	an	an	DET
ajlm-283	167	15	alternative	alternative	NOUN
ajlm-283	167	16	to	to	ADP
ajlm-283	167	17	venous	venous	ADJ
ajlm-283	167	18	blood	blood	NOUN
ajlm-283	167	19	for	for	ADP
ajlm-283	167	20	diagnosis	diagnosis	NOUN
ajlm-283	167	21	of	of	ADP
ajlm-283	167	22	human	human	ADJ
ajlm-283	167	23	immunodeficiency	immunodeficiency	NOUN
ajlm-283	167	24	virus	virus	NOUN
ajlm-283	167	25	type	type	NOUN
ajlm-283	167	26	1	1	NUM
ajlm-283	167	27	infection	infection	NOUN
ajlm-283	167	28	in	in	ADP
ajlm-283	167	29	vertically	vertically	ADV
ajlm-283	167	30	exposed	expose	VERB
ajlm-283	167	31	infants	infant	NOUN
ajlm-283	167	32	in	in	ADP
ajlm-283	167	33	the	the	DET
ajlm-283	167	34	routine	routine	ADJ
ajlm-283	167	35	diagnostic	diagnostic	ADJ
ajlm-283	167	36	laboratory	laboratory	NOUN
ajlm-283	167	37	.	.	PUNCT
ajlm-283	168	1	clin	clin	PROPN
ajlm-283	168	2	vaccine	vaccine	NOUN
ajlm-283	168	3	immunol	immunol	NOUN
ajlm-283	168	4	.	.	PUNCT
ajlm-283	169	1	2007;14(2):201–203	2007;14(2):201–203	X
ajlm-283	169	2	.	.	X
ajlm-283	169	3	http://dx.doi.org/10.1128/cvi.00223-06	http://dx.doi.org/10.1128/cvi.00223-06	PROPN
ajlm-283	169	4	lavanchy	lavanchy	PROPN
ajlm-283	169	5	d.	d.	PROPN
ajlm-283	169	6	worldwide	worldwide	ADV
ajlm-283	169	7	epidemiology	epidemiology	NOUN
ajlm-283	169	8	of	of	ADP
ajlm-283	169	9	hbv	hbv	NOUN
ajlm-283	169	10	infection	infection	NOUN
ajlm-283	169	11	,	,	PUNCT
ajlm-283	169	12	disease	disease	NOUN
ajlm-283	169	13	burden	burden	NOUN
ajlm-283	169	14	,	,	PUNCT
ajlm-283	169	15	and	and	CCONJ
ajlm-283	169	16	vaccine	vaccine	NOUN
ajlm-283	169	17	prevention	prevention	NOUN
ajlm-283	169	18	.	.	PUNCT
ajlm-283	170	1	j	j	PROPN
ajlm-283	170	2	clin	clin	PROPN
ajlm-283	170	3	virol	virol	PROPN
ajlm-283	170	4	.	.	PUNCT
ajlm-283	171	1	2005;34	2005;34	NUM
ajlm-283	171	2	:	:	PUNCT
ajlm-283	171	3	s1	s1	PROPN
ajlm-283	171	4	–	–	PUNCT
ajlm-283	171	5	s3	s3	PROPN
ajlm-283	171	6	.	.	PUNCT
ajlm-283	172	1	http://dx.doi.org/10.1016/s1386-6532(05)00384-7	http://dx.doi.org/10.1016/s1386-6532(05)00384-7	NOUN
ajlm-283	172	2	kramvis	kramvis	NOUN
ajlm-283	172	3	a	a	X
ajlm-283	172	4	,	,	PUNCT
ajlm-283	172	5	kew	kew	PROPN
ajlm-283	172	6	mc	mc	PROPN
ajlm-283	172	7	.	.	PROPN
ajlm-283	172	8	epidemiology	epidemiology	NOUN
ajlm-283	172	9	of	of	ADP
ajlm-283	172	10	hepatitis	hepatitis	PROPN
ajlm-283	172	11	b	b	PROPN
ajlm-283	172	12	virus	virus	NOUN
ajlm-283	172	13	in	in	ADP
ajlm-283	172	14	africa	africa	PROPN
ajlm-283	172	15	,	,	PUNCT
ajlm-283	172	16	its	its	PRON
ajlm-283	172	17	genotypes	genotype	NOUN
ajlm-283	172	18	and	and	CCONJ
ajlm-283	172	19	clinical	clinical	ADJ
ajlm-283	172	20	associations	association	NOUN
ajlm-283	172	21	of	of	ADP
ajlm-283	172	22	genotypes	genotype	NOUN
ajlm-283	172	23	.	.	PUNCT
ajlm-283	173	1	hepatol	hepatol	ADJ
ajlm-283	173	2	res	re	NOUN
ajlm-283	173	3	.	.	PUNCT
ajlm-283	174	1	2007;37(s1):s9	2007;37(s1):s9	NUM
ajlm-283	174	2	–	–	PUNCT
ajlm-283	174	3	s19	s19	NOUN
ajlm-283	174	4	.	.	PUNCT
ajlm-283	175	1	http://dx.doi.org/10.1111/j.1872-034x.2007.00098.x	http://dx.doi.org/10.1111/j.1872-034x.2007.00098.x	PROPN
ajlm-283	175	2	firnhaber	firnhaber	PROPN
ajlm-283	175	3	c	c	NOUN
ajlm-283	175	4	,	,	PUNCT
ajlm-283	175	5	reyneke	reyneke	ADJ
ajlm-283	175	6	a	a	DET
ajlm-283	175	7	,	,	PUNCT
ajlm-283	175	8	schulze	schulze	NOUN
ajlm-283	175	9	d	d	NOUN
ajlm-283	175	10	,	,	PUNCT
ajlm-283	175	11	malope	malope	NOUN
ajlm-283	175	12	b	b	NOUN
ajlm-283	175	13	,	,	PUNCT
ajlm-283	175	14	maskew	maskew	NOUN
ajlm-283	175	15	m	m	PROPN
ajlm-283	175	16	,	,	PUNCT
ajlm-283	175	17	macphail	macphail	PROPN
ajlm-283	175	18	p	p	PROPN
ajlm-283	175	19	,	,	PUNCT
ajlm-283	175	20	et	et	PROPN
ajlm-283	175	21	al	al	PROPN
ajlm-283	175	22	.	.	PUNCT
ajlm-283	176	1	the	the	DET
ajlm-283	176	2	prevalence	prevalence	NOUN
ajlm-283	176	3	of	of	ADP
ajlm-283	176	4	hepatitis	hepatitis	PROPN
ajlm-283	176	5	b	b	PROPN
ajlm-283	176	6	co	co	NOUN
ajlm-283	176	7	-	-	NOUN
ajlm-283	176	8	infection	infection	NOUN
ajlm-283	176	9	in	in	ADP
ajlm-283	176	10	a	a	DET
ajlm-283	176	11	south	south	ADJ
ajlm-283	176	12	african	african	ADJ
ajlm-283	176	13	urban	urban	ADJ
ajlm-283	176	14	government	government	NOUN
ajlm-283	176	15	hiv	hiv	PROPN
ajlm-283	176	16	clinic	clinic	PROPN
ajlm-283	176	17	.	.	PUNCT
ajlm-283	177	1	s	s	PROPN
ajlm-283	177	2	afr	afr	PROPN
ajlm-283	177	3	med	med	PROPN
ajlm-283	177	4	j.	j.	PROPN
ajlm-283	177	5	2008;98(7):541–544	2008;98(7):541–544	PROPN
ajlm-283	177	6	.	.	PUNCT
ajlm-283	178	1	shepard	shepard	PROPN
ajlm-283	178	2	cw	cw	PROPN
ajlm-283	178	3	,	,	PUNCT
ajlm-283	178	4	simard	simard	PROPN
ajlm-283	178	5	ep	ep	PROPN
ajlm-283	178	6	,	,	PUNCT
ajlm-283	178	7	finelli	finelli	PROPN
ajlm-283	178	8	l	l	PROPN
ajlm-283	178	9	,	,	PUNCT
ajlm-283	178	10	fiore	fiore	PROPN
ajlm-283	178	11	ae	ae	PROPN
ajlm-283	178	12	,	,	PUNCT
ajlm-283	178	13	bell	bell	PROPN
ajlm-283	178	14	bp	bp	PROPN
ajlm-283	178	15	.	.	PUNCT
ajlm-283	179	1	hepatitis	hepatitis	PROPN
ajlm-283	179	2	b	b	PROPN
ajlm-283	179	3	virus	virus	NOUN
ajlm-283	179	4	infection	infection	NOUN
ajlm-283	179	5	:	:	PUNCT
ajlm-283	179	6	epidemiology	epidemiology	NOUN
ajlm-283	179	7	and	and	CCONJ
ajlm-283	179	8	vaccination	vaccination	NOUN
ajlm-283	179	9	.	.	PUNCT
ajlm-283	180	1	epidemiol	epidemiol	PROPN
ajlm-283	180	2	rev	rev	PROPN
ajlm-283	180	3	.	.	PUNCT
ajlm-283	180	4	2006;28:112–125	2006;28:112–125	NOUN
ajlm-283	180	5	.	.	PUNCT
ajlm-283	181	1	http://dx.doi.org/10.1093/epirev/mxj009	http://dx.doi.org/10.1093/epirev/mxj009	PROPN
ajlm-283	182	1	shiraki	shiraki	PROPN
ajlm-283	182	2	k.	k.	PROPN
ajlm-283	183	1	perinatal	perinatal	ADJ
ajlm-283	183	2	transmission	transmission	NOUN
ajlm-283	183	3	of	of	ADP
ajlm-283	183	4	hepatitis	hepatitis	PROPN
ajlm-283	183	5	b	b	PROPN
ajlm-283	183	6	virus	virus	NOUN
ajlm-283	183	7	and	and	CCONJ
ajlm-283	183	8	its	its	PRON
ajlm-283	183	9	prevention	prevention	NOUN
ajlm-283	183	10	.	.	PUNCT
ajlm-283	184	1	j	j	PROPN
ajlm-283	184	2	gastroenterol	gastroenterol	NOUN
ajlm-283	184	3	hepatol	hepatol	ADV
ajlm-283	184	4	.	.	PUNCT
ajlm-283	185	1	2000;15(s2):e11	2000;15(s2):e11	NUM
ajlm-283	185	2	–	–	PUNCT
ajlm-283	185	3	e5	e5	NOUN
ajlm-283	185	4	.	.	PUNCT
ajlm-283	186	1	http://dx.doi.org/10.1046/j.1440-1746.2000.02098.x	http://dx.doi.org/10.1046/j.1440-1746.2000.02098.x	PROPN
ajlm-283	186	2	thumbiran	thumbiran	PROPN
ajlm-283	186	3	nv	nv	PROPN
ajlm-283	186	4	,	,	PUNCT
ajlm-283	186	5	moodley	moodley	NOUN
ajlm-283	186	6	d	d	PROPN
ajlm-283	186	7	,	,	PUNCT
ajlm-283	186	8	parboosing	parboose	VERB
ajlm-283	186	9	r	r	NOUN
ajlm-283	186	10	,	,	PUNCT
ajlm-283	186	11	moodley	moodley	NOUN
ajlm-283	186	12	p.	p.	PROPN
ajlm-283	186	13	hepatitis	hepatitis	PROPN
ajlm-283	186	14	b	b	PROPN
ajlm-283	187	1	and	and	CCONJ
ajlm-283	187	2	hiv	hiv	PROPN
ajlm-283	187	3	co	co	NOUN
ajlm-283	187	4	-	-	NOUN
ajlm-283	187	5	infection	infection	NOUN
ajlm-283	187	6	in	in	ADP
ajlm-283	187	7	pregnant	pregnant	ADJ
ajlm-283	187	8	women	woman	NOUN
ajlm-283	187	9	:	:	PUNCT
ajlm-283	188	1	indication	indication	NOUN
ajlm-283	188	2	for	for	ADP
ajlm-283	188	3	routine	routine	ADJ
ajlm-283	188	4	antenatal	antenatal	NOUN
ajlm-283	188	5	hepatitis	hepatitis	PROPN
ajlm-283	188	6	b	b	PROPN
ajlm-283	188	7	virus	virus	NOUN
ajlm-283	188	8	screening	screen	VERB
ajlm-283	188	9	in	in	ADP
ajlm-283	188	10	a	a	DET
ajlm-283	188	11	high	high	ADJ
ajlm-283	188	12	hiv	hiv	PROPN
ajlm-283	188	13	prevalence	prevalence	NOUN
ajlm-283	188	14	setting	set	VERB
ajlm-283	188	15	.	.	PUNCT
ajlm-283	189	1	s	s	PROPN
ajlm-283	189	2	afr	afr	PROPN
ajlm-283	189	3	med	med	PROPN
ajlm-283	189	4	j.	j.	PROPN
ajlm-283	189	5	2014;104(4):307–309	2014;104(4):307–309	PROPN
ajlm-283	189	6	.	.	PROPN
ajlm-283	189	7	http://dx.doi.org/10.7196/samj.7299	http://dx.doi.org/10.7196/samj.7299	PUNCT
ajlm-283	189	8	tran	tran	PROPN
ajlm-283	189	9	tt	tt	PROPN
ajlm-283	189	10	,	,	PUNCT
ajlm-283	189	11	martin	martin	PROPN
ajlm-283	189	12	p.	p.	PROPN
ajlm-283	189	13	hepatitis	hepatitis	PROPN
ajlm-283	190	1	b	b	PROPN
ajlm-283	190	2	:	:	PUNCT
ajlm-283	190	3	epidemiology	epidemiology	NOUN
ajlm-283	190	4	and	and	CCONJ
ajlm-283	190	5	natural	natural	ADJ
ajlm-283	190	6	history	history	NOUN
ajlm-283	190	7	.	.	PUNCT
ajlm-283	191	1	clin	clin	PROPN
ajlm-283	191	2	liver	liver	PROPN
ajlm-283	191	3	dis	dis	PROPN
ajlm-283	191	4	.	.	PUNCT
ajlm-283	192	1	2004;8(2):255–266	2004;8(2):255–266	X
ajlm-283	192	2	.	.	PUNCT
ajlm-283	192	3	http://dx.doi.org/10.1016/j.cld.2004.02.008	http://dx.doi.org/10.1016/j.cld.2004.02.008	PROPN
ajlm-283	192	4	beasley	beasley	PROPN
ajlm-283	192	5	rp	rp	PROPN
ajlm-283	192	6	,	,	PUNCT
ajlm-283	192	7	hwang	hwang	PROPN
ajlm-283	192	8	ly	ly	PROPN
ajlm-283	192	9	,	,	PUNCT
ajlm-283	192	10	lee	lee	PROPN
ajlm-283	192	11	gc	gc	PROPN
ajlm-283	192	12	,	,	PUNCT
ajlm-283	192	13	lan	lan	PROPN
ajlm-283	192	14	cc	cc	PROPN
ajlm-283	192	15	,	,	PUNCT
ajlm-283	192	16	roan	roan	PROPN
ajlm-283	192	17	ch	ch	PROPN
ajlm-283	192	18	,	,	PUNCT
ajlm-283	192	19	huang	huang	PROPN
ajlm-283	192	20	fy	fy	PROPN
ajlm-283	192	21	,	,	PUNCT
ajlm-283	192	22	et	et	PROPN
ajlm-283	192	23	al	al	PROPN
ajlm-283	192	24	.	.	PROPN
ajlm-283	192	25	prevention	prevention	PROPN
ajlm-283	192	26	of	of	ADP
ajlm-283	192	27	perinatally	perinatally	ADV
ajlm-283	192	28	transmitted	transmit	VERB
ajlm-283	192	29	hepatitis	hepatitis	PROPN
ajlm-283	192	30	b	b	PROPN
ajlm-283	192	31	virus	virus	NOUN
ajlm-283	192	32	infections	infection	NOUN
ajlm-283	192	33	with	with	ADP
ajlm-283	192	34	hepatitis	hepatitis	PROPN
ajlm-283	192	35	b	b	PROPN
ajlm-283	192	36	immune	immune	ADJ
ajlm-283	192	37	globulin	globulin	NOUN
ajlm-283	192	38	and	and	CCONJ
ajlm-283	192	39	hepatitis	hepatitis	PROPN
ajlm-283	192	40	b	b	PROPN
ajlm-283	192	41	vaccine	vaccine	NOUN
ajlm-283	192	42	.	.	PUNCT
ajlm-283	193	1	lancet	lancet	PROPN
ajlm-283	193	2	.	.	PUNCT
ajlm-283	194	1	1983;322(8359):1099–1102	1983;322(8359):1099–1102	NUM
ajlm-283	194	2	.	.	PUNCT
ajlm-283	195	1	http://dx.doi.org/10.1016/s0140-6736(83)90624-4	http://dx.doi.org/10.1016/s0140-6736(83)90624-4	PROPN
ajlm-283	195	2	hoffmann	hoffmann	PROPN
ajlm-283	195	3	cj	cj	PROPN
ajlm-283	195	4	,	,	PUNCT
ajlm-283	195	5	mashabela	mashabela	PROPN
ajlm-283	195	6	f	f	PROPN
ajlm-283	195	7	,	,	PUNCT
ajlm-283	195	8	cohn	cohn	PROPN
ajlm-283	195	9	s	s	PROPN
ajlm-283	195	10	,	,	PUNCT
ajlm-283	195	11	hoffmann	hoffmann	PROPN
ajlm-283	195	12	jd	jd	PROPN
ajlm-283	195	13	,	,	PUNCT
ajlm-283	195	14	lala	lala	PROPN
ajlm-283	195	15	s	s	PROPN
ajlm-283	195	16	,	,	PUNCT
ajlm-283	195	17	martinson	martinson	NOUN
ajlm-283	195	18	na	na	NOUN
ajlm-283	195	19	,	,	PUNCT
ajlm-283	195	20	et	et	PROPN
ajlm-283	195	21	al	al	PROPN
ajlm-283	195	22	.	.	PROPN
ajlm-283	196	1	maternal	maternal	ADJ
ajlm-283	196	2	hepatitis	hepatitis	PROPN
ajlm-283	196	3	b	b	PROPN
ajlm-283	196	4	and	and	CCONJ
ajlm-283	196	5	infant	infant	ADJ
ajlm-283	196	6	infection	infection	NOUN
ajlm-283	196	7	among	among	ADP
ajlm-283	196	8	pregnant	pregnant	ADJ
ajlm-283	196	9	women	woman	NOUN
ajlm-283	196	10	living	live	VERB
ajlm-283	196	11	with	with	ADP
ajlm-283	196	12	hiv	hiv	PROPN
ajlm-283	196	13	in	in	ADP
ajlm-283	196	14	south	south	PROPN
ajlm-283	196	15	africa	africa	PROPN
ajlm-283	196	16	.	.	PUNCT
ajlm-283	197	1	j	j	PROPN
ajlm-283	197	2	int	int	PROPN
ajlm-283	197	3	aids	aids	PROPN
ajlm-283	197	4	soc	soc	NOUN
ajlm-283	197	5	.	.	PUNCT
ajlm-283	198	1	2014;17:18871	2014;17:18871	NUM
ajlm-283	198	2	.	.	PUNCT
ajlm-283	199	1	http://dx.doi.org/10.7448/ias.17.1.18871	http://dx.doi.org/10.7448/ias.17.1.18871	PROPN
ajlm-283	200	1	liang	liang	PROPN
ajlm-283	200	2	x	x	PROPN
ajlm-283	200	3	,	,	PUNCT
ajlm-283	200	4	bi	bi	PROPN
ajlm-283	200	5	s	s	PROPN
ajlm-283	200	6	,	,	PUNCT
ajlm-283	200	7	yang	yang	PROPN
ajlm-283	200	8	w	w	PROPN
ajlm-283	200	9	,	,	PUNCT
ajlm-283	200	10	wang	wang	PROPN
ajlm-283	200	11	l	l	PROPN
ajlm-283	200	12	,	,	PUNCT
ajlm-283	200	13	cui	cui	VERB
ajlm-283	200	14	g	g	NOUN
ajlm-283	200	15	,	,	PUNCT
ajlm-283	200	16	cui	cui	NOUN
ajlm-283	200	17	f	f	PROPN
ajlm-283	200	18	,	,	PUNCT
ajlm-283	200	19	et	et	PROPN
ajlm-283	200	20	al	al	PROPN
ajlm-283	200	21	.	.	PUNCT
ajlm-283	201	1	reprint	reprint	PROPN
ajlm-283	201	2	of	of	ADP
ajlm-283	201	3	:	:	PUNCT
ajlm-283	201	4	epidemiological	epidemiological	ADJ
ajlm-283	201	5	serosurvey	serosurvey	NOUN
ajlm-283	201	6	of	of	ADP
ajlm-283	201	7	hepatitis	hepatitis	PROPN
ajlm-283	201	8	b	b	PROPN
ajlm-283	201	9	in	in	ADP
ajlm-283	201	10	china	china	PROPN
ajlm-283	201	11	–	–	PUNCT
ajlm-283	201	12	declining	decline	VERB
ajlm-283	201	13	hbv	hbv	NOUN
ajlm-283	201	14	prevalence	prevalence	NOUN
ajlm-283	201	15	due	due	ADP
ajlm-283	201	16	to	to	ADP
ajlm-283	201	17	hepatitis	hepatitis	PROPN
ajlm-283	201	18	b	b	NOUN
ajlm-283	201	19	vaccination	vaccination	NOUN
ajlm-283	201	20	.	.	PUNCT
ajlm-283	202	1	vaccine	vaccine	NOUN
ajlm-283	202	2	.	.	PUNCT
ajlm-283	203	1	2013;31	2013;31	NUM
ajlm-283	203	2	:	:	PUNCT
ajlm-283	203	3	j21	j21	PROPN
ajlm-283	203	4	–	–	PUNCT
ajlm-283	203	5	j28	j28	NOUN
ajlm-283	203	6	.	.	PUNCT
ajlm-283	204	1	http://dx.doi.org/10.1016/j.vaccine.2013.08.012	http://dx.doi.org/10.1016/j.vaccine.2013.08.012	PROPN